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ABSTRACT 
 
Mycotoxins are naturally occurring toxins produced by moulds which contaminate numerous crops and 
foodstuffs including cereals, nuts and fruits. When consumed, mycotoxins pose a serious threat to both 
human and animal well-being, causing acute poisoning or chronic effects such as immune deficiency 
and cancer. Fusaric acid (FA), a ubiquitous mycotoxin produced by Fusarium species, is a frequent 
contaminate of staple grain-based foods, and is a specific inhibitor of dopamine-β-hydroxylase in 
human and animal hosts, thereby affecting the autonomic nervous system by causing significant 
alterations in catecholamine metabolism. The latter effect is believed to occur through the competitive 
binding of FA with tryptophan to albumin in circulation. Although several studies have reported the 
oral activity of FA in circulation and the nervous system, the immuno- and neurotoxic effects of FA are 
unknown. Therefore, in this study we aimed to investigate the immunotoxic and neurotoxic potential of 
FA, using in vitro human and in vivo murine models. 
 
On a daily basis, protein kinases are required to integrate developmental cues and environmental stimuli 
to decide cell fate (cell death or survival). Thus, alterations to mitogen-activated protein kinases 
(MAPKs) in the immunotoxicity of FA was assessed in vitro on healthy human peripheral blood 
mononuclear cells (PBMCs) and on the human acute monocytic leukemic (Thp-1) cell line at an acute 
exposure (1 day) (Chapter 2); with Thp-1 cells (IC50-107.7 µg/ml) showing a greater susceptibility to 
FA exposure than PBMCs (IC50-240.8 µg/ml). Notably, elevated stress-induced stimuli (increased 
oxidative stress and ATP depletion) activated the pro-apoptotic signalling of phosphorylated-
extracellular signal-regulated kinase (p-ERK), resulting in initiation of intrinsic apoptosis evidenced by 
the decreased phosphorylation of B-cell lymphoma 2 (p-Bcl-2; an anti-apoptotic protein) and 
subsequent activation of caspase-9 and caspase-3/7 activities in Thp-1 cells. In contrast, a caspase-
independent (reduced caspase -8, -9 and -3/7 activities) form of cell death (paraptosis) was induced in 
PBMCs that was possibly mediated by ERK and c-Jun N-terminal kinase (JNK) in response to 
metabolic stress (decreased cellular ATP availability). 
 
The significant ATP depletion in immune cells then led to the assessment of the metabolic effects of 
FA in the brain; since the brain is exposed to the peripheral effects of FA and is a highly metabolic 
organ. Therefore, the next chapter (Chapter 3) investigated the neurometabolic effects of FA via the 
protein kinase B (Akt) and AMP-activated protein kinase (AMPK) signalling pathways (which are 
central regulators of cellular energy and metabolism) in C57BL/6 mice at acute (1 day) and prolonged 
exposure (10 days). Acute exposure to FA, augmented Akt signalling following the increased 
expressions of upstream regulators phosphatidylinositol 3-kinase (PI3K), mammalian target of 
rapamycin (mTOR) and p70 ribosomal S6 protein kinase (p70S6K). Activated Akt inhibited glycogen 
 
 xxiv 
synthase kinase 3 (GSK3) activity with the simultaneous activation of AMPK, p53 phosphorylation and 
reduced glucose transporter (GLUT)-1 and -4 expression, potentially suppressing neuronal glucose 
entry. However, following prolonged exposure, FA dampened PI3K/Akt and AMPK signalling, but 
increased the expression of GLUT transporters (1 and 4) in mice brain. Despite the differential 
regulation of glucose receptors by the PI3K/Akt and AMPK pathways (at acute and prolonged 
exposures), neuronal ATP failed to rise despite the increased pyruvate dehydrogenase E1ß (PDHE1β) 
activity [a regulatory subunit of glycolysis and the tricarboxylic acid cycle (TCA) cycle] at both 1 and 
10 days; suggesting that FA mediates ATP depletion independent of metabolic signalling.  
 
Given the evident neurometabolic disturbances mediated by FA and its importance as a risk factor for 
neurometabolic-related diseases, the next chapter (Chapter 4) investigated the neurotoxic potential of 
FA in C57/BL6 mice following acute (1 day) and prolonged exposures (10 days) and its influence on 
cyclic AMP (cAMP) response element binding (CREB) signalling, an essential transcription factor, 
commonly activated by MAPKs, that is responsible for the brain’s neuroprotective responses through 
the regulation of neurotrophic and metabolic signals in the brain. After an acute administration of FA, 
CREB signalling was enhanced with a simultaneous increase in brain derived neurotrophic factor 
(BDNF) expression; whilst FA suppressed CREB/BDNF signalling following a prolonged exposure. In 
contrast, protein expressions of MAPKs (ERK, JNK and p38) negatively correlated with CREB activity; 
inferring that FA induced MAPK-independent activation of CREB responses. Consistent with caspase 
activation in Thp-1 cells, FA increased caspase activities (8, -9 and -3/7) at 1- and 10 days post-
exposure, although to a lesser extent at a prolonged treatment. However, despite enhanced caspase 
activity, microanalysis of brain tissue showed no prominent histological markers of damage to 
extracellular tissue or neuronal cells. Although FA showed no significant neurotoxicity, alterations in 
glial cell density patterns at both acute and prolonged exposures were observed. Besides the 
neuroprotective roles of CREB/BDNF signalling in the brain, CREB and BDNF are also involved in 
memory development and psychiatric disorders. Therefore, although FA may have not been neurotoxic, 
dysregulation of CREB/BDNF signalling impacts normal brain functions which potentially plays a role 
in the development of neurological disorders with longer periods of exposure. 
 
Collectively, although FA demonstrated significant toxicity towards Thp-1 cells, FA did not display 
cytotoxicity to healthy immune and neuronal cells, suggesting that compromised cellular systems may 
be more vulnerable to the effects of FA. In addition, while FA did alter MAPK, PI3K/Akt, AMPK and 
CREB pathways, which are important regulators of cell survival/death and energy homeostasis, these 
pathways are also involved in several other fundamental cellular processes, including gene expression, 
cell differentiation, inflammation, and synaptic plasticity; thus, modifications to their activities could 
have severe outcomes in health and disease. 
 
 
CHAPTER ONE 
1.1.  Introduction 
 
With a rapidly increasing global population and warming climates that affect the growth of food crops; 
food security and its impact on public health and economic stability is an inevitable concern (Abdallah 
et al. 2018). Regions such as Africa, America, China and India, have emerged as hot spots for climate 
change, providing conditions which are ideal for fungal contamination (Reilly 2007). This has severely 
impacted agricultural sustainability and the quality of agricultural products (Reilly 2007). Fungal 
moulds produce secondary metabolites, known as mycotoxins, that contaminate a large proportion of 
the world’s staple diets including groundnuts, maize, spices, fruits and other essential commodities 
(Misihairabgwi et al. 2019). For many low-income countries, including Africa, these dietary staples are 
frequently contaminated by high mycotoxin concentrations (Abdallah et al. 2018; Misihairabgwi et al. 
2019). Burdened by poverty and a demanding well-stocked food reserve, has increased the demand for 
low cost foodstuff, the use of substandard ingredients (Streit et al. 2012). In developing countries, 
communities are largely unaware of the risks associated with mycotoxin exposure and often follow poor 
harvesting methods, improper storage systems, and inadequate transportation and marketing, that 
contribute to fungal growth and the proliferation of mycotoxins (Shephard 2008). Although exposure 
to mycotoxins occurs mostly through ingestion of contaminated food stuff, human exposure can occur 
via the dermal and inhalation routes during the pre- and post-harvest storage periods; and therefore, 
represents a major threat to human and animal health (Zain 2011). Whilst the extent to which 
mycotoxins affect human health and disease is unclear, mycotoxins which impact human health include 
aflatoxins, ochratoxins (produced by Aspergillus species), trichothecenes, deoxynivalenol, and 
fumonisins (produced by and Fusarium species); and these mycotoxins possess carcinogenic, 
mutagenic, oestrogenic, gastrointestinal, immunotoxic and neurotoxic properties (Freire and da Rocha 
2017; Fung and Clark 2004; Zain 2011).  
 
Most importantly, several Fusarium species are rapidly spreading globally due to their acclimatization 
to environmental changes in various regions arounds the world, increasing their occurrence (Bertero et 
al. 2018). Among the Fusarium metabolites, the mycotoxigenic properties of trichothecenes, 
deoxynivalenol, zearalenone and T2-toxin are well-characterized based on their impact on public health 
(Freire and da Rocha 2017); whilst it is not clear how other Fusarium mycotoxins, such as enniatins, 
moniliformin and FA impact the biological system. Fusaric acid, in particular, has a high prevalence in 
feed and food products worldwide, sometimes at relatively high concentrations, which increases the 
risks of FA exposure via the food chain (Smith and Sousadias 1993; Streit et al. 2013; Swamy et al. 
2002).  
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Primarily described as a plant pathogen, FA exerts its pathogenicity by altering membrane- and 
mitochondrial activity, together with the inhibition of ATP synthesis and metalloenzymes which result 
in apoptotic and necrotic cell death events (López-Díaz et al. 2018; Singh et al. 2017). In animals, acute 
doses of FA have been shown to cause lethargy, vomiting and appetite suppression, whilst significantly 
inhibiting dopamine-ß-hydroxylase activity, altering monoamine tissue levels (Diringer et al. 1982; 
Leung et al. 2007; Osumi et al. 1973); with the latter effect attributing to FA’s pharmacological activity 
in hypertension and behavioural disorders in the human population (Goodwin and Sack 1975; Terasawa 
and Kameyama 1971; Terasawa et al. 1976). More recently, in vitro studies have supported FA’s 
cytotoxic activity on various human cancer cell lines and viral infections, crediting FA with 
antiproliferative and antiviral properties (Elaasser and El Kassas 2013). 
 
Chemically diverse from its Fusarium mycotoxin counterparts, FA is a structural derivative of picolinic 
acid (PA) and contains a butyl functional group that confers its lipophilic nature and enhances its ability 
to cross biological membranes (Kim et al. 2014). Additionally, FA’s physiochemical properties (being 
lipophilic and of low molecular weight) contributes to its biological significance which allows for easy 
passage across the brains’ protective, blood brain barrier (BBB), in order to exert its neurological 
effects. FA also indirectly alters neurological activity due to its effects in peripheral circulation, where 
immune cells are first exposed to its toxicity. In circulation, FA competitively binds to albumin 
preventing the binding of tryptophan, which is then shuttled to the brain and alters the production of 
neurotransmitters via the tryptophan pathway (Chaouloff et al. 1986; Osumi et al. 1973). However, 
despite FA’s ability to directly interact with the immune and nervous systems the exact immuno- and 
neuro-toxicities of FA remain unknown. 
 
The immune system is a diverse network that is divided into two distinct components, the innate and 
adaptive immune systems, comprised of various types of immune cells (lymphoid and myeloid) with 
defence (against foreign particles), surveillance and homeostatic functions (Abbas et al. 2015; Council 
1992). Whilst, the brain is a complex and highly compartmentalized organ that is responsible for 
controlling essential processes such as maintaining heart rate and respiration (brainstem), vision and 
sight (cerebrum), and voluntary movements (cerebellum) (Aloisi 1999; Kolb and Whishaw 2001). The 
reciprocal communication between the immune system and the brain using both humoral and neuronal 
routes of communication for fine-tuning immune (antibody and cytokine production) and nervous 
(appetite, behaviour and thermoregulation) responses is well-established and has recently gained 
significant attention for the role of metabolic and immune dysfunction in psychiatric diseases such as 
Alzheimer’s, dementia and major depressive disorder (Louveau et al. 2015; Russo and McGavern 2015; 
Wilson et al. 2010). This intricate relationship between the immune system and the brain is thought to 
be influenced by a number of signalling pathways. These pathways include major serine threonine 
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kinase proteins MAPK, Akt, AMPK and CREB that regulate inflammatory responses, neurotransmitter 
metabolism, neuroendocrine activity, neural plasticity and alterations of brain circuitry (Walsh et al. 
2015). 
 
The activation (inflammatory response), proliferation, differentiation and survival of immune cells are 
important in directing immunomodulatory responses associated with immune susceptibility and tissue 
homeostasis (Fang et al. 2009). Several studies have shown that the primary regulation of these critical 
immune-behavioural responses, are mediated by the MAPK signalling pathway (Fang et al. 2009). The 
MAPKs are an evolutionary conserved family of serine/threonine protein kinases that are present in 
various cell compartments, including the nucleus, mitochondrion and cell membrane (Jeanneteau and 
Deinhardt 2011; Kim and Choi 2010). Grouped into three major components: ERK, JNK and p38, each 
MAPK signalling axis is activated by a sequential three-step phosphorylation process, notably 
composed of a MAPK kinase kinase (MAP3K), a MAPK kinase (MAP2K), and a MAPK (Jeanneteau 
et al., 2011; Kim et al., 2010). MAPKs modulate the activities of several proteins (by phosphorylation 
of their tyrosine, serine, or threonine amino acids) in response to various stimuli, such as environmental 
stresses (toxins, ionizing radiation, osmotic shock, oxidative stress), inflammatory cytokines and 
growth factors, which alters gene expression, mitosis, metabolism, cell differentiation, cellular stress 
responses and cell death or survival (Schroeter et al. 2002). In addition to their critical roles in key 
cellular activities, including cell fate and inflammation, the MAPK signalling pathways have been 
implicated in the pathogenesis of many inflammatory and neurological human diseases such as 
allergies, hepatitis, rheumatoid arthritis, gliosis, Alzheimer’s and Parkinson’s disease (Schroeter et al. 
2002). 
 
Although the mechanism of FA-induced toxicity has not yet been elucidated, its cytotoxicity has been 
associated with impaired mitochondrial function, decreased cellular energy availability and increased 
oxidative stress. As the brain is exposed to FA activity, these characteristic changes could have a 
significant impact on neuronal vulnerability to stress and may also play a role in the pathogenesis of 
several neurological diseases (Al Shahrani et al. 2017; Butterfield and Halliwell 2019). While MAPKs 
are central regulators of many physiological functions, MAPK proteins collaborate with other signalling 
pathways at several substrate target points to control cellular processes. The PI3K/Akt signalling 
cascade is a major receptor-mediated metabolic pathway closely related to MAPKs and promote cell 
proliferation, survival, nutrient uptake and metabolism (Zhou et al. 2015). Apart from the classical 
activation of receptor tyrosine kinases by growth factors and cytokines, other physiological stresses, 
such as oxidative stress, glucose deprivation, endoplasmic reticulum (ER) stress, and DNA damage 
activate PI3K and its downstream mediators, Akt (a serine/threonine protein kinase) and mTOR (an 
essential kinase required for the full activation of Akt), both key components of the PI3K/Akt signalling 
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cascade (Manning and Toker 2017; Vincent et al. 2011; Zhao et al. 2017). Following activation, Akt 
phosphorylates many target proteins, most notably caspase-9, GSK3, and CREB, which explains its 
involvement in cell proliferation, apoptosis and metabolism (Case et al. 2011; Saxton and Sabatini 
2017). 
 
Another primary effector in response to metabolic stress is the serine/threonine AMPK. Referred to as 
the master regulator of metabolism, AMPK is activated downstream of liver kinase B1 (LKB1) or 
calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2), by low intracellular energy levels 
and promotes metabolic reprogramming to increase glucose transport and ATP generation (Kim et al. 
2016; Mihaylova and Shaw 2011). In addition, AMPK’s activity is negatively regulated by Akt via 
direct phosphorylation or through the downstream effectors, p70S6K and GSK3. While AMPK and Akt 
are antagonistic pathways, they share downstream mediators [such as mTOR and forkhead box O 
(FoxO)] which is important in cell proliferation, survival and metabolism (Richter and Ruderman 2009). 
 
Most of the current molecular knowledge which integrates nutrition, metabolic signalling and neuronal 
survival are orchestrated through the transcription factor, CREB. Activated by numerous growth 
factors, neurotransmitters and stress signals, CREB is a focal substrate of various signal transduction 
pathways, including MAPK and Akt, and has been extensively studied for its transcriptional control of 
cell proliferation, survival, differentiation, adaptive responses, glucose homeostasis, circadian rhythms, 
and synaptic plasticity (Lonze and Ginty 2002; Wang et al. 2018; Wen et al. 2010). Notably, in the 
brain, CREB mediates many of its adaptive (e.g. mitochondrial biogenesis during nutrient starvation) 
and cytoprotective responses through neurotrophic support (Nakazawa et al. 2002). Brain derived 
neurotrophic factor (BDNF) is the most widely investigated neurotrophin associated with CREB 
signalling, whose gene expression is directly regulated by CREB (Luo et al. 2017; Nakazawa et al. 
2002). In addition, extracellular BDNF activates the receptor tropomyosin receptor kinase B (TrkB), 
engaging in downstream CREB signalling by promoting the expression of GLUT-3 (to stimulate 
neuronal energy metabolism), peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
(PGC-1α) (to increase mitochondrial biogenesis) and Bcl-2 (to inhibit apoptotic cell death), either 
directly or indirectly through CREB (Luo et al. 2017; McGregor and English 2018). Accordingly, 
BDNF has been suggested to be critical in numerous neuronal processes, including cell metabolism, 
survival and structure (Wang et al. 2018). 
 
Given that these kinases (MAPK, Akt, AMPK and CREB) collaborate in transmitting signals from 
numerous stimuli to control precise intracellular processes in different subcellular compartments, this 
study aimed to evaluate the toxicity and metabolic effects of FA in lymphoid and myeloid immune cells 
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and the brain using in vitro immune cell culture and in vivo murine models by investigating FA-induced 
alterations to major protein kinase signalling cascades. 
 
1.2.  Literature review 
 
1.2.1. Mycotoxins and human health 
 
The world is currently inhabited by more than 7.6 billion people, with one in nine experiencing chronic 
undernourishment or starvation (Belz 2018). With the world population expected to reach 8.2 billion 
people by the year 2030, food security represents a significant challenge and a global struggle (De 
Laurentiis et al. 2016; Misihairabgwi et al. 2019). As the world confronts more pressing concerns 
relating to climate change, energy expenditure, severe poverty, food demand and the global economy, 
food safety is often neglected and overlooked (Reilly 2007). In continents such as Africa, majority of 
the population are challenged by extreme climates, decreasing amounts of arable land and face hunger 
daily (Abdallah et al. 2018; Misihairabgwi et al. 2019). As a result, maize-based commodities, which 
are easily grown in warmer temperatures, form staple diets and provide sustenance and management of 
hunger in many households (Reilly 2007). However, maize and small grain (wheat, barley and rye) 
crops cultivated in temperate regions (high temperatures and humidity) are prone to fungal colonization 
that produce toxic secondary metabolites, known as mycotoxins (Beukes et al. 2017). In addition to 
environmental factors, poor harvesting methods, improper storage and inadequate transportation of 
produce increases the risk of mycotoxin propagation (Shephard 2008). While exposure to mycotoxins 
most commonly occurs via the ingestion of contaminated foods, exposure can also occur through the 
dermal and inhalation routes (Abdallah et al. 2018; Bertero et al. 2018; Corrier 1991).  
 
Mycotoxins are low molecular weight natural products that are capable of inducing a toxic response at 
low concentrations in animals and humans (Beukes et al. 2017). Globally, approximately 25% of grain 
production is contaminated by mycotoxins which are either destroyed or diverted to animal feed leading 
to agricultural and economic losses (Alshannaq and Yu 2017). Since mycotoxins are highly stable 
compounds, their removal is extremely difficult (even with heat and chemical treatment), which allows 
them to survive food processing methods and potentially form deposits in animal-derived products such 
as milk, meat, and eggs (Hossam 2013; Zain 2011). Therefore, human exposure occurs at various stages 
in the food chain. 
 
Notably, the most significant agricultural mycotoxigenic fungi include Aspergillus, Fusarium, 
and Penicillium, which are known to produce some of the most hazardous toxins such as aflatoxin 
(Aspergillus), ochratoxin A (Aspergillus), fumonisin, trichothecenes (Fusarium) and patulin 
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(Penicillium) which contaminate a large portion of the world's major food sources, including maize, 
cereals, nuts and fruits (Bertero et al. 2018; Zain 2011). Moreover, the effects of these mycotoxins on 
human and animal health are influenced by exposure (dosage and period), nutritional status, exposure 
to infectious diseases or other mycotoxins (synergistic effects); and have been associated with 
hepatotoxic, mutagenic, carcinogenic, oestrogenic and teratogenic properties, as well as, 
gastrointestinal, urogenital, vascular, kidney, immunosuppressive and nervous disorders (Abdallah et 
al. 2018; Freire and da Rocha 2017; Fung and Clark 2004). 
 
Despite the frequent co-existence of these fungal genera, the synthesis of mycotoxins is strongly 
influenced by geographic climate patterns (oxygen level, humidity and temperature) (Liew and Mohd-
Redzwan 2018; Medina et al. 2015). In tropical or subtropical climates, Aspergillus species are the most 
prevalent agricultural contaminate (Paterson and Lima 2017; Perrone et al. 2014). While temperate 
regions of America, Europe and Asia, had the greatest frequency of Fusarium toxins (deoxynivanelol, 
zearalenone, T-2 toxin and fumonisins) (Adegoke and Letuma 2013; Hossam 2013). In developing 
countries, such as those in Africa, that experience warmer conditions, the incidence of fumonisins, 
aflatoxins and ochratoxin A were reported to be the most significant (Abdallah et al. 2018; Beukes et 
al. 2017).  
 
With the increasing frequency Fusarium species worldwide, Fusarium mycotoxins have adapted to 
moderate climates and represent a growing global health concern (Bertero et al. 2018). While 
fumonisins, deoxynivanelol, zearalenone and T-2 toxin are recognized as the most important 
fusariotoxins, recent studies have found the high occurrence of other fusarium toxins, such as enniatins, 
beauvericin, moniliformin, fusaproliferin and FA, in feed and foodstuffs (Gruber-Dorninger et al. 
2016). While many countries have established regulatory limits for known mycotoxins (aflatoxins, 
fumonisins, ochratoxin A, deoxynivalenol and zearalenone), data related to the toxicity of emerging 
mycotoxins are limited, preventing proper regulatory and risk assessments (Panasiuk et al. 2019). 
 
1.2.2. Fusaric acid: A Fusarium metabolite  
 
Fusaric acid, a naturally occurring Fusarium secondary metabolite, was first isolated from Fusarium 
heterosporium as a potent phytotoxin (Devaraja et al. 2013; López-Díaz et al. 2018). Since then, several 
studies have identified the production of FA by a substantial number of fungal species belonging to the 
Fusarium and Giberella genera (Bacon et al. 2006; Misihairabgwi et al. 2019; Streit et al. 2013). 
Subsequently, various investigations have reported the frequent contamination of FA on grain-based 
foods and feeds worldwide (Bacon et al. 2006; Streit et al. 2013). While there are a limited number of 
surveys on the amount of FA produced commercially, FA has been shown to occur naturally in animal 
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feed and cereal grains in cold (14-26 mg/kg) and warm temperate regions (0.643 mg/kg) at 
concentrations exceeding those of deoxynivalenol and zearalenone (Streit et al. 2013; Swamy et al., 
2002). Despite this, FA demonstrates low toxicity to animals when compared to other Fusarium 
mycotoxins; however, FA may have synergistic interactions with co-occurring mycotoxins (Smith and 
Sousadias 1993). Although moderately toxic to animals, FA has been reported to be an effective 
hypotensive agent as a result of neurochemical alterations within human and animal hosts (Terasawa 
and Kameyama 1971; Goodwin and Sack 1975). Notably, the latter effect is similar to the toxicology 
of trichothecenes. 
 
Trichothecenes, such as deoxynivalenol and T-2 toxin, are among the most agriculturally important 
mycotoxins and have been acknowledged for their impact on human health (Sudakin 2003). 
Trichothecenes are ubiquitously produced by certain species of Fusarium, Myrothecium, and 
Stachybotrys fungi that colonise wheat, rye, barley, oats, and other cereals (Shi et al. 2017). Like FA, 
trichothecenes alter the brain neurochemistry, although by a different mechanism to that of FA. Adverse 
effects such as loss of appetite, vomiting, lesions of the intestinal tract, lethargy and ataxia have been 
reported in experimental animals that were fed a trichothecene contaminated diet (Smith and 
MacDonald 1991; Smith and Seddon 1998). In addition to its emetogenic properties, trichothecenes 
have immunomodulatory properties and inhibit protein synthesis at varying degrees; which is likely the 
cause of many of the human pathologies associated with trichothecene toxicosis (Smith and Seddon 
1998; Sudakin 2003). Although FA and trichothecenes are structurally diverse, they share similar 
neurochemical and behavioural effects (Smith and MacDonald 1991). However, it has not yet been 
established if FA displays similar cytotoxic and immunomodulatory effects as trichothecenes in 
humans.  
 
Fusaric acid is a structural derivative of PA also known as 5-butylpicolinic acid (Figure 1.1), with PA 
being produced through the metabolism of L-tryptophan via a sequent side branch of the kynurenine 
pathway (Grant et al. 2009). Picolinic acid has been detected in various biological mediums including, 
blood serum, cerebrospinal fluid (CSF), human milk, pancreatic juice and intestinal homogenates 
(Prodinger et al. 2016). In addition, several investigations have reported the neuroprotective, 
immunological, and anti-proliferative effects of PA (Prodinger et al. 2016). Like FA, PA is an 
amphiphilic chelating agent, extensively studied for its efficient chelating properties of nickel, zinc, 
cadmium, palladium and copper (Prodinger et al. 2016). Due to its potent metal chelating properties, 
PA-metal complexes are now being exploited as a means of introducing bioactive metals into biological 
systems (Prodinger et al. 2016). This evidence demonstrates that FA may possess similar 
pharmacological properties to PA and have widespread biological effects. 
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1.2.2.1. Structural characteristics of Fusaric acid 
 
Fusaric acid comprises of a carboxylic acid moiety linked to a pyridine ring with a butyl group 
which enhances FA’s ability to permeate cytosolic membranes more efficiently than PA 
(Figure 1.1) (Kim et al. 2014). In addition, FA’s biological chelating-activity is believed to be 
mediated by the nitrogen present in the pyridine ring and the deprotonated, negatively charged 
oxygen on the carboxylic acid group (Figure 1.1) (Gutterman 2005; Kwiatkowski et al. 2000). 
 
 
Figure 1.1: Chemical structures of picolinic acid and fusaric acid containing a pyridine ring (red), 
a carboxylic acid (black) and butyl moiety (blue). (Prepared by author) 
 
Although FA has been described as a neurologically active toxin, no studies have shown its 
distribution in the brain. However, according to Lipinski’s “rule of five” (molecular weight, 
lipophilicity, polar surface area, hydrogen bonding, and charge), a molecule with a molecular 
mass less than 500 Da, no more than 5 hydrogen bond donors (-NH-, -OH), 10 or fewer 
hydrogen bond acceptors (-N-, -O-), and an octanol–water partition coefficient, log P not 
greater than 5, has a greater likelihood of permeating the BBB (Lipinski et al. 1997). Notably, 
the low molecular mass (Table 1) and high lipid solubility of FA, likely promotes its passage 
across the lipophilic phospholipid BBB and into the brain (Bacon et al. 2006; Bohni et al. 2016). 
 
 
Table 1: Molecular properties of fusaric acid. (Prepared by author) 
 
Molecule name Molecular formula Molecular mass (Da) 
Fusaric acid C10H13NO2 180.1025 
Da: Dalton 
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1.2.2.2. Pathogenicity of Fusaric acid 
 
1.2.2.2.1. Plants 
 
Among the various plant-pathogenic toxins produced by the genus Fusarium, FA is 
considered the most potent phytotoxin causing significant physiological and 
biochemical dysfunction leading to wilting, necrosis and plant cell death of many 
economically important fruit and grain crops such as tomatoes, bananas, cucumbers, 
corn, rice, wheat, sorghum and barley  (Singh et al. 2017; Singh and Upadhyay 2014). 
Fungi commonly infect their hosts through the roots and clog the xylem vessels with 
their spores, mycelia or metabolites; thereby, restricting the movement of water in the 
vascular bundles leading to plant wilt (López-Díaz et al. 2018; Singh et al. 2017). The 
fungal metabolite FA, then induces mitochondrial dysfunction, inhibits respiration and 
lowers intracellular ATP levels which stimulates the production of reactive oxygen 
species (ROS) (Pavlovkin et al. 2004; Singh et al. 2017; Singh and Upadhyay 2014). 
The toxin further inhibits anti-oxidative enzymes, such as superoxide dismutase (SOD) 
and catalase (CAT), as well as metal containing enzymes, contributing to respiratory 
dysfunction, lipid peroxidation, increased electrolyte leakage, and fluctuations in the 
electrochemical gradients across the plasma membrane (Li et al. 2013; Singh and 
Upadhyay 2014). As a result, this leads to membrane hyperpolarisation and changes to 
the membrane permeability which consequently leads to a reduction in root growth 
(Wang et al. 2015). Additionally, FA is transported to the leaves from the xylem 
vessels, reducing chlorophyll synthesis along the veins of leaves that result in decreased 
photosynthesis, disruption of cellular permeability and dysfunction in transpiration 
(Pavlovkin et al. 2004; Singh et al. 2017). These biological events rapidly lead to leaf 
epinasty, wilting, necrosis, browning and plant death (Kim and Choi 2010; Pavlovkin 
et al. 2004; Singh et al. 2017). While most studies have reported the toxic effects of FA 
at concentrations greater than 10-5 M (apoptosis at 50-100 µM; necrosis at  >200 µM), 
FA produced by non-pathogenic Fusaria at non-toxic concentrations (below 10-6 M) 
were found to activate signal transduction components essential for plant defence 
responses that contribute to the biological control against pathogens (Singh et al. 2017; 
Singh and Upadhyay 2014). 
 
1.2.2.2.2. Animals 
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Despite its high pathogenicity towards plants, FA has been reported to be only mildly 
toxic in animals fed a FA-contaminated diet (plant and grain-based feedstuff), with 
several important pharmacological activities, including cardiovascular and 
neurological effects (Bacon et al. 1996). These effects are influenced by the inhibitory 
effect of FA on dopamine-ß-hydroxylase in the synthesis of catecholamine (dopamine, 
norepinephrine and epinephrine) metabolism (Terasawa and Kameyama 1971). Early 
investigations in the 1960’s, found that FA was an effective, specific inhibitor of 
dopamine-ß-hydroxylase (a key enzyme responsible for converting dopamine into 
norepinephrine which is important for memory and stress responses), and had 
significant hypotensive effects in acute animal studies (rabbits and dogs), which was 
possibly attributed to decreased peripheral vascular resistance (through the action of 
adrenergic receptors) and peripheral arteriolar dilation  (Hidaka et al. 1969; Terasawa 
and Kameyama 1971). Additionally, with FA being a physiological metabolite of 
tryptophan (an amino acid bound to albumin in circulation), Chaouloff et al. (1986) 
discovered its ability to compete with tryptophan for albumin binding sites, thereby, 
displacing tryptophan and elevating its circulating levels, which is subsequently 
shuttled across the blood brain barrier to promote serotonin synthesis.  
 
Due to FA’s discovery as a potent dopamine-ß-hydroxylase inhibitor, investigations by 
(Haycock et al. 1978; 1977) determined the effect FA-induced catecholamine 
alterations on memory retention in rats and mice, reporting reduced norepinephrine and 
epinephrine concentrations in both animal models. Despite decreased catecholamine 
levels correlating with deficits in retention performance in rats, FA administration did 
not affect the memory in mice. Consistent with its inhibitory effect on dopamine-ß-
hydroxylase, several other studies have observed significant increases in serotonin, 5-
hydroxyindoleacetic acid (a major metabolite of serotonin), dopamine and tyrosine 
levels with FA in animals; and was also found to have partial inhibitory effects on 
tyrosine-hydroxylase (Chaouloff et al. 1986; Diringer et al. 1982; Porter et al. 1995). 
Additionally, the modulatory effect of central catecholamines on animal aggression and 
motor activity were reportedly decreased at acute doses of FA (mice: 10-75 mg/kg; 
rat:11-99 mg/kg) (Diringer et al. 1982; Ross and ÖGren 1976; Svensson and Waldeck 
1969).  
 
While acute doses of FA have shown therapeutic effects in rats and mice, in swine FA 
caused vomiting and lethargy at acute doses (200 mg/kg) with simultaneous elevations 
in tryptophan, serotonin, and 5-hydroxyindoleacetic acid concentrations (Smith and 
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Sousadias 1993). In dogs, acute administration of FA (20 mg/kg daily via the 
intramuscular or oral route) displayed no toxic effects on physical and mental activity, 
body weight, water and food consumption, urinalysis, haematology analysis and 
auditory function over a 6-month period, with the exception of emesis in some dogs 
orally dosed (Terasawa and Kameyama 1971). Histological analysis of various organs 
further showed no significant differences in cellular morphology with FA-treatment. In 
large doses (125 mg/kg), however, FA caused nausea, loss of appetite, retardation of 
physical and mental activity, decreases in body weight, gastric and/or duodenal ulcers 
and slight impairments of some liver functions; which appeared together with its 
hypotensive activity (Terasawa and Kameyama 1971). In contrast, in poultry FA 
administration had no effects on feed intake, body weight and frontal cortex mass in 
animals fed doses between 300-400 mg.kg (Ogunbo et al. 2005); but reduced the cell-
mediated cutaneous activation of T lymphocytes between 14-27 µg/g concentrations in 
a natural feeding blend (Swamy et al. 2002). Whilst FA has many pharmacological 
activities, at high doses FA has been reported to be lethal in several animals (rats: LD50 
>210 mg/kg; mice: LD50 >75 mg/kg; rabbit: LD50 >150 mg/kg) (Matsuzaki et al. 1976).  
 
Notably, a study by Porter et al. (1996), reported the lactational transmission of FA 
from the feed of nursing dams to their offspring and observed reduced pineal serotonin 
and tyrosine levels with restricted weight gain in the neonates. A more recent study by 
Yin et al. (2015) described the teratogenic properties of FA in zebra fish, in which FA 
induced undulated notochord phenotypes at concentrations between 110-600 µM, that 
caused abnormal curvature of the spine. Moreover, embryos at early stages post-
fertilisation showed a greater sensitivity to low concentrations of FA. Whilst, 
concentrations above 600 µM resulted in necrosis or death of the embryo. These effects 
were suggested to be caused by the chelation of copper from the active site of lysyl 
oxidase, an enzyme important for normal respiratory function, wound healing, and 
ovulation (Yin et al. 2015). On the other hand, other studies have shown that oral 
administration of FA (1 mg/mL) slows the progression of squamous cell carcinoma 
xenografts in Balb/C mice and decreases cardiac fibrosis in vivo by altering 
transforming growth factor ß-1 (TGFß-1)/SMAD, MAPK and P13K/Akt signalling 
cascades (Li et al. 2017). 
 
In addition, studies have suggested that FA may have synergistic interactions with other 
naturally occurring mycotoxins. In a study on broilers fed a naturally contaminated diet 
containing Fusarium mycotoxin (FA, deoxynivalenol and zearalenone), erythrocyte 
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numbers and serum uric acid concentrations were elevated while decreasing serum 
lipase activity (Swamy et al. 2002). While another study demonstrated no synergistic, 
additive or antagonistic effects of FA on the sub-chronic toxicity of fumonisin in rats 
(Voss et al. 1999).  
 
1.2.2.2.3. Clinical  
 
Guided by in vivo animal studies, initial clinical investigations have focused on FA as 
an active inhibitor of dopamine-ß-hydroxylase in the management of hypertension and 
psychopathological disorders (mania and depression). Consistent with preclinical 
animal trials, a preliminary study on elderly hypertensive patients using a FA calcium 
salt showed a hypotensive response in both hypertensive and normotensive patients, 
despite the simultaneous administration or absence of other antihypertensive agents 
(Terasawa and Kameyama 1971). Notably, the hypotensive response of FA in 
normotensive patients was minor compared to its depressive effects in hypertensive 
patients during the 6-month trial (Terasawa and Kameyama 1971). This outcome was 
confirmed in a subsequent trial on elderly hypertensive patients over a period of two 
years, which incited FA as a hypotensive drug in the treatment of hypertension 
(Terasawa et al. 1976). A study by Matta and Wooten (1973) described the rapid 
reduction of plasma dopamine-ß-hydroxylase activity after 30 minutes in patients with 
Parkinson's disease or Huntington's chorea, with almost complete inhibition at 2.5 
hours (hrs) post-administration (a single oral dose of 200 mg FA), proving that FA was 
rapidly absorbed from the gastrointestinal tract. In addition, a reduction in the arterial 
pressure in the patients was observed, even at 10 hours post-withdrawal of FA 
treatment (Matta and Wooten 1973).  
 
Several studies have investigated the behavioural effects of FA on psychopathological 
disorders. While FA showed slight improvements in patients with mild hypo-manic 
symptoms, patients with severe manic symptoms or with evidence of pre-existing 
psychotic features became consistently worse (Sack and Goodwin 1974). In 
conjunction with the exacerbation of manic symptomatology, homovanillic acid (HVA, 
metabolite of dopamine), and 3-methoxy-4-hydroxy-phenylglycol (MHPG, metabolite 
of norepinephrine), were increased and decreased in the CSF, respectively, suggesting 
that brain dopamine levels had risen with norepinephrine levels falling as a result of 
FA treatment (Sack and Goodwin 1974). On the basis of these findings, Sack and 
Goodwin (1974) concluded that the improvement of mania was related more to a 
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reduction in dopamine than to alterations to norepinephrine levels. These effects were 
further substantiated by Goodwin and Sack (1975) who observed changes in central 
amine metabolism in the cerebrospinal fluid; specifically, reduced MHPG and 
increased HVA levels in psychiatric patients following administration of FA. 
Additionally, 5-hydroxy-indoleacetic acid levels were slightly elevated in the 
cerebrospinal fluid, indicating increased serotonin turnover as a result of increased 
brain tryptophan concentrations (Goodwin and Sack 1975). In contrast, treatment with 
FA in patients with parkinsonism, showed neither improvement or worsening of the 
condition; although, involuntary adventitious movements in the patients were 
significantly reduced (Mena and Cotzias 1971). However, the sustained effects of FA 
following withdrawal was inconsistent amongst subjects. Despite FA’s promising 
pharmacological activity, it was eventually abandoned due to its significant 
hepatotoxicity (Murphy 2000). 
 
In addition to the cardiovascular and neurological effects of FA, a study by Yoshimura 
et al. (1977) investigated the effect of FA calcium salts on the release of thyroid 
hormones [triiodothyronine (T3) and thyroxine (T4)], responsible for regulating body 
temperature, heart rate and metabolism, in patients with hypertension and primary 
hypothyroidism. While the study did not measure the physiological parameters (body 
temperature, heart rate and metabolism), FA significantly reduced elevated basal serum 
thyroid stimulating hormone (TSH) (which acts on the thyroid gland to produce T3 and 
T4) levels in patients suffering from hypothyroidism, with no changes to T3 and T4 
serum concentrations in healthy and hypertensive subjects; suggesting that FA has the 
ability to improve endocrine function in hypothyroidic individuals. 
 
1.2.2.2.4. In vitro 
 
In vitro studies have demonstrated that FA effectively inhibits 50% of dopamine-ß-
hydroxylase activity at a concentration of 23 ng/ml and approximated the biological 
half-life of FA to be 12 hrs. While several studies were centred around FA’s 
cardiovascular and psychiatric activity, Devaraja and colleagues (2013) investigated 
FA’s effects on blood coagulation and showed that at low concentrations (10-50 ng) 
FA promoted clotting, whilst functioning as an anti-coagulant at concentrations above 
100 ng. In addition to its circulatory effects, FA (5x10-4 mol/L) reduced the synthesis 
of norepinephrine in circulating human lymphocytes with implications on lymphocyte 
activity (Musso et al. 1996). 
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Despite failed efforts into the development of FA as a hypotensive or anti-depressant 
drug; in recent years, a handful of studies have investigated FA’s anti-cancer and anti-
viral potential. Notably, at low concentrations FA exhibited significant cytotoxicity 
against several malignant cell lines, including human breast carcinoma (MCF-7, IC50: 
15 µg/ml), human colon carcinoma (HCT- 117, IC50: 14 µg/ml), human epidermoid 
larynx carcinoma (HEp-2, IC50: 4.4 µg/ml) and human hepatocellular carcinoma 
(HepG2, IC50: 24 µg/ml) (Elaasser and El Kassas 2013). Similarly, Mamur et al. (2018) 
reported cytotoxic and genotoxic effects of FA in human cervical carcinoma (HeLa) 
cells, evidenced by the decreased viability (IC50: 200 µg/ml) and mitotic index, albeit 
at much higher concentrations. Mamur and colleagues (2018) also evaluated the 
toxicity of FA in healthy human lymphocytes; and observed cytotoxicity at 
concentrations ranging from 25-400 µg/ml in healthy human lymphocytes, with no 
accompanying genotoxic effects. Likewise, another study demonstrated the enhanced 
anti-proliferative effectiveness of FA (0.1, 0.3 and 0.5 mM) in UM-SCC-1 cells [a 
human head and neck squamous cell carcinoma (HNSCC) cell line] when co-
administered with chemotherapeutic drugs, paclitaxel and carboplatin (Jaglowski and 
Stack Jr 2006).  
 
While the exact mechanism of FA’s cytotoxicity in mammalian cells remains unclear, 
a study by Devnarain et al. (2017) revealed the induction of intrinsic and extrinsic 
apoptosis in human oesophageal epithelial carcinoma (SNO) cells by FA at an IC50 of 
78.81 µg/ml. The genotoxic properties of FA were further demonstrated by Devnarain 
et al. (2017) who showed an increase in DNA damage markers (comet tail length and 
PARP-1 protein expression). Similar to plants, FA increased oxidative stress (ROS) 
and induced membrane damage whilst reducing anti-oxidant activity and ATP 
availability in SNO cells (Devnarain et al. 2017). Subsequently, Abdul and colleagues 
(2016) confirmed the mitochondrial toxicity of FA in the HepG2 cell line (IC50: 104 
µg/ml) with significant reductions to cellular ATP levels. Despite the evident increased 
metabolic stress, FA decreased mitochondrial biogenetic protein expressions of PGC-
1α, p-CREB, nuclear respiratory factor 1 (Nrf1) and heat shock protein 70 (HSP70). 
This led to an increased production of ROS, which up-regulated the anti-oxidant 
response protein nuclear respiratory factor 2 (Nrf2). However, exposure to FA induced 
both apoptosis (increased activity of caspases-3/7) and necrosis in HepG2 cells (Abdul 
et al. 2016). Coupled with the mitochondrial dysfunction induced by FA, Abdul et al. 
(2019) assessed the cytoprotective potential of anti-oxidant proteins and its association 
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with inflammatory responses in HepG2 cells. Although oxidative stress can stimulate 
an inflammatory response, FA suppressed the priming of the pro-inflammatory 
cytokine, interleukin-1ß (IL-1β), suggesting the immunosuppressive potential of FA 
(Abdul et al. 2019). Concurrently, the activation of anti-oxidant transcription factors 
maintained mitochondrial homeostasis by the autophagic removal of damaged 
mitochondrion (Abdul et al. 2019). 
 
In plants, FA is thought to be active by increasing DNA damage and preventing DNA 
synthesis and repair mechanisms. Recently, Ghazi et al. (2017) demonstrated the 
effects of FA on DNA integrity and the post-translational regulation of the stress 
activated tumour suppressor protein, p53, in HepG2 cells; and found that FA activated 
p53 in response to DNA damage, despite the inverse correlation of p53 post-
translational regulator proteins, which lead to the induction of apoptosis in the 
cancerous cell line. Further investigations by Ghazi et al. (2019) showed decreased 
levels of DNA methyltransferases, which act to suppress the gene expressions of 
several proliferative, apoptotic and cell cycle proteins, including p53. These epigenetic 
modifications were shown to be mediated by the up-regulation of microRNA-29b (a 
post-transcriptional regulator of DNA methyltransferases) (Ghazi et al. 2019).     
 
In addition to FA’s cytotoxic potential, a preliminary report FA (12 µg/ml) displayed 
potent anti-viral activity against herpes simplex virus type 1 (HSV-1) when compared 
to the anti-viral drug, acyclovir (1.8 µg/ml) (Elaasser and El Kassas 2013). However, 
at a lower concentration of 10 µg/ml, FA showed no inhibitory effect against herpes 
simplex virus-1 (HSV-1) and herpes simplex virus-2 (HSV-2). Notably, in combination 
with acyclovir, FA improved acyclovir’s anti-viral activity against HSV-1 and HSV-2 
(Elaasser and El Kassas 2013). 
 
1.2.3. Relationship between the brain and immune system 
 
1.2.3.1. Immune system: structure and function 
 
The immune system is one of the most vital components of the body and is the main defence 
system against foreign materials and biologic agents such as bacteria, viruses, toxins, foreign 
cells and tissues. The immune system can be divided into two distinct, yet integrated systems. 
These include the innate and adaptive immune systems (Figure 1.2) (Abbas et al. 2015). The 
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innate immune system is activated in response to pathogen entry, or upon recognition of injured 
or cancerous cells; and its defence mechanisms are characterized by a generic response with no 
long-term memory (Abbas et al. 2015). The adaptive immune system is highly specific and 
requires antigen presentation to distinguish between self and non-self (Abbas et al. 2015). The 
efficacy of the adaptive immune system is due to its immunological memory (Abbas et al. 
2015). In order to perform its functions properly, these responses are mediated by specific cell 
types that either enhance or suppress extrinsic and intrinsic signals. 
 
The immune system contains a diverse population of cells that remain in a latent or inactive 
state. However, upon infection, inflammation or other perturbations, these cells become 
activated and rapidly respond to the site of infection. Immune cell types of the innate and 
adaptive immune systems are derived from the thymus (T) or bone marrow (B) (Abbas et al. 
2015; Council 1992). The thymus is responsible for the maturation of T lymphocytes, the cells 
developed from here are referred to as the lymphoid lineage (Abbas et al. 2015; Council 1992). 
While, the bone marrow gives rise to the myeloid lineage and includes erythrocytes, platelets, 
granulocytes, B lymphocytes, monocytes, and macrophages (Figure 1.2) (Abbas et al. 2015; 
Council 1992). A central component of immune functions includes the circulatory and 
lymphatic systems where lymphocytes, facilitated by other white blood cells, namely, 
neutrophils, monocytes, macrophages, eosinophils, and basophils, circulate in and out of tissues 
to maintain tissue and whole-body homeostasis (Abbas et al. 2015). 
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Figure 1.2: Cellular interactions involved in eliciting an immune response. (Prepared by author) 
(Adapted from Dranoff 2004) 
 
1.2.3.2. Brain: structure and function 
 
The human brain is a highly complex and compartmentalized organ that is responsible for 
maintaining essential physiological functions as well as processing and interpreting stimuli 
from the external environment. Its basic functions include controlling respiration, heart rate, 
memory, learning, vision hearing and movement amongst others (Ackerman 1992). The basic 
structure of the brain is composed of three primary areas, the cerebrum, cerebellum and the 
brain stem with each part being unique in its structure and functions (Kolb and Whishaw 2001) 
(Figure 1.3). 
 
The cerebrum is the largest part of the brain and is made up of the left and right hemispheres 
which are responsible for higher functions such as vision, hearing, speech, reasoning and 
emotions. The cerebellum’s main functions are related to posture, balance and the coordination 
of muscle movements (Kolb and Whishaw 2001). While the brainstem serves as a connection 
between the spinal cord and the brain, thereby controlling autonomic activities such as heart 
rate, breathing, body temperature, wake and sleep, and digestion (Kolb and Whishaw 2001). 
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Within the brain there also exists a number of specialized structures such as the thalamus and 
hypothalamus which are found below the cerebral cortex which act as a relay station for sensory 
inputs and a point of convergence between the endocrine and nervous systems, respectively 
(Funk et al. 2012). In addition, the hypothalamus plays an essential role in controlling the 
release of hormones, appetite, body temperature and physiological cycles (Aloisi 1999). The 
corpus callosum connects the left and right cerebral hemispheres. While the pons and the 
medulla, the two major components of the brainstem, controls vital functions and voluntary 
movements (Ackerman 1992) (Figure 1.3).  
 
The different areas of the brain are made up of two cell types, neurons and glial cells. The glial 
cells are further divided into i) astrocytes – which have various roles as the caretaker cells, 
regulators of the BBB, maintaining homeostasis, nerve cell repair and scar formation ii) 
oligodendrocytes – secrete myelin that insulates nerve cells to allow for impulse transduction 
iii) ependymal cells – which secrete CSF and iv) microglia – which are resident immune cells 
of the brain, and are responsible for removing debris from the brain (Abbott et al. 2010). 
 
 
 
Figure 1.3: Schematic depicting the major structures of the brain. (Prepared by author) (Adapted 
from Ackerman 1992) 
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For decades the brain was considered to be an “immune privileged organ” protected from 
aggressive immunological responses (Aloisi 1999; Ousman and Kubes 2012). This was 
attributed to the BBB that protected the brain from various pathogens that could enter through 
the circulatory system, thus implying that there was no need for the immune system to be 
present in the brain (Aloisi 1999; Ousman and Kubes 2012). Additionally, in response to 
foreign bacteria, viruses, tumours, and transplant tissue, the immune system becomes active 
targeting pathogens, compromised cells and foreign tissue for destruction; it was believed that 
the BBB protects the brain from this hostile immunological response (Aloisi 1999; Ousman 
and Kubes 2012). 
 
Therefore, the central nervous system was seen as existing separately from the peripheral 
immune system, left to wield its own less aggressive immune defences (Aloisi 1999; Ousman 
and Kubes 2012). An example of this was demonstrated in a study in which foreign tissue was 
grafted into most parts of the body and resulted in an immunologic attack; whilst tissue grafted 
into the central nervous system sparked a far less hostile response (Carson et al. 2006); which 
had suggested that the brain possessed its own complex immune response to foreign bodies. 
 
Efficient immune surveillance and tissue repair within the central nervous system (CNS) are 
achieved through a complex and highly regulated network of interactions between resident 
brain cells and the immune system (Ousman and Kubes 2012; Russo and McGavern 2015) 
(Figure 1.4). Due to its unique structure and environment, the CNS exerts strict control on the 
development of inflammatory and immune reactions that can be extremely injurious to the brain 
(Ousman and Kubes 2012; Russo and McGavern 2015). Major features that contribute to the 
immune privilege of the CNS include: the presence of structural barriers such as the tight 
endothelial junctions of the brain vasculature restricting the passage of circulating immune cells 
and molecules; the belief that the brain lacks a lymphatic drainage system and the absence of 
potent antigen presenting cells (APC) such as dendritic cells that capture potential antigens in 
the tissues and transport them to regional lymph nodes to initiate immune responses (Ousman 
and Kubes 2012; Russo and McGavern 2015).  
 
In order to achieve immunity, the brain is routinely patrolled by blood-borne lymphocytes and 
that antigens within the brain can be carried, through the lymphatics, into the periphery (Russo 
and McGavern 2015; Tamura et al. 2019) (Figure 1.4). To protect this vital system, the healthy 
brain and spinal cord are under continual immune surveillance to detect and eliminate potential 
mediators of infection and damage (Russo and McGavern 2015; Tamura et al. 2019). Both 
resident microglia and immune cells from the general circulation function as primary guardians 
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of the CNS, and their sentinel duties contribute to the maintenance of homeostasis and thus 
optimal functioning of the brain and spinal cord (Russo and McGavern 2015; Tamura et al. 
2019) (Figure 1.4).  
 
Previously, the brain was believed to lack a lymphatic system. Lymphatic vessels return 
intracellular fluid to the bloodstream while lymph nodes – stationed periodically along the 
vessel network – serve as storehouses for immune cells (Tamura et al. 2019; Wilson et al. 2010) 
(Figure 1.4). In most parts of the body, antigens are presented to white blood cells in our lymph 
nodes causing an immune response. But it was assumed that this doesn’t occur in the brain 
given its lack of lymphatic structures (Tamura et al. 2019; Wilson et al. 2010). However, a 
recent study by Louveau and colleagues (Louveau et al. 2015) caused a shift in this paradigm 
when they discovered the presence of a meningeal lymphatic network in the central nervous 
system of mice that was responsible for shuttling fluid and immune cells from the CSF to a 
group of lymph nodes in the neck. Another study by Walsh et al., (2015) provided further 
evidence of a unique CNS immune system that showed peripheral T cell–derived interleukin-4 
(IL-4) protects and induces recovery of injured neurons by activation of neuronal IL-4 
receptors, which potentiated neurotrophin signalling via the Akt and MAPK pathways.  
 
Experimental and clinical evidence has now described the close association between the 
immune and nervous systems, and their influence on each other’s function via morphological 
and molecular-mediated communication (Kioussis and Pachnis 2009). Accordingly, the 
nervous system influences immune function by the direct innervation of lymphoid organs that 
allow the immune system to recruit local neuronal elements for fine tuning of immune 
responses (Dantzer 2017; Jeon and Kim 2016). In addition, the secretion of neurotransmitters 
(e.g., epinephrine, norepinephrine and serotonin) and circulating hormones produced by the 
neuroendocrine system (e.g., cortisol, growth hormone and prolactin) regulate immune activity 
and cytokine balance (Jeon and Kim 2016). Reciprocally, peripheral immune cells secrete 
numerous cytokines that regulate synaptic plasticity, neuroendocrine function and 
neurotransmitter metabolism in the brain, which impacts appetite, sleep and body temperature 
(Dantzer 2017). Notably, several studies have linked alterations between the brain and 
peripheral immune system communication with the development of neuropsychiatric disorders 
and immune-mediated pathogenic infections (Baganz and Blakely 2012; Kempuraj et al. 2017; 
Misiak et al. 2019). 
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Figure 1.4: Anatomical and cellular interactions between the central and immune systems. 
(Prepared by author) (Adapted from Smith et al. 2014) 
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1.2.4. Kinase signalling 
 
Although the bi-directional interaction between the immune and nervous system is complex, significant 
evidence have shown the profound influence of aberrant protein kinase signalling on peripheral immune 
responses and neurological behaviour with the onset and progression of immuno- and neuropathological 
conditions (Jeanneteau and Deinhardt 2011; Schroeter et al. 2002; Zhao et al. 2017).  
 
1.2.4.1. Activation of Mitogen-Activated Protein Kinase (MAPK) 
 
Mitogen-activated protein kinases are serine-threonine kinases ubiquitously expressed in all 
tissues including the central nervous and immune systems. MAPK signal transduction 
integrates a wide range of extracellular signals (e.g. osmotic stress, radiation, neurotrophins, 
cytokines and neurotransmitters) to initiate several precise intracellular programs including cell 
proliferation, differentiation, cell survival/death, inflammation, metabolism and synaptic 
plasticity (Jeanneteau and Deinhardt 2011; Kim and Choi 2010). The diversity and specificity 
of MAPKs’ biological functions are orchestrated through three sequential phosphorylation 
events consisting of a MAP3K, a MAP2K, and a MAPK (Jeanneteau and Deinhardt 2011; Kim 
and Choi 2010). Three distinct groups of MAPKs are extensively studied, these include the 
ERKs (isoforms: ERK1-ERK8), the JNKs (isoforms: JNK1-JNK3) and the p38 (isoforms: α, -
β, -γ, and -δ) MAPKs (Jeanneteau and Deinhardt 2011). Commonly, activation of ERK 
integrates survival programs induced by growth factors, cytokines, osmotic stress and 
microtubule disorganization; whilst, JNK and p38 [also known as stress-activated protein 
kinases (SAPKs)] respond to oxidative stress, hypoxia and inflammatory cytokines amongst 
others (Jeanneteau and Deinhardt 2011; Kim and Choi 2010). For full activation of MAPKs, 
phosphorylation of threonine-X-tyrosine motifs by MAP2Ks are required [ERK: MAP/ERK 
kinase 1/2 (MEK1/2); JNK: mitogen-activated protein kinase kinase 4 (MKK4), mitogen-
activated protein kinase kinase 7 (MKK7); p38: mitogen-activated protein kinase kinase 3 
(MKK3), mitogen-activated protein kinase kinase 6 (MKK6)] (Jeanneteau and Deinhardt 2011; 
Kim and Choi 2010). In turn, MAP2Ks are phosphorylated and activated by MAP3Ks, which 
are the serine/threonine kinases, [ERK: A-Raf, B-Raf, C-Raf, G protein coupled receptors 
(GPCRs); JNK: MAPK/ERK kinase kinase 1 (MEKK1), apoptosis signal-regulating kinase 1 
(ASK1), mixed-lineage kinase (MLK), transforming growth factor ß-activated kinase 1 
(TAK1); p38: ASK1, TAK1] (Jeanneteau and Deinhardt 2011; Kim and Choi 2010; Schroeter 
et al. 2002). Once activated, MAPKs modulate various transcription factor-associated activities 
found in the nucleus, cytoplasm, mitochondria, Golgi apparatus, and the ER, including those of 
CREB, p53, c-Jun, ribosomal s6 kinase ½ (RSK1/2), signal transducer and activator of 
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transcription 3 (STAT3), c-Myc, activator protein 1 (AP-1), mitogen-and-stress-activated 
kinase 1/2 (MSK1/2), nuclear factor-kappa B (NF-!B), Tau, etc. (Figure 1.5) (Funk et al. 2012; 
Jeanneteau and Deinhardt 2011; Schroeter et al. 2002). 
 
 
 
 
Figure 1.5: Mechanism of MAPK activation and downstream targets responsible for MAPK 
signalling functions. (Prepared by author) 
 
1.2.4.1.1. The role of MAPK signalling in cell survival and apoptosis 
 
Over the past decades, several studies have investigated ERK survival mechanisms and 
demonstrated the inhibition of apoptosis by post-translational phosphorylation of 
apoptotic regulatory molecules such as Bad, Bim, Mcl-1, caspase-9 and Bcl-2 (Mebratu 
and Tesfaigzi 2009; Wada and Penninger 2004). In myeloid progenitor cells, ERK 
directly phosphorylated transcription factors such as Elk1, CREB and Fos and 
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promoted the transcription of certain genes, such as interleukin-3 (IL-3), that stimulated 
the growth and survival of early myeloid progenitor cells (Chang et al. 2003). 
Furthermore, neuronal apoptosis was reported in neonate mice following the 
suppression of ERK activity by the MAP/ERK kinase 1/2 (MEK1/2) inhibitor, SL327 
(Thei et al. 2018). In addition, impaired memory and social behavior deficits were also 
observed by the preventative phosphorylation of ERK in the developing mice (Thei et 
al. 2018).  
 
Likewise, JNK has been extensively studied in mice genetic models for its contribution 
to cell fate and has been reported to be a central activator of transcription factors (c-
Jun, ATF2, Elk-1, p53, and c-Myc) and non-transcription factors such as Bcl-2 and 
Bcl-xL involved in cell death and survival (Guma and Firestein 2012). In adult mice, 
the genetic deletion of JNK resulted in increased resistance to CD3-induced apoptosis 
in CD4+ splenic and thymocyte cells (Rincón et al. 1998). Similarly, JNK deficient 
mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (a 
neurotoxin) prevented neurodegeneration of brain tissue (Jiao et al. 2015; Youdim and 
Arraf 2004). Moreover, multiple studies with antioxidant and anti-inflammatory 
compounds have also shown the neuroprotective roles of JNK inhibition against MPTP 
and 6-hydroxydopamine (6-OHDA) (a neurotoxin that selectively destroy 
dopaminergic and noradrenergic neurons) Parkinson’s induced models (Duty and 
Jenner 2011; Pérez-Hernández et al. 2016). 
 
p38 signalling pathways are involved in a variety of cellular responses, and the 
outcomes of these responses are varied and complicated. Similar to JNK pathways, the 
involvement of p38 in apoptosis is also diverse (Wada and Penninger 2004). While 
several studies have implicated p38 in promoting cell death by the phosphorylation of 
Bcl-2 family members, other studies have shown its role in enhancing survival, cell 
growth, and differentiation (Mathew Loesch 2008; Munshi and Ramesh 2013). This 
was demonstrated in CD4+ T cells in which initiation of apoptosis by T cell receptor 
(TCR) stimulation was prevented upon p38 inhibition with SB203580 (Merritt et al. 
2000). In contrast, other studies have reported the execution of apoptosis by antigen 
receptors despite the suppression of p38 activity with SB203580 (Deschesnes et al. 
2001; Wada and Penninger 2004). Moreover, in vitro and in vivo studies with 
neurotoxins such as rotenone (an inhibitor of the mitochondrial complex I) and 
montelukas (a leukotriene inhibitor) induced the degeneration of glial cells through the 
activation of p38, p53 and Bax (Bohush et al. 2018; Mansour et al. 2018; Sharma and 
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Ebadi 2014). These data therefore indicate that the p38-MAPK pathway is required for 
apoptosis and survival depending on cell types and conditions. 
 
Additionally, the collective contribution of each MAPK family member to cell death 
was investigated in PC-12 pheochromocytoma cells treated with nerve growth factor 
(NGF) (Le-Niculescu et al. 1999). Withdrawal of NGF led to the sustained activation 
of JNK and p38 and inhibition of ERK which resulted in cell death (Le-Niculescu et 
al. 1999). These results suggest further establish ERK as a survival factor, and JNK and 
p38 as key components for the execution of cell death. 
 
1.2.4.2. Activation of Protein kinase B (Akt) and Adenosine 5′ monophosphate-activated 
protein kinase (AMPK) 
  
An extensive body of literature have demonstrated numerous intracellular signalling cascades 
linked with MAPK pathways (Zhou et al. 2015). The MAPK and PI3K/ Akt signalling 
pathways converge at several points making them the major serine/threonine kinases implicated 
in cellular dynamics (survival, metabolism, differentiation, plasticity, etc.) (Zhou et al. 2015). 
Like MAPKs, the PI3K/Akt pathway is controlled by a multistep process. PI3K, a lipid kinase, 
acts downstream of receptor tyrosine kinases (RTKs) and GPCRs (activated by numerous 
growth factors and cytokines), and generates the phospholipid phosphatidylinositol-3-
Phosphate (PI3P3) (Grozinsky-Glasberg et al. 2008; Vincent et al. 2011; Yang et al. 2012; Zhao 
et al. 2017). In turn, the serine-threonine kinase, Akt (isoforms: Akt1-3), binds to PI3P3 
allowing phosphoinositide-dependent kinase-1 (PDK1) access to phosphorylate Akt’s 
threonine-308 (T308) residue leading to the partial activation of Akt (Manning and Toker 
2017). For full activation of Akt, a second phosphorylation at serine-473 (S473) by 
hydrophobic motif (HM) kinase (also called PDK2) [PDK2: integrin- linked kinase (ILK), 
ataxia telangiectasia mutated (ATM) and mammalian target of rapamycin complex 2 
(mTORC2)] is required (Grozinsky-Glasberg et al. 2008; Huang et al. 2015; Vincent et al. 2011; 
Yang et al. 2012). Once Akt is activated at both sites, it mediates its functions via the 
phosphorylation of transcription factors, namely, GSK3, FoxOs and mTORC1 (Figure 1.6) 
(Case et al. 2011; Saxton and Sabatini 2017; Zhao et al. 2017). 
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Figure 1.6: Mechanism of Akt activation and downstream targets responsible for Akt signalling 
functions. (Manning and Toker 2017) 
 
The maintenance of energy homeostasis (i.e. ATP production: ATP expenditure) is a 
fundamental requirement of all cells. Adenosine 5′ monophosphate-activated protein kinase, 
acts as a cellular energy sensor and is activated in response to numerous conditions that reduce 
cellular ATP levels, such as nutrient starvation (especially glucose deprivation), hypoxia and 
exposure to toxins that inhibit the mitochondrial respiratory chain complex (Kim et al. 2016; 
Mihaylova and Shaw 2011; Richter and Ruderman 2009). Adenosine 5′ monophosphate-
activated protein kinase is a heterotrimeric serine-threonine kinase, composed of a catalytic α-
subunit (isoforms: α1and α2) and regulatory β (isoforms: β1and β2) and γ subunits (isoforms: 
γ 1, γ 2 and γ3), responds to increased AMP and ADP levels (Kim et al. 2016; Richter and 
Ruderman 2009). According to literature, AMP or ADP binds to the γ-subunit triggering a 
conformational change that promotes the phosphorylation of threonine-172 (T172) on the α-
subunit by upstream kinases (Kim et al. 2016; Manning and Toker 2017; Richter and Ruderman 
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2009). The two major upstream kinases responsible for AMPK activation are the tumour 
suppressor LKB1 and CaMKK2. Liver kinase B1 activates AMPK during energy stress, 
whereas CaMKK2 activity is induced by increased intracellular Ca2+ levels, regardless of the 
energy status of the cells (Figure 1.7) (Kim et al. 2016; Richter and Ruderman 2009). Once 
activated, AMPK maintains energy equilibrium by suppressing non-essential anabolic 
pathways that consume ATP, such as lipid and protein synthesis, and cell growth and 
proliferation; whilst, promoting catabolic programs that increase ATP levels, including fatty 
acid oxidation and glucose transport, that is mediated by the phosphorylation of transcription 
factors and co-activators (Figure 1.8) (Kim et al. 2016; Zhao et al. 2017). In addition to 
AMPK’s critical role in metabolic reprogramming, increasing evidence has demonstrated a 
much wider range of AMPK actions which regulate diverse events such as mitochondrial 
biogenesis, angiogenesis, cell polarity and hypothalamic control of food intake and whole-body 
energy expenditure (Hardie 2013; Huang et al. 2015; Kim et al. 2016; Richter and Ruderman 
2009). The latter was described in a study by Hurtado-Carneiro et al., (2012) by which 
glucagon-like peptide 1 (GLP-1) induced fluctuations in hypothalamic glucose levels and 
inhibited AMPK and p70S6K (a downstream target of mTOR) activities, in response to feeding 
behaviour in lean and obese male rats. Despite opposing AMPK (catabolic) and Akt (anabolic) 
functions, accumulating evidence has established a cross-talk between the AMPK and Akt 
pathways by mutual phosphorylation (either directly or indirectly) of downstream targets 
suggesting their synergistic influence on cellular processes (Figure 1.8) (Han et al. 2018; Saha 
et al. 2018; Zadra et al. 2015; Zhao et al. 2017). 
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Figure 1.7: Mechanism of AMPK activation. (Prepared by author) 
 
 
 
Figure 1.8: Cross-talk between AMPK and Akt signalling pathways on cellular responses. (Zhao 
et al. 2017) 
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1.2.4.2.1. The role of Akt and AMPK in metabolic signalling  
 
 
Glucose deprivation is one of the main patterns of metabolic stress due to its 
crucial function in glycolysis (breakdown of glucose for cellular energy 
production) (Cui et al. 2017). Thus, a deficiency in glucose directly reduces 
ATP production which impacts cellular function and survival (Caro-Maldonado 
et al. 2010; Cui et al. 2017). The Akt and AMPK signalling pathways are central 
regulators of cellular metabolism (Zhao et al. 2017).  
 
The PI3K/Akt pathway plays an important role in regulating aerobic glycolysis 
by increasing glucose uptake via the up-regulation of cell surface glucose 
transporters and the activation of several glycolytic enzymes such as hexokinase 
(Coloff and Rathmell 2006; Whiteman et al. 2002). Additionally, Akt promotes 
the activation of ATP citrate lyase, which enhances the conversion of citrate to 
acetyl-CoA for entry into the TCA cycle (Koundouros and Poulogiannis 2018). 
In addition to the direct role in glycolytic metabolism, Akt indirectly regulates 
glycolysis through downstream control of GSK3 and mTORC activity (Jason 
and Cui 2016; Khorami et al. 2015). Glycogen synthase 3 is a direct target of 
Akt and is inactivated upon phosphorylation, which consequently reduces the 
activation of glycogen synthase (Khorami et al. 2015; Manning and Toker 
2017). Likewise, activation of mTORC1 by Akt promotes glycolysis by 
upregulating the expression of hypoxia-inducible factor 1 (HIF1) (Jason and 
Cui 2016; Manning and Toker 2017). Moreover, mTORC1 positively regulates 
mitochondrial function and oxidative metabolism by selectively promoting the 
translation of nucleus-encoded mitochondria-related mRNAs (Hoxhaj and 
Manning 2019; Jason and Cui 2016). While data from several studies in 
mammalian cells have shown the hyperactivation of Akt and its downstream 
targets with the accumulation of ATP; other studies have found an increased 
susceptibility to metabolic stress and cell death with prolonged Akt activity 
(under glucose deprivation) (Robey and Hay 2009). Thus, implying the dual 
roles of Akt in metabolic survival and stress resistance. 
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Under glucose deprivation, AMPK is activated in cells to mediate metabolic 
reprogramming in order to survive. Notably, AMPK phosphorylates the 
regulatory-associated protein of mTOR (Raptor) and tuberous sclerosis 
complex 2 (TSC2), which indirectly leads to inhibition of mTORC1; thereby 
decreasing protein synthesis and increasing autophagy (Zhao et al. 2017). The 
decreased anabolism reduces ROS production, while enhanced autophagy and 
glycolysis increases the resilience of cells to ROS (Zhao et al. 2017). In 
addition, multiple studies have shown an enhanced mitochondrial biogenesis 
and oxidative phosphorylation mediated by AMPK through activation of the 
p38/ PGC1α pathway (Herzig and Shaw 2018). This indicates AMPK is not 
only involved in glycolytic regulation, but also participates in ATP generation 
from oxidative phosphorylation (Herzig and Shaw 2018). 
 
1.2.4.3. Activation of cyclic AMP response element-binding protein (CREB) and brain 
derived neurotrophic factor (BDNF) 
 
Cyclic AMP response element-binding protein, an important transcription factor recognized for 
its roles in cell growth and survival, differentiation, learning and memory, and synaptic 
plasticity is activated in response to a vast array of physiological stimuli (stressors, growth 
factors, cytokines, neurotransmitters and neurotrophins) (Lonze and Ginty 2002; Wang et al. 
2018). Phosphorylated at its serine-133 (S133) residue [located in the kinase inducible domain 
(KID)] by several receptor-activated protein kinases, such as protein kinase A (PKA), 
calmodulin-dependent protein kinase (CaMK) and MAPKs, CREB binding protein (CBP) 
facilitates the binding of the transcriptional coactivator, to the KID domain initiating the 
transcription of numerous target genes containing a cAMP-responsive element (CRE) (Figure 
1.9A) (Wang et al. 2018). The diversity of CREB responses are facilitated by specific initiation 
or inhibitory transcriptional gene expressions involved in metabolism (PEPCK, cytochrome c), 
transcription factors (STAT3, c-fos, NF-!B), cell survival proteins (bcl-2, cyclin D1, and cyclin 
A) and growth factors (BDNF, IGF-1, NGF) (Figure 1.9B) (Wang et al. 2018; Wen et al. 2010; 
West et al. 2002). 
 
Over the past decade, CREB has been extensively studied for its role in cognitive and emotional 
disorders, with BDNF being the most important target (Luo et al. 2017). Brain derived 
neurotrophic factor is a central neurotrophin that promotes the development of neuronal cell 
populations and confers neuroprotection under different conditions (McGregor and English 
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2018). Furthermore, the mutual relationship between CREB and BDNF are well documented 
whereby BDNF promotes the phosphorylation of CREB, which, in turn, promotes the 
transcription of the BDNF gene. Numerous studies have validated BDNF-induced CREB 
activation in neurons through the activation of CaMK, Trk B receptors and the Ras/ERK/RSK 
pathway (Luo et al. 2017). In several other investigations, CREB phosphorylation was 
independent of BDNF stimuli and was activated by monoamine neurotransmitter (dopamine 
and serotonin) receptor signalling, promoting the expression of BDNF (Huang et al. 2015; 
Lonze and Ginty 2002; Luo et al. 2017; Nakazawa et al. 2002; Wang et al. 2018).  
 
1.2.4.3.1. The role of CREB and BDNF in neurometabolism and neuroprotection 
 
While the relationship between CREB and cell survival is well-established, recent 
studies have demonstrated CREB’s role as a metabolic sensor and regulator of glucose 
homeostasis in brain, liver and fat tissue; and has also been shown to be a key 
component in the control of appetite and food intake in the hypothalamus (Altarejos 
and Montminy 2011; Yadav et al. 2011). In its active form, CREB regulates 
metabolism in several ways; namely, through the up-regulation of glucose receptor 
expressions and glycolytic enzymes [Pyruvate kinase isozymes M2 (PKM2), triose-
phosphate isomerase (TPI), alpha-enolase], and by enhancing mitochondrial 
respiration and biogenesis via the expression of several genes (i.e. BDNF, PGC-1α, 
Nrf1, PPARα, and TFAM) (Steven et al. 2017).  
 
Apart from CREB’s role in metabolic homeostasis, the proliferative and anti-apoptotic 
characteristics of CREB extend to its protective ability. During lymphocyte 
development, analysis of Bcl-2 transcription revealed the direct binding of CREB to its 
promoter region, thereby up-regulating Bcl-2 gene expression; and whose transcription 
was blocked upon CREB mutation (Walton and Dragunow 2000). Similarly, in PC-12 
pheochromocytoma cells, Bcl-2 transcription was dependent on IGF1R-induced CREB 
activation; suggesting that various stimuli that activate receptor mediated CREB 
activity, such as neurotrophins, may also promote survival (Zheng and Quirion 2006). 
In particular, endogenous BDNF has been shown to stimulate CREB phosphorylation 
via the activation via of kinase-regulated pathways, directly regulate BDNF 
transcription; suggesting that a positive-feedback loop might promote resistance to 
brain injury (Pizzorusso et al. 2000). The cytoprotective roles of BDNF induced by 
metabolic stress was further evidenced by the effects of exercise and intermittent 
fasting on neuronal bioenergetics and stress resistance; and was shown to stimulate 
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neuronal energy metabolism by increasing the expression of GLUT 3, sodium-
dependent amino acid transport and protein synthesis, ketone utilization and expression 
of peroxisome PGC-1α to increase mitochondrial biogenesis (Duan et al. 2001; 
Rothman et al. 2012; Wrann et al. 2013). 
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Figure 1.9: Activation of CREB signalling (A) and its downstream target genes (B). (Wang et al. 
2018) 
 
1.2.5. Aim and objectives  
 
Despite the toxicity of FA being well-established in plants, its cellular effects on the mammalian 
immune and nervous system is unknown. Therefore, the main aim of this study was to evaluate the 
immuno- and neurotoxic effects of FA and its alterations to major kinase signalling pathways associated 
with survival and metabolic functions in in vitro cell culture [normal human peripheral blood 
mononuclear cells (PBMCs) and monocytic leukaemia cells (Thp-1)] and in vivo murine (C57BL/6 
mice) models.  
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The immuno- and neuro-toxic effects of FA were determined by assessing immune and neuronal cell 
viability. Metabolic alterations and influences to kinase signalling pathways were also measured. The 
immunotoxicity of FA was determined (in vitro) at an acute (1 day) exposure. Whilst the assessment of 
FA neurotoxicity was investigated (in vivo) at acute (1 day) and prolonged (10 days) exposures. The 
specific objectives of this study were to determine: 
 
- The immunotoxicity of FA on normal PBMCs and Thp-1 cell viability and expression of cell 
death markers 
- The effect of FA exposure on the oxidative status and intracellular energy levels in PBMCs and 
Thp-1 cells 
- The regulation of MAPK survival signalling pathways in PBMCs and Thp-1 cells treated with 
FA 
- The metabolic effect of acute and prolonged FA-exposure on intracellular energy levels and 
alterations to the Akt and AMPK signalling pathways in murine brain 
- The neurotoxic potential of FA following acute and prolonged treatment on microscopic tissue 
structure in murine brain 
- Differential regulation of CREB/BDNF signalling by MAPK pathways following acute and 
prolonged exposure to FA in murine brain 
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CHAPTER TWO 
 
Manuscript title: Fusaric Acid immunotoxicity and MAPK activation in normal peripheral blood 
mononuclear cells and Thp-1 cells 
 
The nervous and immune systems share a complex bi-directional communication network, with the 
nervous system influencing immune function via the secretion of neurotransmitters (e.g., epinephrine, 
norepinephrine and serotonin) and circulating hormones produced by the neuroendocrine system (e.g., 
cortisol, growth hormone and prolactin) and through the direct regulation of immune organs which 
allows the immune system to recruit local neuronal elements for the fine tuning of immune responses. 
Conversely, the immune system modulates brain activity (body temperature, sleep and feeding 
behaviour) by secretion of several chemical messengers, among which cytokines are the most well 
recognized. Although the brain was classically considered “immunologically privileged”, it is now 
acknowledged that peripheral immune cells may be active in the brain and shifts in the peripheral 
immune system may be an important factor which could initiate or stabilize neuropathological 
conditions. The complexity of this communication network and responses are regulated by key 
intracellular components. Of these various systems, the MAPK signalling pathway regulates several 
fundamental cellular functions including growth, cell migration, differentiation, apoptosis, immune 
responses and synaptic plasticity indicating its high relevance. FA, a neurologically active mycotoxin, 
induces significant cytotoxicity in plants and in vitro models; whilst it is moderately toxic to animals 
upon dietary exposure. Although mycotoxins have varying effects and target organs, they all interact 
with the immune system (the primary defence system). While the neurobiochemical effects of FA has 
been recognized, it’s impact on the immune system remains largely unknown. Therefore, this chapter 
determined the immunotoxicity of FA and its effect on MAPK activity in lymphoid and myeloid cells.  
 
 
 
 
 
 
 
 
Scientific Reports (2017), 7(1), 3051 
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Fusaric acid (FA), a food-borne mycotoxin, is a potent divalent metal chelator. The human 
immune system is complex and susceptible to environmental insults, however, the 
immunotoxity of FA remains unknown. We investigated the immunotoxicity of FA on human 
peripheral blood mononuclear cells (PBMCs) and Thp-1 cells. FA was cytotoxic to PBMCs 
(IC50-240.8µg/ml) and Thp-1 (IC50-107.7µg/ml) cells at 24h. FA induced early apoptosis but 
significantly decreased caspase activity in PBMCs, a characteristic of paraptosis. In Thp-1 
cells, FA induced apoptosis and increased caspase -9 and -3/7 activities. In PBMCs, FA 
maintained mitochondrial membrane potential and decreased protein expression of Bax whilst 
increasing expression of p-Bcl-2; FA induced oxidative stress and depleted ATP levels in both 
cell types. In Thp-1 cells, FA increased mitochondrial membrane depolarization and decreased 
p-Bcl-2 expression. In PBMCs, FA significantly up-regulated the MAPK protein expression of 
p-ERK and p-JNK but down-regulated p-p38 expression. In Thp-1 cells, FA up-regulated 
MAPK protein expression of p-ERK whilst p-JNK and p-p38 expression were down-regulated. 
In conclusion FA induced programmed cell death and altered MAPK signaling in healthy 
PBMCs and Thp-1 cells strongly suggesting a possible mechanism of FA induced 
immunotoxicity in vitro. 
  
Keywords-10: Fusaric Acid; immunotoxicity; ROS; MAPK; intrinsic apoptosis; paraptosis 
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Introduction  
 
Endophytic fungi produce mycotoxins that are toxic to animals and humans 1. Fusaric acid 
(FA, 5-butylpicolinic acid), is a picolinic acid derivative produced by several strains of 
Fusarium species 2,3. These fungal strains are ubiquitous in soil and are known to parasitize 
maize and many other cereal grains 4,5. 
 
FA contains a pyridine ring with a butyl side chain that allows it to easily permeate cell 
membranes 6. The toxicity of FA is also due to its ability to chelate divalent ions such as 
magnesium, calcium, zinc and iron 2,7. The nitrogen in the pyridine ring and the deprotonated, 
negatively charged oxygen on the carboxylic acid group are responsible for FA’s divalent 
metal chelating ability 8,9. 
 
The human immune system functions in host defense against environmental exposure to 
bacteria, viruses, parasites, fungi and other perturbations, and in acquiring immunity against 
invading pathogens 10,11. In response to foreign particle or pathogen, several signaling 
pathways are activated in immune cells 12. Foremost of these pathways, is the activation of 
mitogen-activated protein kinases (MAPKs) 12. MAPK activity directs diverse immune 
responses ranging from stress, cell death/survival and immune defense 12-14. 
 
Optimal cellular mitochondrial function increases ATP synthesis and reactive oxygen species 
(ROS) that mediate cell signaling pathways 8. The amount of intracellular ROS will 
significantly influence the MAPK pathway 6. The MAPK family comprises of three universal 
serine/threonine protein kinases; these include the extracellular signal-regulated kinase 
(ERK), c-Jun N-terminal kinase (JNK) and p38 kinase 15,16; each group of MAPK is activated 
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via a series of phosphorylation events 16. The first event involves the phosphorylation and 
activation of a MAPK kinase kinase (MAPKKK), which in turn, phosphorylates and activates 
a MAPK kinase (MAPKK). MAPKKs activate MAPKs through dual phosphorylation on 
both threonine and tyrosine residues located within the tri-peptide motif of the MAPK 
14,15,17,18. Once activated, MAPKs phosphorylate several transcription factors, thereby 
regulating gene expression and cellular functions 13,14. 
 
Apoptosis is executed by immune cells to maintain homeostasis of the immune system19-21. 
Apoptosis occurs via two main pathways, the intrinsic and extrinsic apoptotic pathways 
19,22,23.  Both the intrinsic and extrinsic pathways are activated by caspases; the initiator 
caspases (-8 and -9) are involved in the intrinsic pathway, whilst the executioner caspases (-
3/7) are integral to the extrinsic pathway 19,24. Paraptosis is distinct from necrotic and 
apoptotic cell death and its features are defined by the lack of apoptotic morphology and 
independent of caspase activation 19,22,23,25-27. 
 
The phytotoxicity of FA is well documented and includes altered mitochondrial membrane 
potential and inhibition of ATP synthesis 28,29. In animals, FA inhibits the activity of 
dopamine-β-hydroxylase, synthesis of nucleic acids (zinc finger proteins involved in DNA 
repair) and impairs protein synthesis 30. In young swine, FA showed moderate toxicity, 
induced vomiting and increased concentration levels of tryptophan and serotonin in the brain 
31. Elevated levels of serotonin results from its impaired regulation and consequently 
amplifies behaviors distinctive of the firing of serotonergic neurons such as loss of appetite 
and lethargy 32. In zebrafish, FA had teratogenic effects by inhibition of lysyl oxidase (a 
copper-dependent enzyme) 33. FA also decreased norepinephrine levels in the brain, heart, 
spleen and adrenal gland of rats 34.  
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To date, no study has investigated the effect of FA on the mammalian immune system. In this 
study, we assessed the immunotoxicity of FA associated with MAPK activity in healthy 
human peripheral blood mononuclear cells (PBMCs) and the acute monocytic leukemic 
(Thp-1) cell line. It was hypothesized that FA altered MAPK signaling was immunotoxic in 
both cell types.  This study shows that FA, a common food borne mycotoxin, is toxic to the 
human immune system. This data may help develop a better understanding of the immune 
risks associated with FA consumption. This is of importance in South Africa, the epicenter of 
infectious diseases, where the majority population relies on maize as a food staple.  
 
Results 
 
• Cell viability of PBMCs and Thp-1 cells 
 
The WST-1 assay showed that FA induced a dose dependent decrease in PBMC and Thp-1 
cell viability over 24 h (Supplementary Tables: S3-PBMC, S4-Thp-1). Thp-1 cells were more 
susceptible than PBMCs to FA toxicity. An IC50 of 240.8 µg/ml (Fig. 1A) and 107.7 µg/ml 
(Fig. 1B) determined for PBMCs and Thp-1 cells respectively; and was used in all 
subsequent assays. 
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Figure 1: Cytotoxicity of FA on PBMCs and Thp-1 cells. FA induced a dose dependent 
decrease in PBMC (A) and Thp-1 (B) cell viability.  
 
• FA activates caspase-independent cell death in PBMCs and intrinsic apoptosis in Thp-
1 cells 
 
To confirm the toxicity of FA, we assessed the externalization of phosphatidylserine (PS) on 
the plasma membranes of PBMCs and Thp-1 cells. FA significantly increased the 
externalization of PS in PBMCs and Thp-1 cells by 1.42 (18.43 + 0.006% vs. 26.16 + 
0.003%; p=0.0003) and 2.27 (8.03 + 0.004% vs.18.19 + 0.002%; p<0.0001) fold, respectively 
(Fig. 2). Propidium iodide (PI) staining showed a decreased percentage of necrotic cells by 
FA as compared to the controls in both PBMCs and Thp-1 cells (Supplementary Fig. S1). 
This was confirmed by quantifying the release of lactate dehydrogenase (LDH). FA did not 
induce membrane leakage in both PBMCs and Thp-1 cells (Supplementary Fig. S2), 
therefore, necrotic cell death was excluded. 
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Figure 2: Translocation of PS in PBMCs and Thp-1 cells. FA induced PS externalization 
in both PBMCs and Thp-1 cells. Data are expressed as mean + SD. **p<0.005 relative to 
respective control; ***p<0.0001 relative to respective control. 
 
Next, we measured caspase -8, -9 and -3/7 activities to determine the type of programmed 
cell death induced by FA in PBMCs and Thp-1 cells. Interestingly, despite the increase in PS 
externalization, FA significantly decreased caspase -8 activity by 0.81 fold (1.09 + 0.001x104 
RLU vs. 0.88 + 0.042x104 RLU; p=0.0022), caspase -9 by 0.73 fold (10.89 + 0.609x104 RLU 
vs. 7.92 + 0.241x104 RLU; p=0.0070) and caspase -3/7 activities by 0.10 fold (1.19 + 
0.258x104 RLU vs. 0.12 + 0.026x104 RLU; p=0.0035) in PBMCs, relative to the control 
(Table 1). This result suggests that FA induced caspase-independent cell death in PBMCs. In 
Thp-1 cells, however, FA significantly decreased caspase -8 activity by 0.74 fold (4.52 + 
0.306x104 RLU vs. 3.3265 + 0.021x104 RLU; p=0.0211), but significantly increased both 
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caspase -9 activity (1.43 fold; 62.67 + 3.701x104 RLU vs. 89.37 + 0.590x104 RLU; 
p=0.0065) and caspase -3/7 activity (5.33 fold; 0.82 + 0.482x104 RLU vs. 4.38 + 0.604x104 
RLU; p=0.0041) when compared to the control (Table 2); an indicator of activation of 
intrinsic apoptosis. 
 
Table 1: Effect of FA on caspase (-8, -9, -3/7) activity in healthy PBMCs 
 
 Mean + SD (RLU x104) Fold change p value 
PBMC 
Control FA 
Caspase -8 1.0918 + 0.0007 0.8831 + 0.0419 
 
0.81 0.0022** 
Caspase -9 10.8855 + 0.6094 
 
7.9185 + 0.2409 0.73 0.0070* 
Caspase -3/7 1.1858 + 0.2581 
 
0.1218 + 0.0261 0.10 0.0035** 
SD: standard deviation; RLU: relative light units; *p<0.05; **p<0.005. 
 
Table 2: Effect of FA on caspase (-8, -9, -3/7) activity in Thp-1 cells 
 
 Mean + SD (RLU x104) Fold change p value 
Thp-1 
Control FA 
Caspase -8 4.5235 + 0.3055 3.3265 + 0.0206 0.74 0.0211* 
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Caspase -9 62,6683 + 3.7013 
 
89.3652 + 0.5900 1.43 0.0065* 
Caspase -3/7 0.8210 + 0.4816 
 
4.3758 + 0.6041 5.33 0.0041** 
SD: standard deviation; RLU: relative light units; *p<0.05; **p<0.005. 
 
• FA induces oxidative stress in PBMCs and Thp-1 cells 
 
Increased intracellular ROS is known to promote oxidative stress, that is not only injurious to 
cells but may also regulate cell signaling pathways 8. Lipid peroxidation, a marker for 
oxidative stress, was measured by quantifying malonaldehyde (MDA) using the 
Thiobarbituric acid (TBARS) assay. FA significantly elevated MDA levels in PBMCs (7.59 
fold; 0.02 + 0.010 µM vs. 0.16 + 0.016 µM; p=0.0006) and Thp-1 cells (1.59 fold; 0.18 + 
0.020 µM vs. 0.28 + 0.010 µM; p=0.0039) (Fig. 3A).  FA induced oxidative stress in both 
normal human PBMCs and Thp-1 cells. 
 
Mitochondria are important in maintaining cellular redox homeostasis and activation of the 
intrinsic apoptotic pathway.  The evaluation of FA induced mitochondrial membrane integrity 
by flow cytometry in PBMCs showed that despite increased MDA levels, there was no effect 
on the mitochondrial membrane potential; however, in Thp-1 cells, mitochondrial membrane 
depolarization was significantly increased (1.95 fold; 33.58 + 1.425% vs. 65.48 + 0.329%; 
p=0.0007) when compared to the controls (Fig. 3B).  
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Further, FA significantly depleted ATP levels in both PBMCs (0.16 fold; 38.97 + 1.183x104 
RLU vs. 6.11 + 0.266x104 RLU; p=0.0002) and in Thp-1 cells (0.52 fold; 225.21 + 8.014x104 
RLU vs. 117.26 + 10.017x104 RLU; p=0.0007) relative to controls (Fig. 3C). 
 
 
 
Figure 3: Effect of FA on the oxidative status and mitochondrial function in PBMCs 
and Thp-1 cells. FA increased MDA levels in both PBMCs and Thp-1 cells (A), had no 
effect on the mitochondrial membrane potential in PBMCs but increased depolarization of the 
mitochondrial membrane in Thp-1 cells (B). FA depleted ATP levels in PBMCs and Thp-1 
cells (C). Data are expressed as mean + SD. **p<0.005 relative to respective control; 
***p<0.0001 relative to respective control. 
 
• Effect of FA on Bax and p-Bcl-2 protein expression in PBMCs and Thp-1 cells 
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To validate caspase-dependent and –independent cell death, protein expressions of pro-
apoptotic Bax and anti-apoptotic p-Bcl-2 was determined. FA significantly decreased Bax 
protein expression (0.71 fold; 100 + 10.33 % vs. 70.90 + 7.34 %; p=0.0201) and increased p-
Bcl-2 protein expression (1.18 fold; 100 + 6.40 % vs. 118.30 + 2.83 %; p=0.0455) in PBMCs 
compared to the control (Figure 4A and 4B), whilst it only significantly decreased the protein 
expression of p-Bcl-2 (0.78 fold; 99.39 + 0.89 % vs. 77.40 + 2.82 %; p=0.0007) in Thp-1 
cells (Fig. 4C and 4D). 
 
 
 
Figure 4: Effect of FA on apoptotic regulator proteins Bax and p-Bcl-2 in PBMCs and 
Thp-1 cells. Protein expressions of Bax and p-Bcl-2 in healthy PBMCs (A) and Thp-1 cells 
(C). Percentage of Bax and p-Bcl-2 protein expression in healthy PBMCs (B) and Thp-1 cells 
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(D). Percentage of protein expressions were represented as mean + SD. *p<0.05 relative to 
respective control; **p<0.005 relative to respective control.  
 
• Effect of FA on MAPKs expression in PBMCs and Thp-1 cells 
 
Finally, to evaluate the effect of FA on MAPK signaling, phosphorylation of MAPK protein 
expressions was determined using western blotting. In PBMCs, FA significantly increased 
expression of p-ERK (42 kDa fragment and 44 kDa fragment; 1.94 fold; 100 + 5.73 % vs. 
194.19 + 26.83 %; p=0.0271 and 1.36 fold; 99.80 + 0.68 % vs. 136.20 + 5.29 %; p=0.0006, 
respectively) and p-JNK (46 kDa fragment and 54 kDa fragment; 1.46 fold; 97.10 + 10.06 % 
vs. 141.39 + 0.92 %; p=0.0035 and 1.13 fold; 96.56 + 11.92 % vs. 108.77 + 2.45 %; 
p=0.0454, respectively) (Fig. 5A and 5B). In Thp-1 cells, FA also significantly increased p-
ERK (42 kDa and 44 kDa fragments; 1.35 fold; 100 + 3.54 % vs. 135.13 + 15.06 %; 
p<0.0001 and 1.05 fold; 100 + 5.15 % vs. 104.68 + 6.93 %; p=0.0006, respectively) (Fig. 5C 
and 5D), whilst significantly decreasing p-JNK (46 kDa and 54 kDa fragments; 1.02 fold; 
105.85 + 20.25 % vs. 108.37 + 0.75 %; p=0.0461 and 0.62 fold; 103.48 + 12.05 % vs. 63.98 
+ 7.03 %; p=0.0055, respectively) (Figure 5C and 5D). Furthermore, FA significantly 
decreased the expression of p-p38 in PBMCs and Thp-1 cells (0.75 fold; 100 + 9.17 % vs. 
74.73 + 11.08 %; p=0.0401 and 0.70 fold; 100 + 17.40 % vs. 69.86 + 9.89 %; p=0.0033, 
respectively) (Fig. 5A, 5B, 5C and 5D). 
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Figure 5: Effect of FA on MAPK protein expression. MAPK protein expression in healthy 
PBMCs (A) and Thp-1 cells (C). Percentage of MAPK protein expression in healthy PBMCs 
(B) and Thp-1 cells (D). Percentage of protein expressions were represented as mean + SD. 
*p<0.05 relative to respective control; **p<0.005 relative to respective control; ***p<0.0001 
relative to respective control.  
 
Discussion 
 
The promising role of divalent ion chelators in proliferative and virulent diseases has led to 
growing interest 35-37. FA, a picolinic acid analogue and potent divalent metal chelator, has 
shown potential as an anti-cancer, anti-microbial and anti-viral agent 35-37. Recently, the role 
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of divalent ion chelators in proliferative and virulent diseases has been extensively studied. 
However, the toxicity of FA, a food-borne mycotoxin, on the immune system containing a 
diverse population of cells, has to date not been studied.  
 
In this study, we showed the immunotoxic potential of FA to both healthy PBMCs (diverse 
population of immune cells) and the distinct immune Thp-1 cells. Interestingly, FA inhibited 
Thp-1 cell proliferation at an IC50 value less than half that of PBMCs (Fig. 1A and 1B). This 
result is in agreement with other studies that showed cytotoxic effects of FA on WI-38 cells 
(fibroblastic cells), LoVo cells (colorectal adenocarcinoma cells) and MDA-468 cells (human 
breast adenocarcinoma cells) in which FA had preferentially inhibited the proliferation of 
cancerous cells (LoVo and MDA-468) when compared to the normal cells (WI-38) 35. Our 
data suggests that FA may exert selective toxicity to distinct immune cell types as evidenced 
by the Thp-1 response, albeit a leukemic cell line. Additionally, in comparison to the anti-
neoplastic drug, ellipticine failed to inhibit PBMC and Thp-1 cell viability; which further 
exemplifies the potency of FA.  
 
Contrary to the study by Fernandez-Pol (1998), FA significantly increased the externalization 
of PS in both PBMCs and Thp-1 cells by 26.16% and 18.19%, respectively (Fig. 2). Given 
that the externalization of PS occurs during both apoptosis and paraptosis, activities of 
caspases -8, -9 and -3/7 were assayed to determine type of cell death induced by FA in both 
cell lines; apoptosis requires caspase activation whilst paraptosis is independent of caspase 
activation. FA substantially decreased caspase activities in PBMCs (Table 1), strongly 
suggesting that paraptosis was the preferred mode of cell death. In Thp-1 cells, however, FA 
significantly increased caspase -9 and -3/7 activities were (Table 2), indicating the induction 
of intrinsic apoptosis in Thp-1 cells.  
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Immune cells respond to stimuli by activating MAPK signaling to amplify other signals to 
elicit an appropriate physiological response for programmed cell death 14,38. Previous studies 
showed that prolonged activation of MAPK signaling induced cell death via ROS-activation 
of MAPK signaling pathways 16. ROS are continuously generated by cellular processes, with 
the mitochondrion being the major source 6. Excessive ROS generated during oxidative 
phosphorylation can cause oxidative damage to proteins, DNA and phospholipids 16; 
oxidative degradation of lipids results in the formation of lipid peroxides such as MDA 39. FA 
significantly increased MDA levels in both PBMCs and Thp-1 cells (Fig. 3A), indicative of a 
prolonged oxidative stress environment. Furthermore, FA disrupted mitochondrial membrane 
potential by increasing mitochondrial depolarization in Thp-1 cells (Fig. 3B). This could be 
due to the weak acidic nature of the carboxylic acid group of FA 40. Weak acids act as proton 
carriers across lipid membranes, thereby disrupting the proton gradient along the electron 
transport chain (ETC) 41,42. Interestingly, FA did not disrupt the mitochondrial membrane 
potential in normal PBMCs (Fig. 3B) despite the significant depletion of ATP levels in both 
normal PBMCs and Thp-1 cells (Fig. 3C). In Thp-1 cells, this is substantiated by the 
decreased cell viability (decreased redox potential) and increased mitochondrial membrane 
depolarization. Also, the activation of ATP dependent caspases -9 and -3/7 may further 
deplete ATP levels 43. In PBMCs, however, the decreased ATP levels may be due to 
increased activation and prolonged activation of ATP dependent protein kinases. 
 
Intracellular ROS not only alters cellular integrity but is also important to MAPK signaling 
cascades 6; FA induced increased ROS production and up-regulated protein expression of 
ERK in Thp-1 cells (Fig. 5C and 5D). Although ERK signaling pathways are well known for 
their role in promoting cell survival, recent studies have demonstrated their ability to 
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potentiate apoptosis 44. Prolonged activation of ERK may be due to the inhibition of tyrosine 
phosphatases, a group of enzymes responsible for the removal of phosphate groups on 
phosphorylated tyrosine residues, hence inactivating the protein 3. However, tyrosine 
phosphatases are sensitive to increased ROS and become oxidized, thereby inhibiting their 
activity and prolonging ERK activation 3,45.  
 
JNK and p38 MAPK signaling pathways are generally directed towards initiating cell death 
upon activation by stress signals. Recently, however, these signaling pathways have been 
associated in both cell death and survival 38. In Thp-1 cells, FA significantly decreased p-JNK 
activation and p-p38 protein expressions (Fig. 5C and 5D). A study by Pedram et al. (1998) 
documented the cross-talk between the ERK and JNK MAPKs where the activation of JNK 
by ERK MAPK was followed by the activation of ERK by vascular endothelial growth factor 
(VEGF) whilst JNK stimulated ERKs proliferative signaling. Therefore, it can be inferred 
that a decrease in JNK activity hinders the cross-talk between JNK and ERK MAPKs, 
preventing survival signaling by ERK 46.  
 
Additionally, JNK and ERK MAPKs regulate the expression of Bcl-2 family proteins that are 
central in regulating the mitochondrial apoptotic death pathway 3,47. Bcl-2 inhibits apoptosis 
by forming a complex with pro-apoptotic proteins such as Bax 47,48. Phosphorylation of Bcl-2 
compromises it’s protein stability and affects dimerization with Bax 49. Thus, dissociation 
from the complex at the mitochondrial membrane leads to the formation of mitochondrial 
permeability transition pore (mPTP) and subsequent caspase activation 50. In support of the 
increased caspase -9 and -3/7 activities in Thp-1 cells, FA decreased p-Bcl-2 expression 
resulting in apoptotic cell death (Fig. 4C and 4D). JNK signaling regulates the expression of 
Bcl-2 and is up-regulated in response to JNK activation. FA activated ERK death signaling, 
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decreased p-Bcl-2 expression and induced apoptosis in Thp-1 cells, but had no significant 
effect on Bax expression (Fig. 4C and 4D). This may be due to the deletion of the p53 gene in 
the Thp-1 cell line as p53 acts as a transcription factor for Bax expression and recruitment to 
the mitochondrial membrane 24,51-55. Additionally, increased ERK activity regulates 
mitochondrial membrane potential 56 and corresponds with the increased caspase -9 and -3/7 
activities, and the subsequent activation of cell death in Thp-1 cells by FA. In PBMCs, FA 
increased p-Bcl-2 expression (Fig. 4A and 4B) and decreased Bax expression (Fig. 4A and 
4B), with a corresponding decrease in caspase -8, -9 and -3/7 activities. Increased p-Bcl-2 
expression helps maintain the mitochondrial membrane integrity and subsequent 
mitochondrial membrane potential by preventing the release of cytochrome c, activation of 
caspase -9 and the initiation of intrinsic apoptosis, further validating the induction of 
paraptosis in normal PBMCs by FA. 
 
Although the molecular activation of paraptosis remains unknown, studies have suggested the 
involvement of MAPK signaling in the induction of cell death. In PBMCs, FA significantly 
increased the expression of ERK and JNK whilst decreasing p38 expression (Fig. 5A and 
5B). Sperandio et al., (2000) reported that ERK and JNK activity mediated paraptosis 
stimulation by insulin-like growth factor 1 receptor, and that inhibition of these MAPKs 
prevented the induction of paraptosis in 293T cells 57. Another study by Yumnam et al., 
(2014) showed the involvement of ERK MAPK in hesperidin-induced paraptosis of human 
hepatocellular carcinoma (HepG2) cells 58. Sugimori and colleagues (2015) recently showed 
that activated JNK induced paraptosis induction in HL-60 and NB4 human promyelocytic 
leukemic cell lines and in bone marrow blasts treated with benfotiamine 59. Contrary to the 
studies by Sperandio et al., (2000) and Yumnam et al., (2014), benfotiamine inhibited the 
activity of ERK in bone marrow blasts and had no effect on ERK activity in HL-60 and NB4 
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cell lines 57,58. This suggests that the involvement of MAPK in the induction of paraptosis 
may be dependent on the cell line and type of activation. Additionally, caspase -9 was 
reported to be a direct target of ERK MAPK, and that phosphorylation at threonine 125 on 
caspase -9 inhibits its pro-apoptotic activity 60. These findings support the activation of 
MAPK signaling pathways in the induction of paraptosis in PBMCs treated by FA. 
 
Conclusion  
 
FA is immunotoxic to both healthy PBMCs and Thp-1 cells, albeit at a higher concentration 
in PBMCs. The cancerous Thp-1 cells are highly susceptible to FA toxicity. Collectively, the 
results show that the host response to FA exposure augmented MAPK signaling and 
induction of apoptosis in Thp-1 cells (via the mitochondrial apoptotic pathway) and 
paraptosis in PBMCs. This study shows that FA, a common food borne mycotoxin, is toxic to 
the human immune system. This data may help develop a better understanding of the immune 
risks associated with FA consumption. This has great importance in socio-economically 
challenged countries where the majority population relies on corn as a food staple. 
 
Material and methods 
 
• Materials  
 
Cell culture reagents for PBMC maintenance and FA (Gibberella fujikuroi) were purchased 
from Sigma Aldrich (Johannesburg, SA). The Thp-1 cells and media were purchased from 
ATCC (University Boulevard Manassas, USA) and Scientific group (Johannesburg, SA), 
respectively. Luminometry reagents were obtained from Promega (Madison, USA). 
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• Cell culture 
 
PBMCs were isolated from whole blood using Histopaque 1077 (Sigma Aldrich) and gradient 
centrifugation from young healthy males following institutional ethical approval (BE057/15) 
and written informed consent. Collection and use of blood was in compliance with relevant 
institutional guidelines and procedures. Isolated PBMCs were maintained at 37 0C with 5% 
CO2 in RPMI 1640 medium (supplemented with 10% FCS, 1% L-glutamine and 1% 
pencillin-streptomycin). Thp-1 cells were cultured in RPMI 1640 medium supplemented with 
10% FCS, 1% L-glutamine, 1% pencillin-streptomycin, 1 mM sodium pyruvate and 0.05 mM 
β-mecaptoethanol. Thp-1 cells were maintained at 3 x105 cells/ml in 75 cm3 ventilated flasks 
at (37 0C, 5% CO2) and were split at a cell count of 8 x105 cells/ml. Viability of cells was 
assessed using trypan blue exclusion. 
 
• Cell viability 
 
The cytotoxicity of FA on PBMCs and Thp-1 cells was analyzed using the WST-1 reagent. 
Briefly, PBMC and Thp-1 cells (20,000 cells/well) were seeded into a 96-well microtitre 
plate. The cells were incubated with varying FA concentrations (30-300 µg/ml) in triplicate 
(200 µl/well) for 24 h (37 0C, 5% CO2). Ellipticine, anti-neoplastic agent, was used as a 
positive control to FA toxicity (Data shown in Supplementary Tables: S1 PBMC; S2 Thp-1). 
A positive control of cells with RPMI only and a negative control with RPMI/WST-1 reagent 
solution was also seeded. Following incubation, the plate was centrifuged at 24 0C, 400 xg for 
10 min. The supernatant was then aspirated and 110 µl/well of a RPMI/WST-1 reagent 
solution (1:10) was added and incubated for 3 h (37 0C, 5% CO2). The optical density of the 
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colorimetric reaction was measured at a wavelength of 450 nm and reference wavelength of 
620 nm using a spectrophotometer (Bio-Tek uQuant, Winooski, VT, USA). The percentage 
cell viability was calculated by standardizing untreated (control) cells to 100% and then 
comparing FA treated cells to the control cells (Detailed calculation shown as supplementary 
information). The concentration of half maximum inhibition (IC50) was determined using 
GraphPad Prism v5.0 software. All assays were performed in triplicate, twice independently. 
 
• Cell death parameters  
 
• PS Externalization 
 
Flow cytometry was performed to determine the externalization of PS. Following treatment, 
100 µl of an Annexin V-FITC Fluos solution (1:1:50; annexin V-FITC: PI: staining buffer) 
was added to each sample (200,000 cells in 100 µl PBS) and incubated in the dark at room 
temperature (RT, 15 min). Thereafter, the samples (20,000 events) were analyzed for 
apoptosis on the AccuriTM C6 flow cytometer. The cells were gated to exclude cellular 
debris using the Fl-1 channel (525 nm) (BD Biosciences, Johannesburg, SA). The results 
were expressed as a percentage. 
 
• LDH activity 
 
The LDH cytotoxicity detection kit (Roche, Mannheim, Germany) was used to confirm 
damaged/necrotic cells. In brief, cell homogenates (100 µl) were seeded into a 96-well 
opaque polystyrene microtitre plate in triplicate. Subsequently, 100 µl of a substrate mixture 
containing a catalyst (diaphorase/NAD+) and dye solution (INT/sodium lactate) was added to 
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each homogenate and incubated in the dark for 25 min (RT). The optical density was 
measured (500 nm) using a spectrophotometer (Bio-Tek uQuant, Winooski, VT, USA). The 
results were reported as mean optical density. 
 
• Caspase activity  
 
Caspase activities of -8, -9 and -3/7 were determined using luminometry. Cells (20,000 
cells/well) were seeded into a 96-well opaque polystyrene microtitre plate in triplicate. 20 
µl/well of the reagent (Caspase-Glo® 3/7, Caspase-Glo® 8 and Caspase-Glo® 9 Assays) was 
added to each sample and incubated in the dark for 30 min (RT). Thereafter, the 
luminescence was measured on a Modulus™ microplate luminometer (Turner Biosystems, 
Sunnyvale, USA). All data was expressed as relative light units (RLU). 
 
• Evaluation of oxidative stress 
 
• Lipid peroxidation 
 
The TBARS was used to determine FA generation of ROS 61. Briefly, cell homogenates (400 
µl) were added to a 7% phosphoric acid (400 µl) and a thiobarbituric acid (1%w/v)/ butylated 
hydroxytoluene (0.1 mM) (TBA/BHT) solution. A positive control containing MDA (1 µl) 
and a negative control containing 3 mM hydrogen chloride were prepared. All samples were 
heated in a water bath (100 0C, 15 min) and allowed to cool (RT). Thereafter, lipids were 
extracted with butanol (1.5 ml) and were measured on a spectrophotometer (Bio-Tek uQuant, 
Winooski, VT, USA) at 532 nm with reference wavelength of 600 nm. The mean optical 
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density for each sample was calculated and divided by the absorption coefficient (156 mM-1). 
The results were expressed in µM. 
 
• Mitochondrial membrane potential 
 
Mitochondrial membrane potential was measured using the JC-1 Mitoscreen kit (BD 
Biosciences, Johannesburg, SA) and flow cytometry. Briefly, 100 µl of a JC-1 working 
solution was added to each sample (200,000 cells in 100 µl PBS) and incubated in the dark 
for 30 min (RT). Following incubation, 100 µl flow cytometry sheath fluid was added to each 
sample and were analyzed on the AccuriTM C6 flow cytometer. A total of 20 000 events 
were gated using AccuriTM C6 flow cytometer Fl-1 channel (525 nm) (BD Biosciences, 
Johannesburg, SA). The results were expressed as a percentage. 
 
• ATP levels 
 
Intracellular ATP levels were measured using the ATP CellTitre Glo reagent (Promega, 
Madison, USA). Following treatment, 20,000 cells/well were seeded into a 96-well opaque 
polystyrene microtitre plate in triplicate. The reagent (20 µl/well) was added to each sample 
and incubated in the dark for 30 min (RT). Thereafter, the luminescence was measured on a 
ModulusTM microplate luminometer (Turner Biosystems, Sunnyvale, USA). The data was 
expressed as relative light units (RLU). 
 
• Western blotting 
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Western blots were performed to analyze the protein expressions of p-ERK, p-JNK, p-p38, 
Bax and p-Bcl-2. Briefly, total protein was isolated using CytobusterTM reagent (Novagen, 
San Diego, CA, USA). Cells were re-suspended in 200 µl Cytobuster and incubated on ice 
for 30 min. Following incubation, the cells were centrifuged for 10 min (180 xg, 4 0C). 
Protein samples were quantified by the bicinchoninic acid (BCA) assay and standardized to 
0.2 mg/ml (PBMCs) and 1.0 mg/ml (Thp-1). The samples were then boiled in Laemmli 
Sample buffer (dH20, 0.5 M Tris-HCl (pH 6.8), glycerol, 10% SDS, β-mercaptoethanol, 1% 
bromophenol blue) for 5 min (100 0C). Thereafter, the samples (25 µl- Thp-1; 40 µl- PBMC) 
were electrophoresed in sodium dodecyl sulphate polyacrylamide (SDS-PAGE) gels (4% 
stacking gel, 7.5% resolving gel) for 1.5 h at 150 V (Bio-Rad compact power supply). The 
separated proteins were electro-transferred onto nitrocellulose membranes for 30 min (400 
mA) using the Trans-Blot Turbo Transfer system (Bio-Rad). The membranes were then 
blocked for 1 h (RT) with 5% bovine serum albumin (BSA) in Tris Buffer Saline with tween 
20 (TTBS- NaCl, KCl, Tris, dH2O, 0.5% tween 20, pH 7.5) or 5% Non-Fat Dry Milk 
(NFDM) in TTBS for phospho- and non-phospho- antibodies, respectively. Thereafter, the 
membranes were incubated with primary antibody [mouse anti-p-ERK (9106), mouse anti-p-
JNK (9255), rabbit anti-Bax (5023), rabbit anti-p-Bcl-2 (2827), Cell Signalling, 1: 1000; 
mouse anti-p-p38 (M8177), β-actin (A3854), Sigma Aldrich, 1: 5000] for 1 h (RT) and then 
overnight at 4 0C. The membranes were washed 5 times with TTBS (10 min intervals) and 
incubated (RT) with horseradish peroxidase (HRP)- conjugated secondary antibody [goat 
anti-rabbit (ab6112), anti-mouse (ab97046), Abcam, 1: 5000] for 1 h. Once more, the 
membranes were washed 5 times with TTBS (10 min intervals). Protein band images were 
detected using Clarity Western ECL Substrate (Bio-Rad) and captured using Alliance 2.7 
Image documentation system (UViTech, Cambridge, UK). The expression of protein bands 
was analyzed using UViBand Advanced Image Analysis software v12.14 (UViTech, 
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Cambridge, UK). All proteins were normalized to β-actin before comparison (i.e. control vs. 
FA treatment. The data was expressed as relative band intensity (RBI). 
 
• Statistical analysis 
 
Statistical analysis was performed using GraphPad Prism v5.0 software (GraphPad Software 
Inc., La Jolla, USA). GraphPad Prism Software was used for the unpaired t-test with Welch’s 
correction to assess the differences between samples. Level of significance (p) was 
established at a p<0.05. 
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CHAPTER THREE 
 
Manuscript title: Fusaric acid alters Akt and AMPK signalling in C57BL/6 mice brain tissue 
 
The previous chapter (Chapter 2) demonstrated FA acute toxicity against lymphoid (PBMCs) and 
myeloid cells (Thp-1 cells), showing moderate toxicity to healthy PBMCs, with significant energy 
deficits in both PBMCs and Thp-1 cells. At the organism level, immune hypometabolic states not only 
significantly impact immune function but also immune interactions with several effector organs in order 
to maintain systemic homeostasis. In particular, compromised immune activity may lead to impaired 
neuronal regulation of body temperature, sleep and appetite. FA-induced immunotoxicity and its 
potential impact on the nervous system, could result in concurrent hypometabolic effects in neuronal 
cells which are critically important due to the brains’ high energy demand. Glucose is the primary 
energy source for the brain and facilitates cellular ATP production that is regulated by the AMPK and 
PI3K/Akt signalling cascades. AMPK is a major metabolic sensor that is activated in response to ATP 
depletion or by alterations in intracellular calcium levels, acting as a nuclear regulator of energy 
metabolism in order to shut down ATP-consuming pathways; Whilst, the PI3K/Akt pathway and its 
downstream mediators (GSK3, mTORC1) have been shown to be central players in regulating neuronal 
survival, cellular energy and metabolism, independent of cellular metabolic states. Given the emerging 
importance of metabolic dysregulation underlying several brain diseases, including amyotrophic lateral 
sclerosis (ALS), Alzheimer's, Parkinson's and Huntington's disease; and that FA targets the brain and 
induces significant immuno-metabolic toxicity, the following chapter aimed to determine the 
neurometabolic effects of FA and its influences on metabolic AMPK and Akt signalling pathways in 
murine brain tissue.  
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ABSTRACT  
 
The brain is a highly metabolic organ and requires regulatory mechanisms to meet its high 
energy demand, with the PI3K/Akt and AMPK signalling pathways being central regulators 
of cellular energy and metabolism, also making them major targets for the development of 
neurometabolic disorders. Fusaric acid (FA), a toxin of fungal origin, was found to be a 
potent hypotensive agent in vivo and in clinical trials by altering brain neurochemistry thus 
demonstrating its neurological effects. Notably, FA is a putative mitochondrial toxin, 
however, the metabolic effects of FA in the brain remains unknown. Therefore, this study 
investigates the neurometabolic effects of FA via alterations to Akt and AMPK signalling 
pathways in C57BL/6 mice at acute (1 day) and prolonged exposure (10 days). Following 1 
day exposure, FA augmented Akt signalling by increasing Akt S473 phosphorylation and the 
upstream regulators PI3K, mTOR and p70S6K. Activated Akt showed inhibition of GSK3 
activity with the simultaneous activation of AMPK, p53 phosphorylation and reduced GLUT-
1 and -4 receptor expressions, potentially suppressing neuronal glucose entry. However, after 
10 days exposure, FA dampened PI3K/Akt and AMPK signalling, but increased the 
expression of GLUT receptors (1 and 4) in mice brain. Further, FA significantly depleted 
ATP levels, at 10 days exposure, despite increased PDHE1β activity (at both 1 and 10 days), 
strongly suggesting that FA mediates ATP depletion independent of metabolic signalling. In 
conclusion, FA mediates neurometabolic disturbances, at 1 and 10 day exposures, which may 
negatively influence normal brain aging and predisposes to neurodegenerative disorders.1 
                                               
1 Abbreviations: 
Fusaric acid (FA); Phosphoinositide 3-kinase (PI3K); Protein kinase B (Akt); mammalian 
target of rapamycin (mTOR); Ribosomal protein S6 kinase (p70S6K); Glycogen synthase 
kinase 3 (GSK3); pyruvate dehydrogenase E1β (PDHE1β); pyruvate dehydrogenase kinase 1 
(PDK1); AMP-activated protein kinase (AMPK); glucose transporter (GLUT); tricarboxylic 
acid (TCA) 
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Keywords: Fusaric acid, Akt, AMPK, ATP, GLUT4, brain 
 
1. INTRODUCTION 
 
Fusaric acid (FA, 5-butylpicolinic acid), a picolinic acid derivative, is a mycotoxin produced 
by the Fusarium species and was first recognised in the 1960’s, for its potency against 
dopamine-beta-hydroxylase activity (Goodwin and Sack, 1975; Hidaka et al., 1969; 
Nagasaka et al., 1985; Sack and Goodwin, 1974; Toshiharu et al., 1970). In animals, FA 
toxicity is associated with the induction of emesis, loss of appetite and lethargy (Smith, 
1992). Studies have also reported FA’s role in plant pathogenesis and metabolic toxicity in 
both plants and animals, resulting in alterations in mitochondrial activity and inhibition of 
ATP synthesis, cell proliferation and DNA synthesis (Bharathiraja et al., 2010; D'Alton and 
Etherton, 1984; Pavlovkin et al., 2004). Despite its toxic potential, FA’s ability to alter brain 
neurochemistry by increasing tryptophan and serotonin levels have proven beneficial against 
hypertension and neurological diseases (Goodwin and Sack, 1975; Matta and Wooten, 1973; 
Terasawa and Kameyama, 1971; Terasawa et al., 1976). Although FA has been shown to be 
neurologically active, it’s metabolic effects on the brain remains unknown. 
 
While the brain only constitutes about 2% of whole body weight, it requires a consistent and 
substantial supply of energy (Bélanger et al., 2011; Magistretti and Allaman, 2015; Raichle 
and Gusnard, 2002). Although glucose is an obligatory energy source, the brain has the 
ability to efficiently utilize additional neuronal substrates, as well as, foster blood-derived 
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energy substrates to meet its energy requirements (Bélanger, et al., 2011; Magistretti and 
Allaman, 2015). At the same time, the brain is highly sensitive to glucose and oxygen 
deficiency hence an intricate control of neurometabolism is imperative (Ronnett et al., 2009; 
Wang et al., 2017). Over the past decade, several studies highlighted the role of AMP-
activated protein kinase (AMPK) in the regulation of neuronal energy homeostasis (Claret et 
al., 2007; Fu et al., 2012). AMPK is a cellular energy sensor that responds to increases in the 
AMP:ATP ratio. Due to this unique capability, AMPK is considered a master regulator of 
metabolism. Activation of AMPK via phosphorylation on the threonine-172 (T172) residue 
(Rosso et al., 2016) enhances energy generating processes [glucose uptake via glucose 
transporter (GLUT) recruitment and fatty acid oxidation] and dampens energy consuming 
processes (protein synthesis). With regard to neuronal activity, AMPK regulates 
mitochondrial metabolism and biogenesis (Fu et al., 2012). A study done on Neuro2α cells 
reported AMPK activation by resveratrol and increased transcripts of mitochondrial 
biogenesis markers - peroxisome proliferator-activated receptor gamma coactivator 1-α 
(PGC1-α) and mitochondrial transcription factor A (TFAM), and Mitofusin 2, a 
mitochondrial protein marker (Amato and Man, 2011). 
 
In addition to being induced by low ATP levels, AMPK activity can also be controlled by 
protein kinase B (Akt) through the alteration of glycogen synthase kinase 3 (GSK3) and p70 
ribosomal S6 protein kinase (p70S6K) activity (Bhattacharya, 2018; Longnus et al., 2005). 
Under basal conditions, Akt is expressed at low levels in the brain, but amplifies substantially 
upon neuronal stress (Dávila and Torres-Aleman, 2008; Yang et al., 2018). Activation of Akt 
is dependent on the phosphorylation of threonine-308 (T308) and serine-473 (S473) residues 
at its catalytic domain by phosphoinositide 3-kinase (PI3K) and mammalian target of 
rapamycin complex 2 (mTORC2), respectively (Hassan et al., 2013). Several studies have 
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shown that disturbances in these regulatory pathways may lead to the development of 
diabetes, obesity, Alzheimer’s disease and Parkinson’s disease (Fu et al., 2012; Rosso et al., 
2016). Although, the effect of FA on mitochondrial function and metabolism have been 
described, its metabolic effect and influence on these crucial pathways have not been 
investigated in the brain. Therefore, in this study we aimed to determine the effects of FA on 
neurometabolism through its role in the alteration of the Akt and AMPK metabolic signalling 
pathways in C57BL/6 mice brain. 
 
2. MATERIALS AND METHODS 
 
2.1. Ethics statement 
 
This study was performed in accordance to the standard approved guidelines of the 
institutional Animal Research Ethics Committee of the University of KwaZulu-Natal 
(AREC/079/016) and in accordance with the ARRIVE N3R guidelines (McGrath et al., 
2010). 
 
2.2. Animal and experimental design  
 
C57BL/6 black male mice were obtained from the Biomedical Resource Unit (BRU) at the 
University of KwaZulu-Natal and housed at the Africa Health Research Institute (AHRI) 
animal facility (University of KwaZulu-Natal, Durban) under standard conditions 
[temperature (23 + 1 ℃) and humidity (40-60 %), a 12-hour light/dark cycle] with ad libitum 
access to a commercially available animal feed and normal drinking water. Mice with mean 
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body weights (BW) of 18-22 g (6-8 weeks old) were randomly divided into four groups (n=3 
per group) for short- (1 day) and prolonged (10 days) treatments: two control groups (1 and 
10 days) and two FA-dosed groups (1 and 10 days). 
 
Fusaric Acid (Gibberella fujikuroi) was purchased from Sigma Aldrich (Johannesburg, SA). 
FA was administered orally via gavage (0.25 ml) once daily at a dose of 50 mg/kg (Reddy et 
al., 1996). Control groups received phosphate buffer saline (0.1 M PBS; 0.25 ml) (by oral 
gavage). At the end of the experimental periods (1 and 10 days), mice were euthanised by gas 
inhalation anaesthesia (Isofor; Safeline Pharmaceuticals). Brain tissue was surgically 
removed, rinsed well in PBS, and stored (-80 ℃) in Cytobuster ™ (Novagen, San Diego, CA, 
USA) and QIAzol lysis reagent (Qiagen, Germantown, MD) for protein and mRNA analysis 
respectively.  
 
2.3. Intracellular ATP levels 
 
Intracellular ATP levels were determined using the CellTiter-Glo kit (Promega, Madison, 
USA). Briefly, fresh brain tissue was dissociated (1-2 mm pieces) in Dulbecco’s Modified 
Eagle Medium (DMEM) containing collagenase type II (15 mg/ml) and incubated at 37 ℃ 
(40 min). The digest was centrifuged (500 xg, 10 min, 4 ℃), and the supernatant was 
aspirated. The pellet composed of live cells was re-suspended and centrifuged (1000 xg, 20 
min, 4 ℃) in DMEM containing 20% bovine serum albumin (BSA). The lipid layer was 
carefully aspirated and the pellet was re-suspended in serum-free DMEM (with 0.1% BSA) 
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for 30 min (37 ℃). Once more, the digest was re-suspended and centrifuged (500 xg, 10 min, 
4 ℃). The pellet was washed once with PBS and the density of viable cells (viable cells/ml) 
was assessed using the trypan blue exclusion method described by Strober (2015). 
Subsequently, the cells (20,000 cells/well) were seeded into a 96-well opaque polystyrene 
microtitre plate (triplicate) and incubated with the reagent (20 µl/ml) for 30 min (dark, RT). 
The luminescent signal was measured on a Modulus™ microplate luminometer (Turner 
Biosystems, Sunnyvale, USA) and was expressed as relative light units (RLU). 
 
2.4. Brain tissue preparation and protein phosphorylation array 
 
Brain tissue stored in Cytobuster TM reagent supplemented with protease and phosphatase 
inhibitors was homogenized mechanically and centrifuged at 10,000 xg (4 ℃, 10 min). 
Cytoplasmic protein fractions were aspirated and quantified by the bicinchoninic acid (BCA) 
assay. Phosphorylation of Akt/mTOR signalling proteins (p-Akt, p-mTOR, p-p70S6K, p-
GSK3α, p-GSK3β and p-p53) were detected using a Human/Mouse MAPK protein 
phosphorylation array (RayBiotech Inc., Norcross, USA) according to the manufacturer’s 
protocol. Briefly, membranes were incubated in blocking buffer (30 min, RT) before being 
incubated overnight (4 ℃) with protein lysates (standardised to 1 mg/ml in blocking buffer). 
Thereafter, the membranes were washed and incubated (overnight, 4 ℃) with a detection 
antibody cocktail. The membranes were subsequently washed and incubated at 4 ℃ 
(overnight) with an HRP-Anti-Rabbit IgG concentrate. The membranes were washed once 
more and incubated with a chemiluminescent detection buffer (Clarity™ ECL Western 
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detection reagent, Bio-Rad, 2 min, RT) before being captured on ChemiDoc XRS+ system 
(Bio-Rad, Johannesburg, SA). Signal spot intensities of phosphorylated proteins were 
quantified with Image Lab™ software 6.0.1 (Bio-Rad, Johannesburg, SA) and normalized 
against positive control spots for comparison (i.e. control vs. FA). This ratio (phosphorylated 
protein/positive control) was expressed as relative protein expression to the positive control. 
2.5. Immunoblotting 
 
Cytoplasmic protein was standardised to 1 mg/ml (in Cytobuster TM reagent) and boiled in 
Laemmli buffer (dH2O, 0.5 M Tris-HCl (pH 6.8), glycerol, 10 % SDS, β-mercaptoethanol, 1 
% bromophenol blue) for 5 min (100 ℃). Proteins were resolved by SDS-PAGE (7,5 %) and 
transferred to a nitrocellulose membrane. The membranes were blocked with 5 % BSA in 
Tween20 Tris-Buffer Saline (TTBS) for 1 hour (RT) and incubated (overnight, 4 ℃) with 
primary antibodies (Table 1). The membranes were washed (5x10 min) with Tris Buffer 
Saline with Tween 20 (TTBS- NaCl, KCl, Tris, dH2O, 0.5 % tween 20, pH 7.5) before an 
additional incubation (2 hrs, RT) in secondary antibody: anti-rabbit (1:5,000; 7074S), anti-
mouse (1:5,000; 7076S), Cell signalling. Chemiluminescent protein expressions were 
visualized using Clarity Western ECL Substrate (Bio-Rad, Johannesburg, SA) and captured 
on ChemiDoc XRS+ system (Bio-Rad, Johannesburg, SA). Protein band densities were 
quantified with Image Lab™ software 6.0.1 (Bio-Rad, Johannesburg, SA). All protein 
expressions were normalized against β-actin (1:5,000, Sigma Aldrich) before comparison to 
the respective control. The intensity ratios of the target proteins (measured relative to β-actin) 
and phosphorylated protein isoforms (measured relative to the total protein form) were 
expressed as relative protein expression.   
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Table 1: Primary antibodies for densitometric protein analyses by immunoblots 
 
Manufacturer Antibody name 
Host 
species 
Catalogue 
number 
Concentration  
Cell signalling 
Technology 
PI3 Kinase p110α Rabbit 4249S 1:1,000 
Akt Rabbit 9272S 1:1,000 
Phospho-AMPKα 
(Thr172) 
Rabbit 2335S 1:1,000 
AMPKα Rabbit 2532S 1:1,000 
Phospho-GSK-3α/β 
(Ser21/9) 
Rabbit 9331S 1:1,000 
GSK-3α/β Rabbit 5676S 1:1,000 
Abcam 
Glucose Transporter 
GLUT4 
Rabbit ab654 1:1,000 
PDK1 Rabbit ab207450 1:1,000 
Phospho-Pyruvate 
Dehydrogenase E1-ß 
subunit (Ser293) 
Mouse ab177461 1:1,000 
Phospho-Akt 
(Ser473) 
Rabbit ab81283 1:1,000 
 
2.6. GLUT mRNA expression 
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Total RNA from whole brain tissue was extracted with QIAzol reagent. Complementary 
DNA (cDNA) was synthesized from RNA (1,000 ng) using an iScriptTM cDNA Synthesis kit 
(Bio-Rad, Hercules, CA) in accordance with manufacturer’s instructions. Quantitative 
detection of GLUT mRNA [GLUT1: Sense 5’GGGAGAGCAAACGGAACCG3', Anti-sense 
5’CTGCCGAATTTTTCGCTGTCG3’; GLUT4: Sense 
5’CTGAAGGTGGAATACTTGGAGC3’, Anti-sense 
5’GCCCAGGAACTGTGAGAAGA3’] levels were detected using the iQTM SYBRÒ Green 
Supermix (Bio-Rad) as per manufacturer’s protocol and performed on the CFX96 TouchTM 
Real-Time PCR Detection System (Bio-Rad). Differences in gene expressions were 
normalized against housekeeping gene GAPDH [GAPDH: Sense 
5’ATGTGTCCGTCGTGGATCTGAC3’, Anti-sense 
5’AGACAACCTGGTCCTCAGTGTAG3’] and analysed according to the methods described 
by Livak and Schmittgen, (2001). The data was represented as relative fold change. 
 
2.7. Statistical analysis 
 
Statistical analysis was performed using GraphPad Prism v6.0 software (GraphPad Software 
Inc., La Jolla, USA). GraphPad Prism Software was used for the unpaired t-test with Welch’s 
correction. Results were expressed as mean + standard deviation (SD). Level of significance 
(p) was established at a p< 0.05. 
 
3. RESULTS 
 
3.1. FA depletes intracellular neuronal ATP levels 
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Given that FA decreased ATP levels in plants, animals and in vitro human models (Abdul et 
al., 2016; Bouizgarne et al., 2006; Dhani et al., 2017; Telles-Pupulin et al., 1998), we 
determined its metabolic effect in whole brain tissue following a once daily 50 mg/kg.b.w 
dose by measuring intracellular ATP levels using luminometry. Consistent with previous 
reports, there was a minimal decrease in ATP levels in mice brain by FA following a 1 day 
exposure (p < 0.3177); however, ATP levels decreased significantly after 10 days exposure (p 
< 0.0116) (Table 2).  
 
Table 2: The effect of FA exposure (1 and 10 days) on mice neuronal ATP levels  
 
Treatment 
period 
Mean + SD (RLUx104) 
Fold change p value 
Control FA 
1 day 6.235 + 0.964 5.690 + 0.824 0.91 0.3177 
10 days 3.555 + 0.324 2.356 + 0.771 0.66 0.0116# 
 
The data are represented as the mean + SD obtained from experiments performed in triplicate 
(n=3). RLU: relative light units. # p< 0.05 (FA relative to control 10 days). 
 
3.2. Effect of FA on neuronal PI3K/Akt/mTOR signalling 
 
As a result of FA-induced ATP depletion, we investigated its subsequent effect on the 
neurometabolic energy sensor AMPK, and metabolic regulator Akt. We first evaluated 
phosphorylation of PI3K/Akt/mTOR signalling cascade using a commercial MAPK protein 
phosphorylation array. After 1 day of FA exposure, Akt signalling was significantly activated 
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as evidenced by the increased S473 phosphorylation (p < 0.0001), its upstream regulator, 
mTOR at serine-2448 (S2448) (p < 0.0010) and, threonine-421/serine-424 (T421/S424) 
phosphorylation on p70S6K (p < 0.0001) (Figures 1A and 1B). However, mice treated with 
FA over 10 days showed decreased phosphorylation of both mTOR (S2448) (p < 0.0018) and 
p70S6K (T421/S424) (p < 0.1257). These results paralleled the significantly reduced S473 
Akt phosphorylation (10 days) (p < 0.0107) as observed from the protein arrays (Figures 1A 
and 1B). 
 
To validate the protein array results, we then analysed the ratio between phosphorylated/total 
Akt and its upstream activator, PI3K by immunoblotting. Densitometric analysis illustrated a 
significant increase in PI3K expression at day 1 (p < 0.0001) (Figures 2A and 2B) and 
confirmed the activation of Akt (array), but no significant differences were noted with Akt 
S473 phosphorylation (1 and 10 days, p < 0.6070 and p < 0.2242, respectively) (Figures 2A 
and 2B). The data demonstrates that FA induced activation of Akt signalling following an 
acute exposure (1 day) whilst dampening Akt signalling at a prolonged exposure (10 days).  
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Figure 1: Effect of FA exposure on Akt signalling in mice brain tissue at 1 and 10 days 
exposure. Densitometric analysis of PI3K/Akt/mTOR signalling pathway proteins (A) were 
analysed using a MAPK protein phosphorylation array (B) for p-AktS473 (1), p-GSK3αS21 (2), 
p-GSK3βS9 (3), p-mTORS2448 (4), p-p53S15 (5) and p-p70S6KT421/S424 (6). The data are 
represented as the mean + SD obtained from experiments performed in triplicate (n=3). * p < 
0.05, ** p < 0.005, *** p < 0.0005 **** p < 0.0001 (FA relative to control 1 day); # p < 0.05, 
## p < 0.005 (FA relative to control 10 days). 
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Figure 2: Validations on the effect of FA on the activation of Akt signalling in mice 
brain tissue at 1 and 10 days exposure. Relative densitometric (A) and protein expressions 
of PI3K, p-AktS473 and Akt were quantified by immunoblotting (B). Detection of β-actin was 
used as an internal control. The data are represented as the mean + SD obtained from 
experiments performed in triplicate (n=3). **** p < 0.0001 (FA relative to control 1 day). 
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3.3. FA regulation of GSK3α/β phosphorylation through Akt signalling and attenuates 
phosphorylation of PDHE1β 
 
To elucidate the downstream mechanism by which Akt phosphorylation regulates 
neuroenergetics, we investigated the expression of GSK3, a downstream component of Akt 
signalling, known for its role in regulating mitochondrial energy metabolism (Case et al., 
2011; Maixner and Weng, 2013; Manning and Toker, 2017; Martin et al., 2018; Medina and 
Wandosell, 2011; Salcedo-Tello et al., 2011; Uranga et al., 2013; Vincent et al., 2011). In 
response to FA-induced Akt phosphorylation and activation, both isoforms of GSK3 (GSK3α 
and GSK3β) were phosphorylated and inhibited at serine-21 (p < 0.0006) and serine-9 (p < 
0.0275), respectively (1 day) (Figures 1A and 1B), while FA decreased serine 
phosphorylation on GSK3α (S21) (p < 0.8450) and GSK3β (S9) (p < 0.1602) at 10 days, 
thereby increasing its activity (Figures 1A and 1B). Changes in FA-induced GSK3α/β 
phosphorylation were confirmed by assessing differences in the ratio between phosphorylated 
GSK3α/β over total GSK3α/β by immunoblotting. Western blotting revealed a decreased S21 
expression on GSK3α following acute FA exposure (p < 0.0497) whilst its expression 
remained unchanged at 10 days (p < 0.7384) (Figures 3A and 3B). Additionally, FA 
increased S9 phosphorylation on GSK3β at both 1 (p < 0.0006) and 10 days (p < 0.0001) 
(Figures 3A and 3B). These discrepancies could be due to minor differences in total protein 
expression. 
 
GSK3 has been shown to regulate mitochondrial function by modulating the activity of 
PGC1-α in human H4 neuroglioma cells (Martin, et al., 2018). Thus, as a result of decreased 
ATP levels, we assessed the expression of pyruvate dehydrogenase E1β (PDHE1β), a 
regulatory subunit of glycolysis and the tricarboxylic acid (TCA) cycle and, its aerobic 
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glycolytic regulator and a PGC1-α gene target, pyruvate dehydrogenase kinase 1 (PDK1). 
PDK1 expression was significantly decreased at 1 day (p < 0.0006) but increased at 10 days 
(p < 0.0018) following exposure to FA (Figures 3A and 3B). Next, we measured serine-293 
(S293) phosphorylation, an inhibitory site on PDHE1β targeted by PDK1. Interestingly, FA 
significantly reduced S293 phosphorylation of PDHE1β at both exposure times (p < 0.0338, p 
< 0.0125) respectively (Figures 3A and 3B). This suggests that PDHE1β was still functional 
despite the increased PDK1 protein levels at 10 days.  
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Figure 3: FA regulates Akt-GSK3α/β phosphorylation and prevents PDHE1β inhibition 
in mice brain tissue at 1 and 10 days exposure. Densitometric protein quantification (A) 
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and expression (B) of p-GSK3α/βS21/S9, PDK1 and p-PDHE1βS293 were detected by 
immunoblotting. Expression of β-actin was used as an internal control. The data are 
represented as the mean + SD obtained from experiments performed in triplicate (n=3). * p < 
0.05, *** p < 0.0005 (FA relative to control 1 day); # p < 0.05, ## p < 0.005, #### p < 0.0001 
(FA relative to control 10 days). 
 
3.4. FA modulation of AMPK-mediated p53 metabolic signalling and GLUT4 
expression 
 
It is well-established that several points of cross-regulation exist between the PI3K/Akt 
pathway and other major signalling pathways in maintaining cellular energy homeostasis. 
Therefore, the effect of FA on the energy sensor AMPK in mice brain tissue was 
investigated. Although, ATP levels were slightly decreased (1 day), AMPK activity was 
amplified as indicated by the increased threonine-172 (T172) phosphorylation (p < 0.0026) 
(Figures 4A and 4B). Surprisingly, despite a significant decline in ATP levels at 10 days, 
T172 phosphorylation was decreased (p < 0.0169) thus reducing the activity of AMPK 
(Figures 4A and 4B). Since glucose is the primary source of energy in the brain, and 
variances in its entry and metabolism could alter energy levels, we assessed the expression of 
the transcription factor p53 in response to the disparities in ATP levels and AMPK activation. 
The metabolic regulation of p53 is directed by GSK3 and AMPK; consistent with AMPK 
activation, p53 serine-15 (S15) phosphorylation was increased (1 day) (p < 0.0038) and 
decreased (10 day) (p < 0.0084) accordingly (Figures 1A and 1B), indicating that activation 
of p53 was targeted by AMPK and not GSK3. To understand the interaction of AMPK and 
p53, we measured the expression of GLUT1 and GLUT4 receptors, whose expression is 
negatively regulated by p53. As expected, GLUT4 transcript and protein expressions were 
 
 98 
decreased (1 day; p < 0.0001) and increased (10 day; p < 0.0001) in correlation with p53 
activity (Figures 4A, 4B and 4C). Likewise, GLUT1 transcript levels were down- (1 day; p < 
0.0001) and up-regulated (10 day; p < 0.0054) after exposure to FA (Figure 4C).  
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Figure 4: FA regulates p53 metabolic signalling and GLUT4 expression via AMPK 
signalling in mice brain tissue at 1 and 10 days exposure. Densitometric (A) and protein 
expressions (B) of p-AMPKT172, AMPK and GLUT4 were measured by immunoblotting. β-
actin was used as an internal control. GLUT1 and GLUT4 transcript levels were quantified 
using qPCR (C). The data are represented as the mean + SD obtained from experiments 
performed in triplicate (n=3). ** p < 0.005, **** p < 0.0001 (FA relative to control 1 day); # 
p < 0.05, ## p < 0.005, #### p < 0.0001 (FA relative to control 10 days). 
 
4. DISCUSSION 
 
In this study, we investigated the neurometabolic potential of FA and its subsequent 
alterations in molecular signalling pathways. Several studies have described the metabolically 
toxic potential of FA, with reports of mitochondrial toxicity in plant tissue (Bouizgarne et al., 
2004; D'Alton and Etherton, 1984; Köhler and Bentrup, 1983; Telles-Pupulin et al., 1996a) 
and catecholamine disturbances in animals (Chowdhury and Smith, 2004; Leung et al., 2007; 
Raymond et al., 2003; Swamy et al., 2002; Yegani et al., 2006). Consistent with this, ATP 
levels were reduced in brain tissue upon FA administration (1 day), and decreased more 
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significantly following a prolonged exposure (10 days). As a result of ATP-depleted levels, 
glucose-uptake regulatory signalling pathways, Akt and AMPK, were activated (1 day). Since 
PI3K and mTOR regulate Akt activity by phosphorylation of T308 and S473 residues, 
respectively, (Abeyrathna and Su, 2015; Islam et al., 2014; Vadlakonda et al., 2013; Vincent, 
et al., 2011; Yung et al., 2011) we assessed their expressions and found an increase in both 
(PI3K and mTOR) following an acute exposure to FA (1 day) (Figures 1A, 1B, 2A and 2B), 
confirming the activation of Akt signalling. A study by Polter et al., (2009), reported 
increased brain serotonin levels and activation of PI3K/Akt signalling upon administration of 
D-fenfluramine in C57BL/6 mice. In support of Akt activation (1 day), various studies 
showed elevated brain tryptophan and serotonin synthesis by FA (Chaouloff et al., 1986; 
Diringer et al., 1982; Ogunbo et al., 2005; Porter et al., 1995), which may also contribute to 
the regulation of Akt signalling. In contrast, 10 day administration of FA suppressed Akt 
stimulation (Figures 1A, 1B, 2A and 2B); since activation of Akt is ATP-dependent, 
dampening its activation may further prevent ATP depletion. 
 
Literature indicates an array of metabolic targets regulated by GSK3, making this enzyme 
among the most extensively studied substrates regulated by Akt (Case, et al., 2011; Uranga, 
et al., 2013). In correlation with Akt activation at 1 day, GSK3 activity was negatively 
regulated by PI3K/Akt/mTOR signalling (Figures 3A and 3B) and likely influenced 
neurometabolism by modulation of the PGC1-α target PDK1. PDK1 responds to high ATP 
and low oxygen levels and regulates PDHE1β activity by inhibiting phosphorylation on S293 
(Kumar et al., 2012; Rardin et al., 2009). Together with decreased ATP levels and GSK3 
inhibition (1 day), PDK1 levels were reduced hence promoting oxidative metabolism by 
PDHE1β (Figures 3A and 3B). Interestingly, despite the sequestered inhibition of its 
upstream regulators, GSK3 and PDK1, PDHE1β remained active following prolonged 
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exposure to FA (10 days) (Figures 3A and 3B), with ATP levels being further depleted (Table 
2). Telles-Pupulin and colleagues, showed that FA impairs mitochondrial respiratory activity 
in maize root mitochondria (1996b) and rat liver mitochondria (1998) at least in part by 
inhibition of succinate dehydrogenase, α-ketoglutarate dehydrogenase or ATPase/ATP-
synthase activity; suggesting that FA affects ATP production more significantly than ATP 
consumption. Another study by Mailloux et al., (2009) revealed that a loss of α-ketoglutarate 
dehydrogenase and succinate dehydrogenase activity elevated succinate concentrations; while 
several independent studies have coupled the regulation of hypoxia inducible factor-1α (HIF-
1α) (transactivates PDK1 gene expression) with increased succinate levels in the brain 
(Chinopoulos, 2013; Kim et al., 2006; Lukyanova and Kirova, 2015; Rutter et al., 2010; 
Semba et al., 2016). Thus, it’s possible that the significant reduction of ATP levels seen at 
prolonged exposure to FA (10 day) led to an accumulation of TCA substrates that induced 
PDK1 activity, mediated by HIF-1α. 
 
The tumor suppressor protein p53 is commonly known for its role DNA repair (Chang et al., 
2012; Merlo et al., 2014; Nagasaka et al., 2006). In the past few decades, its role in 
metabolism emerged (Berkers et al., 2013; Jiang et al., 2015; Maddocks and Vousden, 2011). 
In response to metabolic changes such as metabolic stress or glucose deprivation, kinases 
such as GSK3 and AMPK regulate p53’s metabolic activity by phosphorylating and 
activating it on its S15 residue (Agarwal et al., 2015; Boehme et al., 2008; Jones et al., 2005; 
Loughery et al., 2014; Qu et al., 2004). Since acute administration of FA inhibited GSK3 
activity, it can be insinuated that p53 activity was activated in response to AMPK activation 
(Figures 4A and 4B). p53 is a negative regulator of glycolysis and transcriptionally represses 
the expression of GLUT1 and GLUT4 (Gnanapradeepan et al., 2018; Liang et al., 2013; 
Schwartzenberg-Bar-Yoseph et al., 2004; Zhang et al., 2014). The importance of glucose 
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transporters is now well-established in facilitating glucose diffusion into the brain; with high 
expressions of GLUT-1 (in glia) and -3 (in neurons), and to a lesser extent GLUT4; 
consistent with the high requirement of glucose for normal brain functioning. Correlating 
with p53 activity, GLUT-1 and -4 expressions were decreased at acute exposure to FA 
(Figures 4B and 4C). This was further substantiated by the reversal of p53 activation and 
GLUT-1 and -4 suppression following AMPK attenuation in mice administered with FA for 
10 days (Figures 4B and 4C).  
 
Although a key function of AMPK is to recondition energy levels in response to low ATP 
availability (Dagon et al., 2012; Hurtado-Carneiro et al., 2012; Yang et al., 2012), AMPK 
prevented glucose receptor expression at an acute exposure to FA. Interestingly, prolonged 
administration of FA dampened AMPK signalling promoting GLUT4 expression and glucose 
uptake (Figures 4A, 4B and 4C); likely to promote ATP production as ATP levels were 
further depleted. Taken together, these observations suggest that FA alters neuronal 
metabolic homeostasis by decreasing ATP volume and modifying glucose-mediated entry by 
counter-regulatory cross-talk between the Akt and AMPK signalling pathways (Fig. 5). The 
implications of these findings are significant with several experimental and clinical studies 
associating altered glucose transporter gene expressions and decreased ATP levels with 
premature aging and the progression of neurodegenerative diseases such as Alzheimer’s and 
Parkinson’s disease. Multiple studies have also shown impaired mitochondrial function as a 
common feature in cognitive dysfunction and behavioural disorders. Lastly, it is important to 
consider further investigations to determine how neuronal tissue may compensate for FA-
induced glycolytic reprogramming and energy depletion. 
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Figure 5: Schematic diagram summarising the alterations to Akt and AMPK signalling 
pathways by FA in mice brain tissue at acute (1 day) and prolonged (10 day) exposures. 
 
5. CONCLUSION 
 
To conclude, this study demonstrates a mechanism by which FA differentially controls 
glucose receptors by modulation of Akt and AMPK signalling pathways. This is of particular 
significance considering the high metabolic activity of the brain and its dependency on 
glucose as its primary fuel source. Additionally, FA impairs neuronal ATP production, and to 
a greater extent upon prolonged exposure in mice. Collectively, our findings bring a new 
dimension of FA’s role in metabolism with implications in neuronal-mediated regulation of 
glucose homeostasis and its influences on several aspects of brain development, aging and 
behaviour. 
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CHAPTER FOUR 
 
Manuscript title: Differential regulation of CREB/BDNF signalling by Fusaric acid in C57BL/6 
mice brain tissue 
 
Impaired homeostatic function by immune cells (such as the cytokine mediated regulation of appetite), 
and cerebral energy deficits are commonly seen in patients who present with psychiatric and 
neurodegenerative disorders. Although FA was moderately toxic to healthy immune cells (Chapter 2), 
both the previous chapters (Chapters 2 and 3) revealed substantial immuno- and neuro-metabolic 
deficits, which have significant implications on brain function and has the potential for the subsequent 
development of neurological disorders. CREB is an important intracellular protein that regulates the 
expression of genes involved in neuronal survival, development, inflammation and metabolism such as 
B Cell Lymphoma-2 (Bcl-2), insulin-like growth factor 1 (IGF-1), leptin and BDNF. Importantly, 
CREB/BDNF signalling was found to be a critical component of the neuroprotective transcriptional 
network, and its dysregulation contributes to an array of neuropathological conditions. Furthermore, 
CREB activity and its target genes are regulated by neurotransmitters, growth factors, neurotrophins 
and various upstream kinases including MAPKs, calmodulin-dependent protein kinases and protein 
kinases -A, -B (Akt) and -C. Since FA demonstrates the ability to modify the activity of several protein 
kinases, including MAPK (Chapter 2) and Akt (Chapter 3), the following chapter aimed to determine 
the neurotoxicity of FA and its alterations to MAPK/CREB/BDNF signalling in C57BL/6 mice.  
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ABSTRACT 
 
Fusaric acid (FA), a Fusarium metabolite identified for its potency against dopamine-β-hydroxylase, alters brain 
neurochemistry and exhibits substantial inhibitory effects on mitochondrial respiration, represents an important 
risk factor to neurometabolic-related diseases. However, FA’s neurotoxicological relevance in human and 
animal health is limited. cAMP response element binding (CREB) is an essential transcription factor that is 
responsible for neuroprotective responses through the regulation of neurotrophic and metabolic signals in the 
brain. Therefore, the present study investigated the neurotoxic potential of FA (50 mg/kg) and its influence on 
CREB signalling in C57/BL6 mice following short (1 day) and prolonged exposures (10 days). FA increased 
caspase activities at 1- and to a lesser extent at 10-days post exposure. However, despite enhanced caspase 
activity, there were no histological markers of cellular damage to extracellular tissue or neuronal cells, 
evidenced by microanalysis of brain tissue. Further, FA enhanced CREB signalling by increasing CREB serine-
133 phosphorylation with a simultaneous increase in brain derived neurotrophic factor (BDNF) expression 
whilst suppressing CREB/BDNF signalling following 10-day exposure. In contrast, protein expressions of 
mitogen-activated protein kinases (MAPK) (ERK, JNK and p38) negatively correlated with CREB activity; 
inferring FA induced MAPK-independent activation of CREB responses. Although FA showed no significant 
neurotoxicity, alterations in glial cell density patterns at both acute and prolonged exposures were observed. 
Collectively, FA alters CREB/BDNF signalling with profound influences on neuronal function via glial cell 
modifications and could impact normal brain functions and may play a role in the development of neurological 
disorders. 
 
Keywords: Fusaric acid, MAPK, CREB, BDNF, Brain 
 
INTRODUCTION  
 
Fusarium species frequently contaminate grain and cereal products worldwide and produce many secondary 
chemical metabolites known as mycotoxins that are associated with various acute and chronic diseases in 
humans, presenting a growing concern to both human and animal health [1-3]. In the 1960’s Fusaric acid (FA, 
5-butylpicolinic acid), a Fusarium mycotoxin widely known for its phytotoxicity, was first identified as a 
dopamine-β-hydroxylase inhibitor [4-8]. Since then, several in vivo behavioural studies have associated FA 
toxicity with lethargy, loss of appetite and vomiting [8] while other studies (preclinical and clinical) showed 
elevated levels of tryptophan, serotonin and dopamine as distinct FA-induced neurological effects; a response 
believed to occur as a result of the competitive binding of tryptophan to albumin in circulation [8-11]. In 
addition, the lipophilic nature of FA, enables easy penetration of cell membranes and ability to cross the blood 
brain barrier to exert its neurological effects. However, FA’s neurological impact in human and animal health 
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are poorly documented. Although the precise mechanism of FA toxicity is unclear, various studies have 
attributed the toxicity of FA to impaired mitochondrial function, ATP synthesis, and cell proliferation [6,4,5]. 
 
Several converging reports demonstrate mitochondrial dysfunction and inflammatory changes as key 
pathological phenomena’s in many neurodegenerative disorders including Alzheimers’s, Parkinson’s and 
Huntington’s diseases [12-14]. Over the past decade, multiple studies have emphasized the significance of the 
transcription factor CREB in neuropathologies given its functions in neurophysiological processes such as 
neurodevelopment, synaptic plasticity, and neuroprotection [15-17]. A recent study by Brady et al., (2016) 
showed that neuronal cell loss was associated reduced CREB activity; whilst, increased CREB phosphorylation 
inhibits neuroinflammation and improves neuronal function in a murine model of Alzheimer’s disease. CREB 
facilitates its neuroprotective properties via neurotrophin-mediated process, with BDNF, an essential 
neurotrophin associated with neuronal survival, differentiation and synaptic plasticity, being a direct target of 
CREB [18,19]. Accordingly, accumulating evidence has demonstrated the link between reduced CREB activity 
and low BDNF levels with increased neuronal injury in neurodegenerative diseases [18,19]. 
 
Additionally, CREB is well-established for its role as a metabolic sensor in fat, liver and brain tissue and 
recently in the hypothalamic control of appetite and food intake [16,15]. A study by Fusco et al., [20] reported 
significant transcriptional reduction of neuronal metabolic genes in CREB deficient dietary-restricted mice. The 
activity of CREB is largely dependent on the phosphorylation of its serine-133 (S133) residue that is regulated 
by neurotransmitters and several upstream kinases including MAPKs, calmodulin-dependent protein kinases and 
receptor-activated protein kinases [protein kinase A (PKA), protein kinase B (Akt) and protein kinase C (PKC)] 
[21,22,15]. In particular, MAPKs are one of the major regulators of CREB activity and was previously 
implicated in Alzheimers’s, Parkinson’s and various cancers [23-25]. Evidently, phosphorylation of CREB is 
crucial for several neurophysiological responses and alterations to its signal transduction are therefore highly 
relevant as modulators of neurological pathogenic processes.  
 
We have previously shown altered MAPK activity in FA-associated immunotoxicity, and substantially depleted 
energy levels whereby immune cells became hypometabolic. This effect has significant implications on brain 
functioning and subsequent development of neurological disorders. However, the relationship between 
neurometabolism and neurotoxicity of FA and its influence on its neurological manifestations remain elusive. 
The current study aimed to determine the neurometabolic toxicity of FA and its alterations to CREB/BDNF 
signalling in C57BL/6 mice. 
 
EXPERIMETAL DESIGN  
 
Reagents  
 
Fusaric Acid (Gibberella fujikuroi) was purchased from Sigma Aldrich (Johannesburg, SA). Luminometry 
reagents were obtained from Promega (Madison, USA).  
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Animals  
 
All animal procedures were approved by the institutional Animal Research Ethics Committee of the University 
of KwaZulu-Natal (AREC/079/016) and were performed in accordance with the Standard Approved Protocols 
(University of KwaZulu-Natal) guidelines. Experiments were performed using C57BL/6 black male mice 
obtained from the Biomedical Resource Unit (University of KwaZulu-Natal). Mice were housed at the Africa 
Health Research Institute (AHRI, University of KwaZulu-Natal) under standard conditions of temperature (23 + 
1°C) and humidity (40-60%) controlled environment, on a 12-hour (hr) light/dark cycle. All mice received 
commercially available animal feed (mouse pellet diet) and normal drinking water ad libitum. 
 
Experimental procedure and brain tissue harvest 
 
C57BL/6 mice aged 6-8 weeks (mean body weight 18-22 g) were randomly divided into four groups (n=3 per 
group): with two control groups (1 and 10 days) and two FA-treated groups (1 and 10 days). Experimental 
groups were administered FA (50 mg/kg.bw [26]; 0.25 ml) by oral gavage (once daily) against a phosphate 
buffer saline (0.1 M PBS; 0.25 ml) control group for 1- and 10-day treatment periods. Mice were sacrificed at 
the end of each treatment period by inhalation anaesthesia (Isofor; Safeline pharmaceuticals) and the whole 
brain tissue samples were harvested and divided into two hemispheres. Each hemisphere was added to 
Cytobuster ™ (Novagen, San Diego, CA, USA) and QIAzol (Qiagen, SA) reagents, respectively, and stored (-
80°C) for molecular analysis. All assays were performed in triplicate, independently.  
 
Caspase activity 
 
Briefly, fresh whole brain tissue was homogenized (~1x2 mm3 pieces) in Dulbecco’s Modified Eagle Medium 
(DMEM) containing collagenase type II (15 mg/ml) and incubated for 40 min (37℃). Thereafter, the digest was 
centrifuged (500 x g, 10 min, 4℃), and the pellet was washed in DMEM with BSA (20%) and centrifuged (1000 
x g, 20 min, 4℃) once again. The lipid layer was aspirated and the pellet was re-suspended in serum-free 
DMEM (with 0.1% BSA) for 30 min (37℃). The digest was then re-suspended by pipetting prior to 
centrifugation (500 x g, 10 min, 4℃) followed by one wash in PBS. Cell viability was assessed using trypan 
blue staining. Opaque polystyrene microtiter plates (96-well) were prepared with the cell suspension (20,000 
cells/well) and 20 µl of each respective reagent (Caspase-Glo® 3/7, Caspase-Glo® 8 and Caspase-Glo® 9 
Assays). The plate was incubated in the dark for 30 min (RT) and read on a Modulus™ microplate luminometer 
(Turner Biosystems, Sunnyvale, USA). All data was represented as relative light units (RLU). 
 
Histological assessment of brain tissue  
 
Briefly, whole brain tissue samples were dissected into hemispheres, from which one hemisphere was rinsed 
with 0.1 M PBS and drop fixed in 10% formaldehyde (RT). Tissue samples were dehydrated in a series of 
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ethanol solutions and xylene followed by infiltration with paraffin wax. Infiltrated tissues were then embedded 
and sectioned (3 µm thick sections) using a rotary microtome (microTecÒ Laborgeräte GmbH, Walldorf, 
Germany) and routinely stained with Hematoxylin and Eosin (H&E). The sectioned samples were dehydrated in 
ethanol [95% (once) and 100% (twice) at 5 min intervals each] and cleared in xylene. Sagittal tissue sections 
were captured with a Leica SCN400 slide scanner (Leica Biosystems, Berkshire, UK) and viewed using 
SlidePath Gateway ClientTM software (SlidePath Ltd, Leica Biosystems, Dublin, Ireland). 
 
Transmission electron microscopy (TEM) 
 
Tissue sections (approximately 1 mm3 of the cerebral cortex and hypothalamus) were rinsed in 0.1 M PBS and 
fixed in 2.5% glutaraldehyde (overnight, 4°C). The samples were washed 3 times in 0.1 M phosphate buffer 
(PO4, pH 7.2), post-fixed with 0.5% osmium tetroxide on rotation (overnight, RT) and washed (3 times with 0.1 
M PO4, pH 7.2) before being dehydrated through graded acetone solutions [30% acetone, 50% acetone, 75% 
acetone (twice at 5 min intervals each) and 100% acetone (twice at 10 min intervals)]. Next, the samples were 
infiltrated with a 1:1 resin and acetone solution (overnight, RT), resuspended in complete resin (overnight, RT), 
embedded in fresh resin for 5 hrs (on rotation, RT) and polymerized at 60°C (4 hrs). The resin blocks were 
trimmed with an axe saw and cut into ultrathin sections using an Ultramicrotome equipped with a glass knife. 
The sections were placed on copper grids (200 mesh) and contrasted with uranyl acetate (2%). The samples 
were viewed on a JEOL 1010 transmission electron microscope (JEOL, Peabody, MA, USA) at an operating 
voltage of 100 kV. Images were captured using a Megaview III camera and analysed using iTEM software. 
 
Protein phosphorylation array  
 
Proteomic profiles of phosphorylated CREB was detected using a commercially available Human/Mouse 
MAPK protein phosphorylation array (RayBiotech, Inc., Norcross, USA) according to the manufacturer’s 
instructions. In brief, membranes were blocked with a blocking buffer for 30 min (RT) and then incubated 
overnight (4°C) with protein fractions (1 mg/ml; diluted in blocking buffer). Samples were then aspirated and 
the membranes were washed before incubation with a biotin-conjugated detection antibody cocktail (overnight, 
4°C). The membranes were washed once again, followed by additional overnight incubation (4°C) with an 
HRP-Anti-Rabbit IgG concentrate. Thereafter, membranes were washed and incubated with the 
chemiluminescent detection buffer (2 min, RT). Images were captured on a ChemiDoc XRS+ system (Bio-Rad, 
Johannesburg, SA) and analysed with Image Lab™ software 6.0.1 (Bio-Rad, Johannesburg, SA). Relative 
protein signal intensities were normalized to positive control spots prior to comparison (i.e. control vs. FA). The 
data was expressed as relative band density (RBD). 
 
Western blotting 
 
Protein homogenates were quantified by the bicinchoninic acid (BCA) assay and standardised to 1 mg/ml. The 
samples were resolved on SDS-PAGE gels (7.5%) and transferred to nitrocellulose membranes. The membranes 
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were incubated (1 hr, RT) with 5% bovine serum albumin (BSA) followed by an overnight incubation (4°C) 
with primary antibodies (Table 1). The membranes were then washed 5 times with Tris Buffer Saline with 
tween 20 (TTBS- NaCl, KCl, Tris, dH2O, 0.5% tween 20, pH 7.5) and incubated with secondary antibodies 
[anti-rabbit or anti-mouse (1:5,000, Cell signalling)] for 2 hrs (RT). The membranes were washed once more 
before been captured on a ChemiDoc XRS+ system (Bio-Rad, Johannesburg, SA). Protein band intensities were 
analysed using Image Lab™ software 6.0.1 (Bio-Rad, Johannesburg, SA). β-actin (1:5,000, Sigma Aldrich) was 
used for comparison of uniform protein load. The data was expressed as relative band density (RBD). 
 
Table 1: Primary antibodies for immunoblot analysis 
 
Manufacturer Antibody name Host species 
Catalogue 
number 
Concentration 
Cell signalling 
Technology 
Cytochrome c Rabbit 4280S 1:1,000 
Phospho-p44/42 MAPK 
(ERK1/2) 
Mouse 9106S 1:1,000 
p44/42 MAPK (ERK1/2) Rabbit 4695S 1:1,000 
Phospho-SAPK/JNK 
(Thr183/Tyr185) 
Mouse 9255S 1:1,000 
SAPK/JNK Rabbit 9252S 1:1,000 
p38 MAPK Rabbit 14451S 1:1,000 
Phospho-CREB (Ser133) Rabbit 9191S 1:1,000 
Sigma Aldrich 
Phospho-p38 Mouse M8177 1:1,000 
BDNF Rabbit AB1543 1:500 
 
 
Quantitative PCR 
 
Total RNA was isolated from whole brain tissue with QIAzol reagent and reverse transcribed to complementary 
DNA (cDNA) using an iScriptTM cDNA Synthesis kit (Bio-Rad, Hercules, CA) according to manufacturer’s 
instructions. Quantitative detection of mRNA [cytochrome c: Sense 5’CCCATCTTTGAGCATCTTGGT3’, 
Anti-sense 5’GCCCAGCCTGAGTAGTGAAG3’; CREB: Sense 5’GTCCCAGGCTCTCTATCATCTC3’, Anti-
sense 5’ATAGGCATCAAGACGGCAGAA3’; BDNF: sense 5’AAACATCCGAGGACAAGGTG3’, Anti-
sense 5’AGAAGAGGAGGCTCCAAAGG3’] levels were detected using the iQTM SYBRÒ Green Supermix 
(Bio-Rad, Johannesburg, SA) as per manufacturers protocol and performed on the CFX96 TouchTM Real-Time 
PCR Detection System (Bio-Rad, Johannesburg, SA). Differences in gene expressions were normalized against 
the housekeeping gene GAPDH [Sense 5’ATGTGTCCGTCGTGGATCTGAC3’, Anti-sense 
5’AGACAACCTGGTCCTCAGTGTAG3’] and analysed according to the methods described by Livak, 
Schmittgen [27]. The data was represented as relative fold change (2--ΔΔCt). 
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Data analysis 
 
All data were analysed with GraphPad Prism v6.0 software (GraphPad Software Inc., La Jolla, USA) by the 
unpaired t-test with Welch’s correction to assess the differences between samples. Results were expressed as 
mean + standard deviation (SD). A p < 0.05 represented statistically significant differences. 
 
RESULTS 
 
FA induced caspase activation in neuronal tissue 
 
Several studies have reported the induction of apoptosis by FA in vitro and in plants [5,4,6]. Although acute 
activation of caspases in neuronal tissue contributes to development, prolonged activation can be detrimental 
and cause cellular degeneration. Therefore, to determine the toxicity of FA on neuronal tissue, active cleaved 
forms of caspases -8, -9 and -3/7 were measured in fresh whole brain tissue. In keeping with our previous 
findings [28], exposure to FA (1 day) significantly increased initiator (-8 and -9) and effector (-3/7) caspase 
activities whereas at 10-day exposure only caspase 8 activity was significantly increased (p < 0.0026) (Table 2). 
  
Table 2: The effect of FA (1- and 10-days) on caspase activity in mice brain tissue   
 
 
Mean + SD (RLUx104) 
Fold change p value 
Control FA 
1 day 
Caspase 8 
1.1782 + 
0.0330 
1.3400 + 
0.0995 
1.14 0.0428* 
Caspase 9 
2.2143 + 
0.0145 
3.9024 + 
0.1985 
1.76 0.0007*** 
Caspase 3/7 
0.6475 + 
0.0593 
0.7380 + 
0.3123 
1.14 0.0231* 
10 days 
Caspase 8 
0.3826 + 
0.0892 
0.6760 + 
0.0530 
1.77 0.0026 ## 
Caspase 9 
0.8004 + 
0.1941 
8.4456 + 
6.9069 
10.55 0.1952 
Caspase 3/7 
0.1954 + 
0.0489 
0.2736 + 
0.1385 
1.40 0.35009 
 
The data are represented as mean + SD (n=3). RLU: relative light units. * p < 0.05 *** p < 0.0005 (FA relative 
to control 1 day); ## p < 0.005 (FA relative to control 10 days). 
 
FA alters neuronal glial cell density  
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To determine the effect of caspase activation in neuronal tissue, sagittal sections of the cerebral cortex and 
hypothalamus were stained with H&E for the observation of histological abnormalities in brain tissue. While FA 
amplified caspase activation, neuro-histopathology of the cerebral cortex and hypothalamus appeared normal, 
with no apparent signs of histological lesions or apoptotic/necrotic features (1- and 10- days) (Fig. 1). However, 
FA-treated mice showed significant differences between glial cell density patterns when compared to control 
mice in both the cerebral cortex and hypothalamus (1- and 10- days). Reductions in glial cell (astrocytes and 
oligodendrocytes) density and enlarged neurons were observed in the cortical regions following 1-day FA 
exposure (Fig. 1a and 1b). In contrast, FA induced proliferation of glial cells in the cerebral cortex that was 
enhanced along with reduced neuron size at 10 days (Fig. 1e and 1f). Though heightened proliferation of glial 
cells is a characteristic of gliosis, no glial scars were observed. Furthermore, FA reduced hypothalamic glial 
density (1 day) (Fig. 1c and 1d) but significantly at longer exposure (10 day) (Fig. 1g and 1h), as were 
reductions in density and size of hypothalamic neurons. 
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Fig. 1: Histopathological analysis of brain tissue sections from mice treated with FA for 1- and 10-days. 
Healthy (1 day: a and c; 10 days: e and g) and FA treated (1 day: b and d; 10 days: f and h) tissue sections of 
the cerebral cortex and hypothalamus showing no tissue disruptions but visible variations in cytoarchitectural 
densities. Neurons (N) were identified by their large nuclei and cytoplasm; whilst oligodendrocytes (O) were 
distinguished by their small, condensed nuclei and unstained cytoplasm and astrocytes (A) by their large oval 
nuclei. (Objective lens: 20x; Scale bar: 100 µm) 
 
Ultrastructural analysis of the cerebral cortex and hypothalamus  
 
While a relationship between FA and altered mitochondrial bioenergetics has been established, its impact on 
mitochondrial morphology in the brain, an important component that couples cellular metabolism and 
neuropathological processes, remains unknown [29]. To further understand the association and impact of 
increased caspase activity on tissue structure, micro-analysis of the cerebral cortex and hypothalamus brain 
regions were examined using TEM. At short and longer FA exposures (1- and 10-days, respectively), electron 
micrographs exhibited normal tissue characteristics with mitochondria that appeared intact and uniform in shape 
and size in both the cerebral cortex and hypothalamus (Fig. 2).  
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Fig. 2: Transmission electron micrographs of the cerebral cortex and hypothalamus from mice treated 
with FA for 1- and 10-days. Low and high magnification micrographs of healthy [1 day: a and b (cerebral 
cortex), c and d (hypothalamus); 10 days: i and j (cerebral cortex), k and l (hypothalamus)] and FA treated 
[1 day: e and f (cerebral cortex), g and h (hypothalamus); 10 days: m and n (cerebral cortex), o and p 
(hypothalamus)] tissue sections of the cerebral cortex and hypothalamus showed no destruction of tissue 
architecture. Correspondingly, higher magnification micrographs showed unobstructed morphology and uniform 
distribution of mitochondria in healthy and FA treated tissue regions (cerebral cortex and hypothalamus). 
Mitochondrion (M), asymmetric synapse (AS), symmetric synapse (S). Scale bars were depicted as 1 µm (low 
magnification) and 0.5 µm (high magnification) 
 
FA reduced cytochrome c protein levels 
 
Cytochrome c is a well-established mitochondrial protein involved in maintaining mitochondrial membrane 
potential by participating in electron transport and ATP synthesis [30]. Cytochrome c also assists in caspase 
cleavage and execution of apoptosis [31]. Thus, as a result of increased caspase activity and unchanged 
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mitochondrial dynamics, we evaluated the expression of cytochrome c. Consistent with intact mitochondrial 
integrity, cytochrome c protein levels were reduced at both short (1 day) (p < 0.0105) and prolonged (10 days) 
(p < 0.0125) FA-exposures (Fig. 3a and 3b). Moreover, there were invariable differences in transcript 
cytochrome c expression levels (Fig. 3c) following FA administration (1- and 10 days, p < 0.8447 and p < 
0.0613, respectively); suggesting that FA did not cause mitochondrial rupture and release of cytochrome c and 
that cleavage of caspases were independent of cytochrome c.  
 
 
 
Fig. 3: Cytochrome c levels in mice brain tissue. Densiometric protein analysis (a and b) and transcript levels 
(c) of cytochrome c were measured by western blots and qPCR, respectively. Expression of β-actin was used as 
an internal control for western blots. The data are represented as mean + SD (n=3). * p < 0.05 (FA relative to 
control 1 day); # p < 0.05 (FA relative to control 10 days) 
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FA exposure alters CREB/BDNF signalling  
 
CREB activity in the brain has been implicated in several neuronal intracellular processes, including neuronal 
proliferation and differentiation, neurogenesis, survival and neuronal plasticity [15,16]. While activation of 
CREB commonly occurs in response to growth and survival stimuli, its activity can also be stimulated in 
stressful environments. CREB activity was first evaluated using a commercial phosphorylated-protein pathway 
array. In mice treated with FA, at 1-day CREB activity was amplified, as evidenced by increased S133 
phosphorylation (p < 0.0001) from the array results (Fig. 4a). In contrast, prolonged exposure to FA (10 days) 
reduced S133 phosphorylation (p < 0.0002) thus dampening CREB activity (Fig. 4a) [protein phosphorylation 
array membrane (Online resource 1: Fig. S1)]. Differences in CREB phosphorylation were validated by 
immunoblots and revealed an equivalent increase (p < 0.0170) and decrease (p < 0.7342) at short and prolonged 
FA-exposures, respectively (Fig. 4b and 4d). Similarly, CREB transcript levels were slightly up- (p < 0.3893) 
and down-regulated (p < 0.1210) at 1- and 10 days post FA-treatment, respectively (Fig. 4e). 
 
Importantly, CREB mediates its actions through transcriptional control of target genes including cytochrome c 
and BDNF (a crucial neurotrophin associated with neuronal survival and plasticity) [18]. Consistent with 
changes in CREB phosphorylation, BDNF expression was amplified by FA at 1-day exposure (p < 0.0811), and 
significantly decreased after a prolonged exposure (10 days) (p < 0.0004) (Fig. 4c and 4d). Whilst no significant 
differences in transcript levels were noted at both exposure periods (1-day, p < 0.9370 and 10 days, p < 0.4151) 
(Fig. 4e). In addition, cytochrome c transcript levels were inconsistent with CREB activity.  
 
 
 129 
 
 
Fig. 4: FA alters CREB phosphorylation in mice brain tissue. Densiometric expression of the transcription 
factor CREB was determined using a MAPK phosphorylation protein array (a) and was validated by 
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immunoblots (b and d). BDNF protein expression was determined using immunblots (c and d). Expression of 
β-actin was used as an internal control. CREB and BDNF transcript levels were quantified by qPCR (e). 
GAPDH was used as the housekeeping gene. The data is represented as mean + SD (n=3). * p < 0.05, **** p < 
0.0001 (FA relative to control 1 day); ### p < 0.0005 (FA relative to control 10 days) 
 
Short exposure to FA suppresses MAPK activation  
 
An extensive body of literature confirms the profound influence of MAPK signalling on CREB activity in 
multiple neuronal processes [24,23]. Therefore, as a result of differential CREB activation by FA, we 
investigated the activity of MAPK proteins. Mice treated with FA for 1 day revealed significant reductions in 
epitope phosphorylation’s of ERK1 (T202/Y204) (p < 0.0001), ERK2 (Y185/Y187) (p < 0.0423), JNK1(T183) 
(p < 0.0005), JNK2 (Y185) (p < 0.0001) and p38 (T180/Y182) (p < 0.0001) isoforms (1 day) (Fig. 5a and 5b). 
Whilst a prolonged exposure to FA (10 days) amplified activities of ERK1 (T202/Y204) (p < 0.0202), JNK1 
(T183) (p < 0.0035) and JNK2 (Y185) (p < 0.0002) (Fig. 5a and 5b). In contrast, prolonged exposure to FA 
suppressed ERK2 (Y185/Y187) (p < 0.0003) activity and invariably affected p38 (T180/Y182) (p < 0.1223) 
activation (Fig. 5a and 5b). Viewed together, the data demonstrates that acute administration of FA inhibited 
ERK, JNK, and p38 MAPK activities suggesting that CREB activity was regulated independent of MAPK 
signalling (1 day). Inversely, FA augmented ERK and JNK activities and decreased CREB activation at 10 days. 
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Fig. 5: Effect of FA on MAPK activity. Densiometric analysis (a) and protein expressions (b) of 
phosphorylated and total MAPK were determined by immunoblots. Expression of β-actin was used as an 
internal control. The data are represented as mean + SD (n=3). * p < 0.05, *** p < 0.0005, **** p < 0.0001 (FA 
relative to control 1 day); # p < 0.05, ## p < 0.005, ### p < 0.0005, #### p < 0.0001 (FA relative to control 10 
days) 
 
DISCUSSION  
 
Several studies over the past few decades have demonstrated the toxicity of FA through the induction of 
apoptosis and impaired mitochondrial respiration [5,4,6]. Similarly, our previous investigations have shown the 
immunotoxicity and bioenergetic deficits caused by FA in immune cells [28] and murine brain tissue 
(unpublished data), respectively. The latter is of significant importance as metabolic alterations in the central 
nervous system (CNS) have shown to influence various neuropathological processes. Therefore, the present 
study aimed at investigating the relationship between FA-metabolic neurotoxicity and its translations in CREB 
signalling. 
 
Mitochondrial dysfunction is widely believed to be a likely trigger for neuronal cell death and a contributing 
factor in the neuropathology of diseases such as Alzheimer’s-, Parkinson’s-disease and diabetes [12,32,13,14]. 
In apoptosis, rearrangements in mitochondrial ultrastructure is accompanied by elevated cytosolic cytochrome c 
levels which precedes caspase cleavage [31,33]. Notably, the variability in caspase amongst the control groups 
(at 1 and 10 days) could have been caused by several factors such as stress, nutritional status, temperature, 
acclimatisation etc. While these factors were controlled as much as possible across treatment periods (1 and 10 
days), during moderate stress caspase activity is increased in a cell death-independent manner. Therefore, mice 
groups at day 1 may have experienced more stress due to a new environment, handling and being dosed; as 
compared to the prolonged mice groups that may have acclimatised to these factors by the 10th day decreasing 
stress and caspase activity levels. 
 
Despite caspase activity being a hallmark of apoptosis, recent evidence shows that effector caspases have 
prominent non-apoptotic functions in several neuronal processes, such as synaptic plasticity, ageing and learning 
and memory [34,35]. Similar to histological observations by Li et al., [36], who showed a protective mechanism 
of FA (at 50 mg/kg and 100 mg/kg) against cardiac fibrosis and hypertrophy in C57BL/6 mice, microanalysis of 
neuronal tissue revealed no loss of tissue integrity, mitochondrial structure or signs of tissue damage and cellular 
death despite heightened caspase activity (1- and 10- days); suggesting possible non-apoptotic actions of FA-
induced caspase activity. However, the precise non-apoptotic role of caspase activation was undetermined.  
 
Accumulating evidence has demonstrated the importance of CREB activity in brain physiology and on brain-
body communication [15,16]. In particular, CREB has been shown to regulate neurotrophin-induced 
transcriptional programs including metabolism, survival and behavioural responses in the central and peripheral 
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nervous systems [15,16]. In addition, a number of studies have demonstrated the neuroprotective role of CREB-
mediated BDNF signalling against several neurotoxic agents. Notably, in this study CREB activity was 
enhanced followed by an increase in BDNF expression at acute exposure to FA (1 day). In contrast, FA 
suppressed CREB/BDNF signalling after a 10-day treatment. 
 
MAPKs, particularly ERK and p38, are the main protein kinases known to phosphorylate and activate CREB 
[15,25]. Of interest, ERK, JNK and p38 activities were down-regulated by acute exposure to FA (1 day), 
indicating that MAPK signalling was not responsible for CREB phosphorylation. However, in addition to 
MAPKs, the phosphoinositide 3-kinase (PI3K)/Akt signalling pathway, a second major serine-threonine kinase 
signalling cascade, has recently been documented as an important regulator of CREB activity [21,22]. MAPK 
and Akt pathways converge at several points including glycogen synthase kinase 3 (GSK3), ribosomal protein 
S6 kinase (p70S6K) and p53 [15,17]. Consistent with this, our previous data reported up-regulation of Akt 
signalling in response to FA exposure (1 day), which may be attributed to increased CREB phosphorylation and 
activation. A study by Yoo et al., [37] described neuroprotective signalling of serotonin-induced tropomyosin 
receptor kinase B (TrkB)/CREB/BDNF and Akt/Nrf2 (nuclear factor erythroid 2-related factor 2) pathways in 
neuronal cells. Additionally, Mahgoub and colleagues [38] reported increased CREB phosphorylation and gene 
expression by serotonin in hippocampal neurons. Multiple studies have also shown dopamine-induced 
phosphorylation of CREB in the brains of schizophrenia patients, in human airway epithelial cells and during 
substance withdrawal from neuro-stimulants in rat striatum [39,17,40]. Likewise, previous investigations have 
shown enhanced neuronal dopamine and serotonin levels by FA which may have likely been a contributing 
factor to changes in Akt/CREB/BDNF signalling at acute exposure. In addition to MAPK activity, recent studies 
have shown post-translational regulation of caspases through inhibitory phosphorylation by MAPKs [41-43]. 
Correlating with FA-modulated MAPK activity (reduced MAPK activity at 1 day; increased MAPK activity at 
10 days), caspase activities were enhanced (1 day) and suppressed (10 day) respectively, inferring that MAPKs 
may be associated with non-destructive neuronal caspase responses.  
 
Importantly, while the structural integrity of neuronal tissue remained unchanged, FA altered cerebral and 
hypothalamic glial cell densities (1- and 10-days). Glial cells, in particular astrocytes, form an integral part of 
normal neuronal functioning including metabolic control, inflammation and neurotransmission with various 
studies implicating reductions in hypothalamic astrocytes with a suppressed appetite in murine models [44]. 
Unsurprisingly, reduced hypothalamic astrocyte numbers, in response to FA, could explain behavioural changes 
(lethargy, loss of appetite and vomiting) as previously reported in animals fed FA-contaminated diets [45]. 
Additionally, studies by Li et al., [46] and Quinlan et al., [47] highlighted the importance of astrocytes in 
pathophysiological processes and have demonstrated the loss of normal astrocyte function as a primary 
contributor to neurodegenerative disorders such as Alexander’s disease, which is associated with the destruction 
of the myelin sheath. Whilst others have shown neuroprotective activity against ischaemia and 
neuroinflammation through biochemical- and structural- astrocyte modifications [48,49]. While a significant 
number of studies confirm the influence of glial-density alterations in major diseases, the precise mechanisms 
underlying altered glial cell density by FA in neuronal tissue remains unclear. 
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CONCLUSION  
 
In conclusion, this study demonstrates the differential regulation of CREB/BDNF signalling in neuronal tissue, 
independent of MAPK activation; and importantly, significant modifications of FA-induced glial cell densities 
presenting a major concern on the interplay between neuroprotective and neurotoxic effects of FA in- or as a 
risk factor for cognitive and neurodegenerative disorders upon long term exposure to FA. 
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CHAPTER FIVE 
 
5.1. Synthesis and conclusion  
 
In an ever-expanding global population, especially in developing countries on the African continent, 
with shrinking percentages of arable land and a rapidly changing climate, food security is an inevitable 
challenge. Throughout Africa, maize-based diets are an essential staple food for many, however they 
come with a significant risk of contamination with naturally occurring mycotoxins (toxins produced by 
fungi) and presents a major concern for food safety and nutrition. This not only, significantly impacts 
human and animal health but affects worldwide food trade and economic growth. Since many infected 
crops are either destroyed or are diverted into animal feeds, there is potential for the bioaccumulation 
of toxic or bio-transformed residues via meat and dairy/poultry products destined for human 
consumption. Although agricultural and manufacturing practices have improved in many areas, 
mycotoxins are formed “naturally” at both the pre- and post-harvest stages, and often survive 
manufacturing processes (into food components such as flour), making mycotoxin exposure inevitable. 
 
Despite the high incidence of mycotoxins in Africa, smallholder farms and poor communities, who 
struggle with malnutrition, and follow traditional agricultural methods are largely unaware of 
mycotoxins and their adverse health outcomes, which often leads to the trade and consumption of 
contaminated foods.  
 
Aspergillus, Penicillium, Fusarium and Alternaria are the main protagonists of mycotoxin feed 
contamination and have been associated with the development of neurological disorders, malignancies 
and birth defects amongst its other toxigenic properties. Among many genera that produce mycotoxins, 
Fusarium species are the most widespread in cereal-growing regions worldwide as they have adapted 
to moderate climates. Some of the predominant mycotoxins produced by the Fusarium genus include 
trichothecenes, deoxynivalenol, T2-toxin, zearalenone, fumonisins and FA; however, exposure to FA 
is often overlooked. First discovered as a plant pathogen, FA demonstrated pharmacological activities 
against hypertension and neurotransmitter shifts; and more recently, anti-tumorigenic activity. There is 
limited data on FA prevalence in food stuffs, however independent studies in Canada and Austria have 
reported FA concentrations greatly exceeding those of deoxynivalenol, T2-toxin and zearalenone in 
contaminated grains (Smith and Sousadias 1993; Streit et al. 2013; Swamy et al. 2002); highlighting 
the significance of FA as a risk factor to human and animal health, either individually or synergistically 
with other co-contaminating mycotoxins. 
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The important characteristics of FA is its ability to inhibit dopamine-ß-hydroxylase and compete for 
the binding of albumin with tryptophan, altering neuronal neurotransmitter and catecholamine levels, 
that play an important role in the regulation of energy balance, thermoregulation, cardiovascular tone, 
digestion, coagulation, behaviour, and stress response. These neurotransmitters and catecholamines are 
modulators of immune function, with alterations potentially resulting in impaired immune responses. 
Its relationship with the CNS influences physiological homeostasis, immune disorders and immune-
mediated neurological syndromes. Elucidation of the molecular mechanisms of toxicity ultimately aid 
in improving our understanding of its functional and behavioural effects and are important factors in 
the determination of the toxicological and pharmacological relevance of FA. 
 
In addition to modulating immune interaction with other organ systems such as the CNS, the immune 
system is primarily responsible for the host defence against foreign organisms. Consequently, impaired 
immune responses (via ingestion of contaminated food) may lead to an increased susceptibility to 
infectious diseases, reactivation of chronic infections and decreased vaccine efficacy; traits commonly 
observed in malnourished individuals. Therefore, this study aimed to evaluate the immunotoxicity of 
FA in vitro on normal human PBMCs and Thp-1 cells and the neurotoxicity of FA in vivo on C57BL/6 
mice brain tissue following acute and prolonged exposures. 
 
FA demonstrated cytotoxicity to both healthy PBMCs and Thp-1 cells, although at a significantly higher 
concentration in PBMCs. Interestingly, FA-induced cytotoxicity in PBMCs did not show patterns of 
the classical hallmarks of apoptotic or necrotic cell death pathways; and instead demonstrated a caspase-
independent form of cell death that was possibly mediated by ERK and JNK MAPKs in response to 
stress-induced stimuli (increased oxidative status and ATP reduction). Similarly, in Thp-1 cells, cellular 
ATP levels were significantly depleted, accompanied by increased oxidative levels and enhanced ERK, 
a central kinase implicated in transmitting apoptotic signals, activity. Subsequent assessment of cell 
death effector molecules in FA-treated Thp-1 cells, revealed the activation of intrinsic apoptotic 
proteases (caspases) and mitochondrial apoptotic regulator proteins (Bax and Bcl-2) responsible for 
executing intrinsic apoptosis. Although MAPK-dependency of FA immunotoxicity was not 
substantiated with the use of inhibitors, the MAPK family play a central role in the mediation of almost 
all cellular functions including survival, inflammation and differentiation, therefore alterations to 
MAPK activity by FA may not only impact immune survival but simultaneously affect immune 
responses. 
 
For decades the brain has been recognized as an important target for FA. Notably, being the most 
metabolically active organ, the brain relies heavily on ATP, most of which are generated through the 
aerobic cellular respiration of glucose. As such, the magnitude of FA’s ability to substantially reduce 
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cellular ATP levels in immune cells, has significant implications on brain function, activation and 
disease resistance. Consistent with ATP deficits in immune cells, FA depleted ATP levels in murine 
brain tissue, more significantly at a prolonged exposure. However, despite reduced energy levels, 
AMPK, an essential kinase involved in promoting glucose uptake, suppressed the expression of glucose 
receptors (GLUT-1 and -4) following acute exposure to FA. Whilst, concurrent activation of PI3K-Akt 
metabolic signalling failed to improve ATP availability (1 day). On the contrary, activation of AMPK 
and PI3K-Akt pathways and its inhibitory effect on glucose receptors were reversed at a prolonged 
exposure; promoting the expression of GLUT receptors for glucose entry, possibly in an attempt to 
increase cellular ATP levels. Although FA alters glucose-mediated entry by counter-regulatory Akt and 
AMPK signalling cascades, these observations suggest that FA depletes ATP, independent of metabolic 
signalling. 
 
FA-induced neurometabolic restrictions demonstrate profound influences on normal brain development 
and neuronal function, with particular importance in new-borns and infants. While some 
neurometabolically compromised juveniles appear healthy, others present with acute symptoms of poor 
feeding, vomiting, lethargy, seizures and respiratory distress; features commonly seen in animals 
exposed to a FA-contaminated diet. In adulthood, progressive neurometabolic dysfunction results in the 
dysfunctional mental, motor and perceptual functions with patients presenting with mental decline, 
aggressiveness and, mood and sleep disorders that manifest into behavioural and neurological 
conditions such as psychosis, dementia, Alzheimer’s and Parkinson’s disease.  
 
At a cellular level, transcriptional dysregulation, oxidative stress, mitochondrial toxicity, and synaptic 
dysfunction have all been implicated in neuronal dysfunction and cell death. While FA slightly elevated 
caspase activities at acute and prolonged exposures, no signs of neurotoxicity in brain tissue was evident 
by histological and ultrastructural tissue analysis (evaluation of tissue sections showed intact structural 
and mitochondrion ultrastructure). Recent research has been centred around the transcription factor, 
CREB, for its overlapping roles in dietary restriction, energy homeostasis and survival signalling. FA 
modulated CREB/BDNF (a CREB-associated neurotrophin linked with facilitating metabolic 
adaptation and survival) activity in a manner independent of MAPK activity (1 day: increased 
CREB/BDNF activity and decreased ERK, JNK and p38 activities; 10 days: decreased CREB/BDNF 
activity and increased ERK, JNK and p38 activities). In contrast, changes in CREB activity correlated 
with the differential regulation of Akt induced by FA at acute and prolonged exposures. 
 
Collectively, this study demonstrated low to moderate FA toxicity in healthy human peripheral immune 
cells (acute) and murine neuronal cells (acute and prolonged). This was accompanied by significant 
reductions to cellular energy levels and alterations to central signalling pathways that are essential for 
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behavioural changes (appetite, depression, dementia), normal brain and immune development, and 
immune susceptibility to infectious diseases such as human immunodeficiency virus (HIV) and 
tuberculosis (TB) that are predominant in developing countries. The consequent outcome of 
neurochemical disturbances, impaired cellular respiration and immune dysfunction induced by FA, are 
pathophysiological changes often expressed clinically as neurobehavioral and metabolic disorders. 
 
On the other hand, various studies have proven FA’s cytotoxic activity against cancer cells and viral 
infections at low concentrations (Elaasser and El Kassas 2013; Fernandez-Pol 1998; Stack Jr et al. 
2004). While Thp-1 cells represent suitable models to characterize monocytic structure and function, it 
is an immortalized acute monocytic leukaemia cell line known to effectively withstand apoptosis; and 
therefore, serves as an ideal model to identify effective oncological therapies in resistant malignant 
cells. Of note, in this study Thp-1 cells were found to be much more susceptible to FA exposure, at a 
concentration significantly less than that of PBMCs, and may potentiate FA’s pharmacological activity 
at low doses; however, keeping in mind it’s toxicity to healthy cells. 
  
Importantly, while this study demonstrated immunological exposure to FA, in vitro systems are 
unicellular models which limits our interpretations of interactions between various cell types found in 
a multicellular organism. Additionally, long term exposures in primary cells are difficult to maintain 
away from the normal environment and several cellular factors (metabolism, proteins, regulation of 
genes, etc.) may be altered. Also, adhering to ethical guidelines (the 3Rs: replacement, reduction and 
refinement), immune validation in in vivo systems are challenging as they often require large sample 
numbers. Therefore, for a holistic assessment of human health risks associated with mycotoxin exposure 
and its biological effects, several models have to be combined in order to compensate for their respective 
limitations. Notably, findings from this study provides awareness on the potential risks of exposure to FA and 
greatly enhances our understanding of FA’s effect on cellular function and biological responses. Nevertheless, 
further research on the immunotoxicity of FA in vivo and the consequences of the altered neuronal cellular 
architecture, are required to better understand the risks of FA-contaminated food consumption to human and 
animal health. In addition, different vulnerability factors such as age, nutritional status and disease 
susceptibility, and the co-occurrence of other mycotoxins (content on food and routes of exposure), need to be 
taken to account to provide more effective risk assessment studies. 
 
In conclusion, exposure to mycotoxins is a growing health concern, especially in developing countries 
where the effects of poverty and malnutrition exacerbate the adverse effects of these food-borne toxins. 
Moreover, in developed countries, where the risks of human consumption of mouldy grains are 
recognised, contaminated grains are diverted as feed to livestock, impacting on animal productivity and 
food supply, further increasing the probability of poverty and human exposure. Additionally, even when 
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mycotoxins are detected, it is difficult to associate a specific mycotoxin with a given health effect. 
However, there is adequate data from in vitro human-, in vivo animal-models and human 
epidemiological studies to conclude on the importance of mycotoxin exposure in human and animal 
health. Therefore, exposure to these toxins is a global food safety issue and needs to be addressed in 
order to improve human health in developing countries. In addition, public awareness of the possible 
health risks posed by mycotoxigenic fungi and their mycotoxins has to be developed. This coupled with 
the implementation of practical and affordable mycotoxin control methods, especially at the household 
level, is equally important and should be prioritized together with further toxicological studies on 
ubiquitous mycotoxins, such as FA and other co-occurring fungal metabolites, to identify overlapping 
and synergistic toxigenic activities. 
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Supplementary information accompanying the manuscript published by Scientific Reports 
(Chapter 2) 
 
 
 
Fusaric Acid immunotoxicity and MAPK activation in normal peripheral blood 
mononuclear cells and Thp-1 cells 
 
Shanel Dhani1, Savania Nagiah1, Dhaneshree B. Naidoo1, Anil A. Chuturgoon1* 
 
1Discipline of Medical Biochemistry, School of Laboratory of Medicine and Medical 
Sciences, College of Health Science, University of KwaZulu-Natal, South Africa 
 
  
 
 155 
Supplementary information 
 
The percentage cell viability was calculated as follows: 
 
% cell viability =     x 100 
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Supplementary tables 
 
Table S1: Cell viability of PBMCs treated with ellipticine for 24 hours. 
 
Ellipticine 
concentration (µg/ml) 
Average optical 
density (OD) + 
Standard deviation 
(SD) 
Cell viability (%) 
0 0,290 + 0,016 - 
Vehicle control 
(0,1% DMSO) 
0,309 + 0,004 100 
0,01 0,301 + 0,032 97,41 
0,025 0,315 + 0,034 102,05 
0,05 0,314 + 0,015 101,62 
0,1 0,319 + 0,003 103,13 
0,25 0,299 + 0,015 96,87 
0,6 0,322 + 0,000 104,21 
0,8 0,310 + 0,008 100,22 
 
 
Table S2: Cell viability of Thp-1 cells treated with ellipticine for 24 hours. 
 
Ellipticine 
concentration (µg/ml) 
Average optical 
density (OD) + 
Standard deviation 
(SD) 
Cell viability (%) 
0 0,258 + 0,019 - 
Vehicle control 
(0,1% DMSO) 
0,271 + 0,012 100 
0,01 0,272 + 0,024 100,62 
0,025 0,265 + 0,010 97,78 
0,05 0,269 + 0,006 99,51 
0,1 0,290 + 0,030 107,27 
0,25 0,269 + 0,011 99,26 
0,6 0,250 + 0,004 92,49 
0,8 0,274 + 0,010 101,23 
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Table S3: Cell viability of PBMCs treated with FA for 24 hours. 
 
FA concentration 
(µg/ml) 
Log [FA] 
concentration 
Average optical 
density (OD) + 
Standard deviation 
(SD) 
Cell viability (%) 
0  0,340 + 0,048 100 
30 1,477121255 0,274 + 0,014 80,41 
35 1,544068044 0,252 + 0,037 74,05 
40 1,602059991 0,250 + 0,036 73,36 
50 1,698970004 0,262 + 0,013 76,89 
10 2 0,210 + 0,003 61,80 
200 2,301029996 0,221 + 0,009 64,94 
300 2,477121255 0,218 + 0,004 63,96 
 
 
Table S4: Cell viability of Thp-1 cells treated with FA for 24 hours. 
 
FA concentration 
(µg/ml) 
Log [FA] 
concentration 
Average optical 
density (OD) 
Cell viability (%) 
0  2,492 + 0,105 100 
30 1,477121255 2,1223 + 0,117 85,19 
35 1,544068044 2,082 + 0,192 83,57 
40 1,602059991 2,099 + 0,059 84,23 
50 1,698970004 2,010 + 0,205 80,68 
10 2 1,294 + 0,165 51,93 
200 2,301029996 0,140 + 0,010 5,63 
300 2,477121255 0,120 + 0,006 4,83 
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Supplementary figures 
 
 
Figure S1: Effect of FA on necrotic cell death in PBMCs (left) and Thp-1 cells (right). 
**p<0,005. 
 
 
         
 
Figure S2: Quantification of LDH in PBMCs (left) and Thp-1 cells (right) treated with 
FA for 24 hours.   
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APPENDIX B 
 
Involvement of MAPK and Akt signalling proteins on the release of inflammatory cytokines in 
healthy human PBMCs following acute (1 day) FA exposure  
 
Kinase inhibition 
 
Following density separation of whole blood, isolated PBMCs (2×105 cells/ml) were maintained at 37 
°C with 5% CO2 in RPMI 1640 medium (supplemented with 10% FCS, 1% L-glutamine and 1% 
pencillin-streptomycin). The PBMCs were treated for 1 hr with the respective kinase inhibitors [Akt 
(LY294002; 20 µM), ERK (PD98059; 20 µM), JNK (SP600125; 20 µM), p38 (SB203580; 10 µM)] 
before incubation with FA (240.8 µg/ml) for 24 hrs. Following treatment with FA, the supernatants 
were aspirated and used for cytokine detection, whilst the cell homogenate was used for the 
luminometric detection of caspas-1 activity. 
 
Cytokine detection 
 
To evaluate the effect of FA on the inflammatory response in lymphoid cells, pro- [interleikin-6 (IL-
6), IL-1ß and tumour necrosis factor-α (TNF-α) and anti-inflammatory [interleukin-10 (IL-10)] 
cytokine levels were determined by enzyme-linked immunosorbent assay (ELISA) kits (BD 
Biosciences). Briefly, microwells (96-well plate) were coated with 100 µl/well capture antibody and 
incubated overnight at 4°C. Thereafter, the plate was washed three times with 300 µl/well wash buffer 
(1X) and blocked with 200 µl/well assay diluent (1 hr, RT). Subsequently, the plate was once more 
(three times with 300 µl/well wash buffer) before incubation with 100 µl/well of each cytokine 
standard (eight standards of the respective cytokine were prepared as per manufactures instructions) 
and sample (2 hrs, RT). Afterwards, the plate was washed five times with wash buffer (300 µl/well) 
and incubated with 100 µl/well of working detector (prepared as per manufactures instructions) for 1 
hr (RT). Following incubation, the plate was wash seven times with 300 µl/well of wash buffer and 
incubated with 100 µl/well of substrate solution for 30 min in the dark (RT). Thereafter, 50 µl/well of 
stop solution was added to each well. The optical density was measured on a spectrophotometer (Bio 
Tek uQuant) at 450nm with reference wavelength of 570nm. The obtained data was assessed using 
one-way ANOVA (Bonferroni’s multiple comparison test) with GraphPad prism v6 software. 
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Figure 1: Effect of FA on MAPK (ERK and JNK) and Akt signalling on cytokine production in 
healthy human PBMCs following a 24-hr exposure. FA decreased pro- [TNF-α (a), IL-6 (b) and 
IL-1ß (c)] and anti-inflammatory [IL-10 (d)] cytokines independent of MAPK (ERK and JNK) and 
Akt proteins when compared to healthy control PBMCs. The data are represented as mean + SD. ** p 
< 0.005, **** p < 0.0001 (FA relative to control); # p < 0.05, #### p < 0.0001 [i(MAPK/Akt) + FA 
relative to the respective i(MAPK/Akt)] 
 
Caspase-1 activity 
 
Caspase-1 is a cysteine protease that converts the inactive pro-form of IL-1β to the active 
inflammatory cytokine and hence mediates the effects of IL-1β. Additionally, caspase-1 activation 
induces pyroptosis, an immunogenic form of cell death. Therefore, caspase-1 activity was assessed by 
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the Caspase-Glo® 1 Inflammasome Assay kit (Promega, Madison, USA; as per manufactures 
instruction). Briefly, 2×104 cells/well were seeded in a 96-well opaque polystyrene microtitre plate (in 
triplicate) and incubated in the dark with 20µl of the reagent (30 min, RT). The luminescent signal 
was detected on a ModulusTM microplate luminometer (Turner Biosystems, Sunnyvale, USA). The 
obtained data was assessed using one-way ANOVA (Bonferroni’s multiple comparison test) with 
GraphPad prism v6 software were expressed as relative light units (RLU). 
 
 
Figure 2: Effect of FA on MAPK-mediated caspase-1 activity in healthy human PBMCs 
following a 24-hr exposure. FA decreased caspase-1 activity in healthy control PBMCs. However, 
caspase-1 activity was increased upon p38 inhibition, when compared to ip38 control. The data are 
represented as mean + SD. **** p < 0.0001 (FA relative to control); ## p < 0.005 [i(MAPK) + FA 
relative to the respective i(MAPK)] 
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APPENDIX C 
 
Effect of FA on the inflammatory cytokine profile in human monocytes (Thp-1) and 
macrophages  
 
Monocytes and macrophages are vital components of the innate immune system with distinct roles in 
tissue homeostasis and immunity. Monocytes are central players during inflammation and pathogen 
challenge; whereas, macrophages (monocytes differentiate into macrophages and dendritic cells) are 
important in development, tissue homeostasis, regeneration and inflammation. Because the innate 
immune response is rapid (becomes active immediately-hours), the effect of FA on monocytes and 
monocytic-differentiated macrophages were assessed at 3-, 12- and 24-hr intervals. 
 
Protocol for differentiating Thp-1 cells into macrophages 
 
Briefly, Thp-1 cells (3×106 cells/ml) were maintained in RPMI 1640 medium supplemented with 10% 
FCS, 1% L-glutamine, 1% pencillin-streptomycin, 1 mM sodium pyruvate and 0.05 mM β-
mecaptoethanol, and were differentiated into macrophages by incubation (4 days) with 200 nM 
phorbol 12-myristiate-12 acetate (PMA, Sigma-Aldrich) in 25 cm3 ventilated flasks (37 °C, 5% CO2). 
Following incubation, the PMA was aspirated and the cells were washed once with PBS to remove 
undifferentiated cells. The differentiated macrophages were incubated (24 hrs) with RPMI to reach 
M0 polarization. Thereafter, macrophage M1 polarization (pro-inflammatory macrophages) was 
obtained by incubation with lipopolysaccharide (LPS, 100 ng/ml) for 24 hrs; after which the 
macrophages were treated with FA (107.7 µg/ml) at varying time periods (3-, 12- and 24 hrs). 
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Figure 1: Effect of FA on inflammatory cytokine levels in human monocytes at 3-, 12-, and 24 
hrs. FA had little effect on the release of pro- [TNF-α (a) and IL-6 (b)] and anti-inflammatory [IL-10 
(d)] cytokines at 3- 12- and 24 hrs relative to each control. However, at 12- and 24 hrs, FA 
significantly increased IL-1ß (c) levels in Thp-1 cells. The data are represented as mean + SD. * p < 
0.05, **** p < 0.0001 (FA relative to control for the respective treatment period) 
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Figure 2: Effect of FA on inflammatory cytokine levels in human macrophages at 3-, 12-, and 24 
hrs. FA decreased TNF-α (a) levels at 24 hrs despite increases at 3- and 12 hr periods. While FA had 
no effect of IL-6 levels (b), IL-1ß (c) were significantly increased at 12 hrs. Whilst anti-inflammatory, 
IL-10 (d) levels were elevated at 3 hrs and subsequently decreased (12- and 24 hrs) in the pro-
inflammatory macrophages primed cells. The data are represented as mean + SD. * p < 0.05, ** p < 
0.005 (FA relative to control for the respective treatment period) 
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APPENDIX D 
 
Supplementary information submitted with the manuscript “Differential regulation of 
CREB/BDNF signalling by Fusaric acid in C57BL/6 mice brain tissue” (Chapter 4) 
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Fig. S1: Effect of FA exposure on the phosphorylation of CREB. Representative densiometric expression of 
p-CREBS133 (1) phosphorylation using a MAPK protein phosphorylation microarray. 
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APPENDIX E 
 
Effect of FA on Tau in mice brain tissue following acute (1 day) and prolonged (10 days) 
exposures 
 
Tau, a microtubule-associated protein, is important for microtubule stabilization, neurite outgrowth, 
and axonal transport. Microtubules are involved in the maintenance of neuronal morphology and the 
formation of axonal and dendritic processes. Tau’s affinity for microtubules is strongly affected by its 
phosphorylation status. The kinases that phosphorylate tau include GSK-3α and β, cyclin dependent 
kinase 5 (cdk5), protein kinase A (PKA), MAPK and the microtubule affinity regulating kinase 
(MARK) family. In particular, GSK3-β is a prominent tau kinase and directly phosphorylates tau at its 
serine-396 (S396) residue, inhibiting tau’s ability to stabilise microtubules and leading to the 
polymerization of tau. In addition, unbound tau may be hyperphosphorylated by other kinases- an 
early event in neurodegenerative diseases. Furthermore, several studies suggest that impaired glucose 
metabolism contributes to tau hyperphosphorylation. As a result of decreased ATP availability and 
altered metabolic signalling (Chapter 2), the protein and transcript expressions of tau were evaluated. 
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Figure 1: Tau levels in mice brain tissue. Densiometric protein analysis (a and b) and transcript 
levels (c) of Tau were measured by western blots and qPCR, respectively. While tau transcript levels 
were significantly elevated at both acute and prolonged exposures (c), post-translational 
phosphorylation at its S396 residue was decreased at 1 day and increased following prolonged FA 
treatment (a and b). The phosphorylation of tau was consistent with GSK3 activity (Chapter 2). 
Expression of β-actin was used as an internal control for western blots. The data are represented as 
mean + SD. ** p < 0.005 (FA relative to control 1 day); ## p < 0.005 (FA relative to control 10 days) 
 
Effect of FA on MAPK phosphorylated-activation sites in mice brain tissue following acute (1 
day) and prolonged (10 days) exposures 
 
To assess the effect of FA on the phosphorylation of the active sites on MAPK proteins and substrate 
targets in brain tissue, a commercial MAPK protein phosphorylation array was used as per 
manufactures instructions. 
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Figure 2: Effect of FA exposure on the phosphorylation of MAPK signalling proteins. 
Representative densiometric expression of MAPK phosphorylated proteins using a MAPK protein 
phosphorylation microarray for p-CREBS133 (1), p-ERK1T202/Y204/p-ERK2Y185/Y187 (2), p-JNKT183 (3), 
p-MEKS217/221 (4), p-MKK3S189 (5), p-MKK6S207 (6), p-MSK2S360 (7), p-p38T180/Y182 (8), p-RSK1S380 
(9) and p-RSK2S386 (10) 
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Figure 3: Effect of FA exposure on phosphorylation MAPK signalling proteins in mice brain 
tissue. Densitometric protein measurements of phosphorylated MAPK signalling proteins were 
determined using a MAPK phosphorylation protein array for MAPKKs and MAPK expressions. The 
data are represented as mean + SD. * p < 0.05, ** p < 0.005, *** p < 0.0005, **** p < 0.0001 (FA 
relative to control 1 day); ## p < 0.005, ### p < 0.0005 (FA relative to control 10 days) 
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Figure 4: Effect of FA on the phosphorylation of MAPK substrates in mice brain tissue. 
Densitometric protein quantification of RSK1, RSK2 and MSK2 were analysed using a MAPK 
protein phosphorylation array. The data are represented as mean + SD. *** p < 0.0005 **** p < 
0.0001 (FA relative to control 1 day); # p < 0.05, ### p < 0.0005 (FA relative to control 10 days) 
 
 
Effect of FA on miR-132 in mice brain tissue following acute (1 day) and prolonged (10 days) 
exposures 
 
MicroRNA (miR)-132 is an endogenous small RNA responsible for the post-transcriptional regulation 
of gene expression via controlled degradation of mRNA or transcription inhibition. In the nervous 
system, miR-132 is significant for regulating neuronal differentiation, maturation and functioning, and 
widely participates in axon growth, neural migration, and plasticity. It has been shown that the 
expression of miR-132 is induced by BDNF in an ERK1/2-MSK1/2-CREB-dependent manner in 
neurons and may represent a mechanism of fine-tuning protein expressions for neuronal function and 
survival. Therefore, the expression of miR-132 was assessed. 
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Figure 5: Effect of FA on miR-132 expression in mice brain tissue. Despite elevated CREB and 
BDNF levels at 1 day (Chapter 3), miR-132 expression was only slightly elevated in brain tissue. On 
the contrary, miR-132 expression was significantly elevated impartial of the decreased CREB and 
BDNF expressions (Chapter 3) at a prolonged exposure to FA. The data are represented as mean + 
SD. ## p < 0.005 (FA relative to control 10 days) 
 
Effect of FA on c-myc expression in mice brain tissue following acute (1 day) and prolonged (10 
days) exposures 
 
c-Myc is an important oncoprotein that has been extensively studied for its role in proliferation and 
growth of normal and neoplastic cells. In addition, c-myc cooperates with additional transcriptional 
factors (such as p53 and CREB) at target promoters to regulate gene expression. In the brain, c-myc is 
essential for normal brain development. More recently, inhibition of c-myc was shown to be 
neuroprotective whereby elevated c-myc levels rendered neurons vulnerable to cell death. Therefore, 
transcript levels of c-myc were quantified.  
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Figure 6: Effect of FA on c-myc transcript levels in mice brain tissue. In keeping with the lack of 
tissue degeneration observed in Chapter 3, transcript levels of c-myc were significantly reduced at 
both acute and prolonged exposures to FA. The data are represented as mean + SD. * p < 0.05 (FA 
relative to control 1 day); #### p < 0.0001 (FA relative to control 10 days) 
 
 
 
 
 
 
 
